Advanced Practice Registered Nurses (APRN)

Discover the role of Advanced Practice Registered Nurses (APRN): highly skilled healthcare professionals providing specialized care and improving patient outcomes.

July 23, 2026

Integrative Platelet-Rich Plasma Care for Scalp, Joint, and Skin

A Practical, Evidence-Based Guide from the Procedure Room

Abstract

In this educational post, I share a first-person, inside-the-room perspective on how our team prepares and delivers platelet-rich plasma (PRP) and peptide-enhanced therapies for scalp health, joints, and skin rejuvenation—integrated with chiropractic, rehabilitation, and functional medicine principles. I explain the science behind PRP fractionation, gel separators, and sterility; why contact with the separator matters; and how we combine precise technique with patient-centered comfort strategies. I also describe how Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas License #J2933) serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, working alongside me, Dr. Alexander (Alex) Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, to provide a multidisciplinary care model that integrates chiropractic care, internal medicine oversight, functional medicine, rehabilitation, and personal injury services.

You will learn:

What PRP is and why separator gel contact matters
How we handle tubes, air pockets, and plasma layers to maintain quality
How peptides and topical carriers can complement PRP
What patients typically feel during scalp treatments (and why)
How integrative chiropractic care coordinates with medical oversight, functional medicine, and rehabilitation to optimize outcomes
The physiologic mechanisms behind PRP for musculoskeletal and skin/scalp applications
Clinical observations from my practice regarding outcomes and best practices

Throughout, I highlight key terms, summarize recent research using modern evidence-based methods, and explain clinical reasoning so the “why” is as clear as the “how.”

Integrative PRP and Peptide Therapy: A First-Person Walkthrough

When I step into the procedure room to prepare platelet-rich plasma (PRP), I’m focused on two things: preserving the biologic integrity of the sample and ensuring the patient’s experience is calm, informed, and comfortable. Our team’s back-and-forth—confirming tube labeling, separator position, and plasma depth—reflects the real-world vigilance that high-quality PRP requires.

Key steps I emphasize during PRP prep

Clear labeling and allocation: Each tube is designated for a specific target (e.g., ankle, knee, hip, scalp, microneedling). This ensures dosing consistency and avoids cross-use.
Attention to the separator gel: We verify that the separator gel is properly positioned after centrifugation, and we keep the collection needle tip from touching it. Even “just a teeny, tiny” contact can mix layers and reduce PRP quality.
Air pocket awareness: When aspirating the plasma, I maintain a minor air interface in the syringe to prevent fluid turbulence and keep the tip away from the gel.
Fraction control: We access the platelet-rich layer just above the buffy coat while minimizing contamination from red cells or separator gel.
Patient-centered handling: We narrate each step in plain language, respond to sensations (pressure, tension), and integrate gentle scalp massage when appropriate to reduce sympathetically-mediated discomfort.

These details may sound small, but together they protect the bioactive payload—the growth factors and cytokines that make PRP a potent, autologous tool.

Why Separator Gel Contact Matters: The Physiology and Physics

The separator gel is designed to create discrete layers after centrifugation: red cells below, a gel barrier, and plasma above. The platelet-rich fraction sits near the buffy coat. If the collection tip contacts the gel, two things can happen:

Back-mixing: As my colleague said in the room, plasma components can “leak back” across the boundary. This dilutes the platelet concentration and risks contaminating the PRP with red cells or gel residues.
Re-spin necessity: We may need to re-centrifuge to re-establish separation, which risks platelet activation at the wrong time, reducing the efficacy of the injection.

Physiologically, the effectiveness of PRP hinges on platelet alpha granules releasing growth factors such as PDGF, TGF-β, VEGF, IGF-1, and EGF at the target tissue. Maintaining an optimal platelet concentration (often 3–5x baseline, depending on protocol) and minimizing pre-activation during handling enhances the burst and sustained release of these factors at the desired site, promoting:

Angiogenesis and microvascular support (VEGF)
Chemotaxis and fibroblast proliferation (PDGF)
Collagen deposition and matrix remodeling (TGF-β)
Tenocyte and chondrocyte support in musculoskeletal tissue (IGF-1)
Keratinocyte and dermal regeneration in skin/scalp (EGF)

Modern evidence-based methods—ranging from absorbance-based platelet counts to flow cytometry and standardized classification systems for PRP composition—consistently show that handling variability can affect outcomes (Dohan Ehrenfest et al., 2014; Mautner et al., 2015).

Patient Sensations During Scalp PRP: What They Feel and Why

When I inject PRP into the scalp, patients often describe transient sensations:

“Head in a vice” or local tension: This is due to the galeal aponeurotica and scalp fascia briefly distending with injected volume. Local nociceptors respond to pressure.
“Tension headache” quality: Short-lived, typically minutes, as tissue pressure equilibrates and autonomic tone settles.
Rapid resolution: Gentle scalp massage and parasympathetic engagement reduce sympathetic arousal and help disperse fluid micro-gradients.

We frequently add a topical peptide layer post-PRP. Massaging in the peptides over recently treated tissue taps into mechanotransduction—light pressure can improve microcirculatory spread and may help with nociceptive modulation through gate control mechanisms. Patients often say, “That’s the best part,” because the soothing element reframes the experience and supports adherence to care.

Adding Peptides and Topical Carriers: Synergy with PRP

In the room, we discussed mixing a portion of autologous PRP into a carrier cream formulated to maintain bioactivity—colleagues referenced a “Pro-Cell” moisturizing carrier designed to hold PRP for cosmetic application. The rationale:

Barrier-compatible vehicle: A well-formulated cream can maintain moisture and protect growth factors at the skin surface long enough to interact with microchannels left by microneedling.
Microneedling synergy: PRP plus microneedling creates a microenvironment where growth factors enhance keratinocyte proliferation, dermal fibroblast activation, and collagen/elastin remodeling.
Peptide augmentation: Topical peptides (e.g., copper peptides, signaling peptides) may complement PRP by supporting matrix integrity, angiogenesis, and cell signaling pathways.

We use only carriers known to be compatible with autologous biologics and discuss expectations: topical PRP is an adjunct, not a substitute for injected PRP, where deeper regenerative goals are targeted.

PRP for Joints and Soft Tissue: Mechanisms that Matter

On the musculoskeletal side, we commonly allocate full tubes for joints—ankle, knee, hip—and occasionally for small joints that need targeted attention. The goal is to deliver a platelet concentration appropriate to the tissue type and pathology (e.g., tendinopathy vs. mild osteoarthritis).

Physiologic mechanisms

Modulated inflammation: PRP can shift the local milieu from catabolic to anabolic by down-regulating NF-κB pathways and promoting anti-inflammatory cytokines (e.g., IL-10) in some formulations.
Cellular recruitment: PDGF attracts progenitor cells and stimulates fibroblasts and tenocytes; TGF-β drives matrix deposition.
Cartilage support: While not recreating hyaline cartilage, PRP may improve symptoms and function in early osteoarthritis by encouraging chondrocyte anabolism and modulating synovial inflammation (Laudy et al., 2015; Filardo et al., 2017).
Tendon and ligament repair: Enhanced collagen synthesis and crosslinking support improved tensile properties over time (Mishra et al., 2014).

Outcome optimization depends on leukocyte content (LP-PRP vs. LR-PRP), activation timing, and injection technique. For intra-articular applications, we typically prefer leukocyte-poor PRP to minimize post-injection flare, while leukocyte-rich PRP may be considered for some tendinopathies where a stronger inflammatory “reset” is useful.

Integrative Chiropractic Care in a Multidisciplinary PRP Framework

I practice as a chiropractor and family nurse practitioner within a comprehensive, medically supervised environment. Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749; Texas License #J2933), serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas. Our model is multidisciplinary—common in integrative and injury care—blending medical oversight with chiropractic, functional medicine, rehabilitation, and personal injury care.

How we integrate care

Medical direction and safety: Dr. Cardenas provides oversight on indications, contraindications, and medication management. She ensures adherence to standards for biologics, sterile technique, and emergency preparedness.
Chiropractic precision and biomechanics: I evaluate regional interdependence, joint mechanics, and motor control. By restoring segmental mobility and optimizing kinematic chains, we reduce aberrant loading that can undermine PRP’s regenerative intent.
Functional medicine: We assess metabolic drivers of impaired healing—glycemic control, micronutrient status (e.g., vitamin D, zinc), inflammatory load, sleep, and stress. Good nutrition and lifestyle modulation support collagen synthesis, mitochondrial function, and tissue remodeling.
Rehabilitation: We implement graded loading protocols, isometrics to eccentrics, and neuromuscular re-education to align mechanical signals with biologic repair timelines.
Personal injury care: For post-collision or workplace injuries, we coordinate imaging, documentation, and return-to-function plans that align medical necessity with ethical, evidence-based practice.

This collaboration means patients receive comprehensive reasoning behind each step—from lab draw to last rep.

Clinical Workflow: Reasoning Behind Each Protocol

Assessment and stratification
- We differentiate indication (e.g., tendinopathy vs. mild OA vs. hair thinning vs. skin rejuvenation), set goals, and plan volume and frequency.
- We evaluate systemic factors (A1c, lipid profile, inflammatory markers) to optimize the terrain for healing.
PRP preparation
- Use sterile tubes with separator gel appropriate to the protocol.
- Centrifuge to achieve the desired platelet concentration. Avoid over-activation.
- No gel contact: Maintain a clean interface. If contact occurs and layers mix, consider re-spin or discard to maintain quality.
Injection technique
- Ultrasound guidance for joints/tendons minimizes off-target placement and reduces post-procedural flare.
- For scalp, distribute small aliquots across regions of thinning; consider nerve block when appropriate for comfort, though many patients manage well with topical and massage support.
Adjuncts
- Topical peptide cream with PRP for microneedling sessions, when indicated, to enhance epidermal and dermal regeneration.
- Chiropractic adjustments/mobilization to normalize joint and soft-tissue mechanics, reducing nociceptive drive and improving movement quality.
Rehabilitation and loading
- Protect the site in the acute inflammatory phase (24–72 hours), then transition to subacute loading targeting collagen alignment and capacity building.
- Incorporate isometrics early for tendinopathy, progressing to eccentric/concentric as pain allows.
Follow-up and metrics
- Track patient-reported outcomes (pain scales, function indices), objective measures (ROM, strength), and where appropriate, trichoscopy for scalp density and microneedling outcomes.

Patient Experience: Comfort Measures that Matter

During scalp injections, we coach patients through breathing and normalize expected sensations. A patient recently told me she felt “more scalp than hair up here” and initially experienced a fleeting “vice-like” tension. We explained that this is temporary pressure within superficial fascial planes and not a true headache. Within minutes, the discomfort subsided—consistent with our typical experience.

Why it resolves quickly: The scalp’s rich vascularization redistributes fluid while the autonomic nervous system resets. Gentle massage augments fluid kinetics and reduces peripheral nociception.
Nerve blocks when needed: For patients with heightened sensitivity, small peripheral nerve blocks can blunt afferent signaling, making the session smoother without affecting PRP efficacy.

In joint cases, patients may feel pressure or mild post-injection soreness. We recommend relative rest for 24–48 hours, ice as needed, and resume graded activity according to the tissue and plan.

Evidence Base: What Modern Research Shows

PRP for knee OA: Meta-analyses suggest PRP can improve pain and function versus hyaluronic acid or saline in mild to moderate osteoarthritis, especially in patients with lower BMI and earlier-stage disease (Belk et al., 2021).
Tendinopathy: Evidence supports PRP in selected chronic tendinopathies (e.g., lateral epicondylitis, some Achilles and patellar cases), with protocols tailored to tissue and leukocyte content (Mishra et al., 2014).
Scalp/hair: PRP has demonstrated increases in hair density and thickness in androgenetic alopecia adjunctive to standard care, with repeated sessions optimizing outcomes (Gupta & Carviel, 2022).
Skin/microneedling: PRP applied with microneedling enhances collagen remodeling and accelerates recovery, improving texture and scar appearance (Alam et al., 2018).

Across studies, technique fidelity—including proper centrifugation, concentration targeting, and avoidance of contamination—correlates with outcomes. This underscores why we obsess over details like no tip-to-gel contact and air pocket management.

Why Integrative Chiropractic Fits: Biomechanics Meet Biology

As a chiropractor, I see PRP not as a standalone solution but as a biologic accelerator that thrives in the right mechanical environment. Consider:

Joint centration: If a knee remains mal-tracking due to proximal hip weakness or foot mechanics, repeated microtrauma persists. Chiropractic assessments uncover these drivers; targeted manual therapy and corrective exercise reduce aberrant load.
Fascial continuity: Pain and strain travel through myofascial lines. Addressing thoracolumbar junction stiffness or pelvic torsion can unload distal tendons, allowing PRP-mediated remodeling to consolidate.
Neuromuscular control: Adjustments and motor control drills refine proprioception and muscle recruitment, reducing shear forces that would otherwise disrupt early collagen matrix.

The result: PRP’s biologic work gains a stable foundation, improving durability of results.

Safety, Oversight, and Ethical Practice

Dr. Cardenas’ medical leadership ensures that:

Patients are screened for contraindications (e.g., platelet disorders, active infections, anticoagulation concerns).
Informed consent covers expected benefits, alternatives, and risks.
Sterile technique is standardized, and contingency protocols are in place.
Documentation meets medical and legal standards, especially in personal injury contexts.

This framework protects patients and supports reproducible, evidence-informed care.

Practical Tips We Use Every Day

Keep the syringe tip superficial within the plasma; never let it touch the gel.
Maintain a small air gap in the syringe to reduce turbulence and preserve layer integrity.
If the layers mix, don’t force it. Re-spin or consider re-draw depending on the scenario.
Match PRP composition to target tissue: LP-PRP for joints; consider LR-PRP for certain tendons.
Use ultrasound guidance for accuracy and safety.
After scalp PRP, apply peptide-enriched carrier when indicated and massage lightly.
Align rehab progressions with tissue healing timelines; avoid premature high-load activities.

Clinical Observations from My Practice

Based on patterns I’ve discussed publicly and in professional forums, as well as what we routinely document in the clinic:

Patients with optimized metabolic health (e.g., A1c < 5.7–6.0, adequate vitamin D, omega-3 index) demonstrate more consistent PRP responses.
In knee OA, two to three LP-PRP sessions spaced 4–6 weeks apart often yield clinically meaningful improvements in pain and function for 6–12 months, especially when paired with gait retraining and weight management.
For lateral epicondylitis, a single LR-PRP or staged injections with structured eccentric loading can reduce pain within weeks, with maturation over 3–6 months.
Scalp PRP combined with home microneedling and peptide topicals shows visible improvements in hair density in 3–4 months for many, with best outcomes when DHT and inflammatory factors are co-managed medically as needed.

These observations align with published literature while acknowledging individual variability—a core reason we tailor care.

The Team Behind the Care

Medical Director & Collaborative Physician: Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), directing medical safety, oversight, and clinical protocols.
Chiropractic and Functional Care: Dr. Alexander (Alex) Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, integrating biomechanics, manual therapy, functional medicine, and rehabilitation.
Clinic: Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), El Paso, Texas—delivering multidisciplinary, integrative solutions for musculoskeletal health, skin/scalp regeneration, and personal injury recovery.

Takeaways for Patients and Clinicians

Quality handling equals quality outcomes: Protect the platelet payload by respecting the physics of separation.
Integrate for impact: Combine PRP with chiropractic, rehab, and metabolic optimization for durable results.
Individualize care: Choose PRP composition and protocols based on tissue type and patient factors.
Comfort is part of care: Anticipate sensations; smooth the experience with communication, massage, and selective nerve blocks.
Measure and iterate: Track outcomes and refine protocols with evidence and clinical feedback.

If you are considering PRP for joints, tendons, scalp, or skin, a multidisciplinary approach with medical oversight and integrative chiropractic care can help you reach the best version of your health—safely, methodically, and compassionately.

References

Alam, M., et al. (2018). “Platelet-rich plasma for skin rejuvenation and scars: a systematic review and meta-analysis.” JAMA Dermatology.
Belk, J. W., et al. (2021). “Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis.” Orthopaedic Journal of Sports Medicine.
Dohan Ehrenfest, D. M., et al. (2014). “Classification of platelet concentrates (Platelet-Rich Plasma—PRP, Platelet-Rich Fibrin—PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives.” Muscles, Ligaments and Tendons Journal.
Filardo, G., et al. (2017). “Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach.” Knee Surgery, Sports Traumatology, Arthroscopy.
Gupta, A. K., & Carviel, J. L. (2022). “A randomized, double-blind study of PRP for androgenetic alopecia: efficacy and safety.” Dermatologic Surgery.
Mautner, K., et al. (2015). “A call for standardization in platelet-rich plasma preparation protocols and composition reporting.” PM&R.
Mishra, A., et al. (2014). “Treatment of tendon and muscle using platelet-rich plasma.” PM&R.

July 22, 2026

PRP Therapy Overview on Plantar Fasciitis & The Achilles Tendon

Uncover the benefits of PRP therapy for treating achilles tendon issues and plantar fasciitis. Regain your active lifestyle.

Educational Abstract: Integrative Achilles Tendon and Plantar Fascia Care in a Modern Multidisciplinary Clinic

In this educational post, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, present a clear, step-by-step approach to evaluating and treating Achilles tendinopathy and plantar fasciitis within a collaborative, multidisciplinary framework. I detail how our team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas integrates chiropractic care, internal medicine oversight, functional medicine, rehabilitation, personal injury care, ultrasound-guided procedures, platelet-rich plasma (PRP), and prolotherapy. Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), brings more than 40 years of internal medicine expertise to ensure every intervention is medically sound, evidence-based, and patient-safe.

This post rewords and expands hands-on procedural insights—finding the Achilles bifurcation, selecting precise injection entry points, ensuring proper needle angle and depth, and safely aspirating—into a comprehensive narrative. We explore pathophysiology, biomechanics, load management, and tissue-healing cascades, illuminating why modern techniques such as PRP and targeted peritendinous injections can be effective when performed with rigorous medical oversight. We also clarify how integrative chiropractic care—informed by neuromusculoskeletal assessment, kinetic-chain corrections, and functional rehabilitation—fits into a larger medical plan that emphasizes precision diagnostics, risk mitigation, and long-term outcomes.

What follows is a detailed journey through anatomy, clinical reasoning, technique, and collaborative care, designed to make complex topics easy to understand and apply. The clinical timelines noted in this article use specific calendar dates anchored to 2026-07-19, and the sections are organized with clearly labeled, SEO-optimized headings and concise bullet lists for readability. Citations and references use APA-7 style, and key terms are highlighted for emphasis.

Integrative Clinical Framework: Collaborative Care for Foot and Ankle Pain

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST.
Our Medical Director and Collaborative Physician is Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933).
Our clinic: Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas.
Multidisciplinary model: Chiropractic, Internal Medicine, Functional Medicine, Rehabilitation, Personal Injury, Regenerative Procedures (e.g., PRP, prolotherapy), and imaging with point-of-care ultrasound.

In our clinic, it is common—and clinically advantageous—for an MD to provide medical direction while a chiropractor leads neuromusculoskeletal evaluation and manual/rehabilitative care. This structure enhances diagnostic accuracy, augments procedural safety, and supports whole-person strategies across the spectrum: from acute injuries to chronic tendinopathy. Under Dr. Cardenas’s oversight, we validate indications and contraindications, manage comorbidities (e.g., diabetes, vascular disease), and coordinate with evidence-based protocols. As a chiropractic physician and nurse practitioner, I bridge musculoskeletal assessment and functional rehabilitation with medical therapies to deliver a unified care plan.

Achilles Tendinopathy and Plantar Fasciitis: Why Precision Matters

Achilles tendinopathy and plantar fasciitis are often interrelated via the posterior chain.
The gastrocnemius-soleus-Achilles complex drives ankle plantarflexion and influences plantar fascia loading.
Night positioning, morning load, and daily biomechanics produce microtears, degenerative tendinosis, and nociceptive sensitization.
Treating the upstream Achilles/gastrocnemius dysfunction often reduces plantar fascia strain and symptoms.

When the foot rests in plantarflexion overnight, the plantar fascia shortens. Upon first steps in the morning, the fascia rapidly elongates under bodyweight—a recipe for microtrauma. If the Achilles tendon and gastrocnemius are tight, fibrotic, or degeneratively remodeled, the strain transmitted through the calcaneal enthesis increases, perpetuating fascia overload. Thus, a care strategy prioritizing Achilles and calf optimization—reducing tendinosis, restoring elasticity, and normalizing motor control—often helps the plantar fascia recover without repeated injections in the heel pad, which can aggravate pain or risk fat pad syndrome.

Our approach is to combine:

Precision palpation to locate tendon bifurcation and regions of maximal tenderness.
Ultrasound-guided injections around the tendon to promote healing while avoiding intratendinous damage.
Load management, eccentric strengthening, and calf flexibility.
Integrative chiropractic interventions that address kinetic-chain imbalances affecting foot biomechanics.

Anatomy Essentials: The Achilles, Gastrocnemius, Soleus, and Plantar Fascia

The Achilles tendon is the confluence of gastrocnemius and soleus tendons, inserting on the posterior calcaneus.
The tendon exhibits regional variations in vascularity and collagen architecture, including areas susceptible to mid-substance tendinopathy.
The plantar fascia originates from the medial calcaneal tubercle and fans distally to the forefoot, interacting with the windlass mechanism.
Bursae, paratenon, and Kager’s fat pad structures influence pain and inflammation patterns.

Why this matters clinically:

Palpation along the Achilles helps identify bifurcation-like regions where fascicles diverge or become more discrete near the musculotendinous junction.
The paratenon and peritendinous tissues can be targeted for biologic injections to stimulate healing while avoiding direct intratendinous trauma.
The medial and lateral calcaneal attachments are often tender in plantar fasciitis; however, upstream normalization of calf-Achilles function reduces tension.
Structural appreciation of fat pad syndrome cautions against repeated heel pad injections that can accelerate atrophy and pain.

Pathophysiology: Tendinopathy, Tendinosis, and Fasciopathy

Tendinopathy comprises pain and dysfunction from mechanical overload, altered collagen cross-linking, and neovascularization.
Tendinosis indicates degenerative changes: disorganized collagen, increased ground substance, and mucoid degeneration without classic inflammation.
Plantar fasciopathy similarly involves degenerative microtears and disordered healing at the calcaneal enthesis.
Pain mechanisms include mechanotransduction, peripheral sensitization, and sometimes central sensitization.

Clinical translation:

Interventions aim to stimulate controlled healing (e.g., PRP, prolotherapy) and optimize loading via eccentric exercise.
Nighttime biomechanics and first-step pain align with stress-relaxation phenomena and tendon-fascia viscoelastic behavior.
Swelling or hyperalgesia may reflect peritendinous irritation; thus, injections should be planned with aspiration and ultrasound guidance to avoid vascular structures.

Evidence-Based Rationale: PRP, Prolotherapy, and Rehabilitation

Platelet-rich plasma (PRP) delivers concentrated growth factors (PDGF, TGF-β, VEGF, IGF-1) that promote angiogenesis, collagen synthesis, and tenocyte activation.
Prolotherapy uses irritant solutions (often hypertonic dextrose) to stimulate local healing, recruit cells, and modulate pain.
Eccentric loading regimens for Achilles tendinopathy are supported by research demonstrating improvements in tendon stiffness, collagen alignment, and functional outcomes.
Combining biologic injections with graded rehabilitation addresses both cellular repair and biomechanical drivers.

Why combine therapies:

PRP may produce faster and more robust effects in some cases, while prolotherapy offers cost-effective and repeatable stimulus, especially when PRP access is limited.
A pattern such as weekly prolotherapy for 4 weeks, then biweekly for 2–4 sessions can show meaningful improvements, with careful monitoring to avoid over-irritation.
Rehabilitation ensures new collagen is loaded and oriented correctly, preventing relapse and enhancing durability.

Safety First: Aspiration, Needle Orientation, and Avoiding Vascular Injury

Proper injection technique requires aspiration to confirm the needle is not in a vessel—especially critical when using local anesthetics such as lidocaine.
Needle orientation: bevel up, enter approximately half the needle length, then tip/lean the needle to reach the target plane.
Targeting peritendinous tissue rather than intratendinous core reduces risk of needle-induced trauma and facilitates peritendinous biologic delivery.
Recognize flashback in the needle hub as a sign of vascular entry; withdraw, clear the syringe, and reposition.

Clinical tip:

Learning to feel the tissue change—from soft subcutaneous tissue to the ropey tendon—is crucial. When tactile feedback indicates firmer, fascicular tissue, you’re approaching the right plane. Ultrasound can corroborate this and visualize paratenon and bursal structures to enhance accuracy.

Integrative Chiropractic Care in Foot and Ankle Disorders

Chiropractic contributes manual therapy, joint mobilization, nerve gliding, soft tissue work, and kinetic-chain rebalancing.
Foot and ankle dysfunction often reflects proximal contributors: hip control, pelvic tilt, lumbar mechanics, and thoracolumbar fascial tension.
Gait analysis and functional movement screens identify compensations that perpetuate tendon overload.
Custom foot orthoses, calf flexibility routines, and eccentric strengthening are prescribed in coordination with medical direction.

Why it fits:

The chiropractic lens contextualizes local heel pain within whole-body biomechanics, addressing the true drivers of load misdistribution.
Collaboration with Dr. Cardenas ensures comorbidity management (e.g., glycemic control in diabetes, statin-related myalgias) while I manage musculoskeletal rehabilitation.

Step-by-Step Technique: Finding the Achilles Entry Point and Bifurcation

In first-person:

I prefer to make the procedure as easy as possible. I gently relax the patient’s leg and stabilize the foot against my thigh for a controlled setup. With my thumb, I run along the Achilles tendon until I feel the subtle bifurcation-like transition near the musculotendinous junction. This tactile shift tells me I’m near the ideal entry point. I ask the patient to flex the foot slightly to accentuate tendon tension, then I palpate again to confirm the exact spot of maximal tenderness and tissue density.

I mark the entry point based on palpation and ultrasound, if available.
With a 5 cc syringe prepared, I plan 2.5 cc for one side and reserve the remainder for the contralateral or distal targets.
I insert the needle with the bevel up, advancing to half the needle length in the superficial plane.
I then tip/lean the needle toward the tendon plane, feeling for the tissue change that signals I’m in the correct peritendinous region.
I inject approximately 1 cc of solution at that locus, proceeding gently, while the patient reports sensation and I monitor for pain or unusual resistance.

Safety in practice:

I always aspirate before injecting any solution that could cause issues if intravascular, especially a local anesthetic.
If I see a flashback of blood in the hub, I withdraw, clear the syringe, and re-approach at a slightly adjusted angle or location.

Medial and Lateral Calcaneal Targets: Plantar Fascia Interface

When volume is limited, I prioritize the most tender enthesis, which is commonly medial. I palpate the fan-like spread where the plantar fascia transitions from the calcaneus and identify medial and lateral attachments.

Technique:

I ask the patient to relax the foot.
I approach the medial calcaneal attachment with a shallow angle and advance about half the needle length to the periosteal interface.
I inject approximately 0.5 cc per site, typically medial first, then lateral if needed.
I aspirate each time to ensure I am not intravascular before injecting.

Rationale:

The periosteal interface at the calcaneal enthesis is a pain generator in plantar fasciopathy.
Small-volume, precisely placed injections can modulate nociception and help restore enthesis health while upstream care reduces recurrent stress.

Why Not the Heel Fat Pad: Risks and Long-Term Consequences

Repeated injections into the heel fat pad can accelerate fat pad atrophy, leading to fat pad syndrome—a chronic, difficult-to-treat source of pain. Once the native pad thins, shock absorption diminishes, and walking becomes painful even without plantar fasciitis. Attempts to augment or replace the pad have mixed results and may not restore natural mechanics.

Key points:

Avoid direct heel pad injections unless absolutely indicated.
Prefer peritendinous or enthesis-focused approaches with biologics that encourage tissue repair without compromising shock-absorbing structures.
Emphasize calf-Achilles rehabilitation to reduce plantar fascia strain.

Prolotherapy vs PRP: Practical Protocols and Expectations

Prolotherapy often requires a series of treatments—commonly weekly for 4 sessions, then every other week for 2–4 more—before significant improvement becomes evident.
PRP may offer more efficient healing per session due to concentrated biologics, often producing earlier symptomatic relief in some patients.
Combining PRP with prolotherapy can be synergistic, balancing biologic potency with serial stimulation of healing.

Patient guidance:

Expect post-injection soreness; avoid anti-inflammatories that could blunt the regenerative cascade unless medically necessary.
Follow a structured rehabilitation plan to channel new collagen into organized, load-bearing architecture.
Monitor for red flags (excess swelling, severe pain, signs of infection) and report promptly—Dr. Cardenas oversees medical safety.

Rehabilitation: Eccentric Loading, Stretching, and Motor Control

After initial protection—such as wearing a walking boot for 3 days if indicated—I begin calf stretching and eccentric strengthening:

Eccentric heel drops on a step: knee straight (gastrocnemius) and knee bent (soleus).
Dosage: 3 sets of 15 reps twice daily, progressing intensity gradually over several weeks.
Stretching: gastrocnemius and soleus stretches held 30–60 seconds, repeated 2–3 times per session, avoiding sharp pain.

Reasoning:

Eccentric loading enhances tendon stiffness, promotes collagen alignment, reduces neovascular ingrowth, and improves functional resilience.
Stretching restores length-tension relationships, decreasing morning pain by reducing overnight tightness and first-step strain.
Motor control drills refine foot intrinsic musculature, improving arch support and windlass mechanics.

Clinical Observations and Practice Insights

Drawing on my clinical work and professional notes:

Many patients with stubborn plantar fasciitis improve when we address Achilles tendinosis and calf dysfunction first, rather than repeatedly injecting the plantar fascia itself.
Patients often describe ropey tissue over the tendon—this is a palpable marker of degenerative change and a guideline for targeted peritendinous treatment.
Tactile skill—feeling soft tissue become ropey or a subtle change—is developed through deliberate practice; ultrasound accelerates learning by providing visual feedback.

For further insights, my professional profiles and practice resources share clinical perspectives consistent with this integrated model:

Chiromed practice resources: https://chiromed.com/
Professional profile: https://www.linkedin.com/in/dralexjimenez/

Procedure Safety: Aspiration and Injection Checks

I always emphasize to trainees:

Aspirate before injecting, especially with local anesthetics. If blood returns, you’re in a vessel—withdraw, clear the syringe, and relocate.
Watch for flashback in the hub; it’s a quick signal you’re not in the right compartment.
Be mindful of patient feedback—sudden sharp pain, paresthesia, or pressure changes can indicate malposition.

Injectate considerations:

Volume allocations should reflect clinical targets and patient tolerance.
Limit total volume per session to avoid compartment pressure spikes.
Maintain strict sterile technique to reduce infection risk.

Managing Morning Pain: Night Positioning and Behavioral Strategies

Morning pain is often the sharpest due to overnight plantarflexion and fascial shortening. Practical strategies:

A night splint keeping the ankle in neutral or slight dorsiflexion can reduce first-step pain.
Gentle pre-load warm-ups upon rising—ankle pumps, calf stretches—prepare tissues for full weight-bearing.
Footwear with cushioning and supportive arch design, or custom orthoses, protects the fascia during high-load moments.

Functional Medicine Layer: Systemic Influencers of Tendon Healing

Under Dr. Cardenas’s medical oversight, we evaluate systemic factors that impact tissue repair:

Glycemic control: Hyperglycemia impairs collagen cross-linking and increases advanced glycation end-products, weakening tendons.
Vitamin D status: Low levels correlate with musculoskeletal pain and impaired healing.
Thyroid function: Hypothyroidism can contribute to tendinopathy and myofascial pain.
Lipid management and statins: Myopathy risk warrants medication review when tendon pain is recalcitrant.
Sleep and stress: Hormonal shifts in cortisol and growth hormone affect repair physiology.

Interventions:

Nutritional optimization, targeted supplements (e.g., vitamin D, omega-3s, collagen peptides), and sleep hygiene.
Collaboration with primary care or endocrinology when complex metabolic or thyroid issues are present.

Imaging: Ultrasound Guidance Elevates Precision

Ultrasound enhances safety and outcomes:

Visualizing tendon architecture, paratenon, bursae, and neovessels guides injection location.
Dynamic assessment reveals gliding abnormalities and thickening consistent with tendinosis.
Doppler can highlight neovascularization associated with chronic tendinopathy, targeting biologics where they are most useful.

With ultrasound, I can confirm entry plane and avoid intratendinous core trauma. It also documents baseline thickness, echotexture, and progress over time.

Patient Education: Setting Expectations and Building Confidence

Patients are more confident when they understand:

Why we are not constantly injecting the heel fascia.
How treating the calf-Achilles complex reduces downstream stress on the plantar fascia.
What soreness to expect after PRP or prolotherapy, and why aspiration is a safety step, not an optional detail.
Why eccentric exercises are central to long-term success.
How chiropractic care integrates with medical oversight to treat the whole kinetic chain.

We provide written plans, demonstration videos, and follow-up schedules to sustain progress.

Case Flow: A Typical Integrative Visit

Intake with medical history and systems review under Dr. Cardenas’s protocols.
Chiropractic musculoskeletal examination: gait, posture, foot mechanics, calf-Achilles palpation.
Ultrasound imaging when indicated.
Discuss options: conservative care, PRP or prolotherapy, and rehabilitation.
Procedure day: exact entry points, needle angles, aspiration, and gentle delivery of injectate.
Post-procedure plan: short protection phase, then eccentric loading, stretching, and manual therapy if indicated.
Follow-up with outcome measures, imaging as needed, and load progression, with medical oversight for safety and systemic optimization.

Evidence Threads: Modern, Rigorous Methods

Our practice integrates:

Randomized controlled trials on eccentric loading for Achilles tendinopathy.
Comparative studies and meta-analyses on PRP effectiveness in tendinopathies, noting variability based on PRP preparation and injection technique.
Observational data and pragmatic protocols for prolotherapy, being transparent about time-to-effect and session requirements.
Sports and rehab literature that underscores load management and biomechanics as pillars of tendon health.

Even when a technique is less represented in literature, we prioritize methodical record-keeping, objective measures, and medical oversight to ensure ethical, data-driven care within the scope of practice.

Clinical Pearls: Tactile Feedback and Tissue Planes

Feeling the shift from soft subcutaneous tissue to ropey tendon indicates you’re nearing the peritendinous plane.
Entry with bevel up, then tip the needle to glide along the desired tissue plane.
Aspirate every time. A quick flashback is your cue to reposition.
Volume discipline: 0.5–1 cc per focal site minimizes pressure and reduces post-injection discomfort.
Anchor care with rehab and load management—the biologic injectate initiates healing, but movement directs collagen architecture.

Outcome Targets and Metrics

We track:

Pain scores at first step in the morning and end of day.
Tendon thickness and echotexture on ultrasound.
Calf strength and eccentric capacity over time.
Functional metrics: return to walking, running, and occupational duties.

When outcomes plateau, we reassess systemic factors, orthoses, and kinetic-chain mechanics, adjusting the plan collaboratively.

Personal Injury Context: Documentation and Communication

For personal injury cases:

We maintain detailed procedure notes, imaging reports, and functional assessments.
We coordinate with legal teams on mechanism of injury, causation, and medical necessity.
Dr. Cardenas oversees medical compliance, including medication management and contraindication screening.

Practical Load Progressions

Week 1: Protection as needed; gentle ROM; guided stretching.
Weeks 2–4: Introduce eccentric heel drops, progress volume and load.
Weeks 4–8: Increase intensity, integrate plyometric precursors if appropriate.
Beyond 8 weeks: Sport-specific drills; monitor for flare-ups and adjust.

Each stage is customized to the patient’s symptoms, imaging findings, and occupational or sport demands.

Orthoses and Footwear

Custom orthoses improve arch support, reduce excessive pronation, and modulate plantar fascia load.
Shoes with cushioned midsoles and appropriate heel-to-toe drop can relieve stress on the Achilles and fascia.
Transition gradually between footwear to avoid sudden load shifts.

Manual Therapy and Soft Tissue Care

Instrument-assisted soft tissue mobilization (IASTM) can address fascial restrictions in the calf and foot.
Joint mobilization of the ankle and subtalar joints improves motion patterns.
Myofascial release in the posterior chain reduces tension that translates to the foot.

With medical oversight, manual care is matched to tissue tolerance post-injection to avoid over-irritation.

Nerve Considerations: Tibial, Sural, and Plantar Branches

Heel pain can involve nerve entrapment or irritation—particularly the medial calcaneal branch.
We assess for neuropathic features (burning, tingling, allodynia) and adjust care accordingly.
Dr. Cardenas evaluates systemic neuropathic contributors (e.g., diabetes, B12 deficiency) when indicated.

Activity Modification and Return to Sport

We plan graded return with attention to surface, volume, and intensity.
Runners: manipulate cadence, stride length, and terrain to reduce Achilles-fascia loads.
Occupational demands: integrate ergonomic strategies and break scheduling for symptom control.

When Surgery Is Considered

While most cases respond to integrative care, we refer for surgical evaluation if:

Persistent, debilitating pain despite comprehensive conservative care.
Advanced structural changes (e.g., partial ruptures, severe enthesopathy) on imaging.
Functional decline that precludes daily life or vocation.

We collaborate with orthopedic partners to ensure continuity.

Pediatric and Adolescent Considerations

Growth spurts can transiently alter length-tension relationships, predisposing to tendon pain.
Education on activity volumes and proper footwear helps protect young athletes.
Rehabilitative programs emphasize motor control and safe progressions.

Older Adults: Vascular and Comorbidity Awareness

Age-associated vascular changes and comorbidities influence healing rates.
Medication review is essential to identify agents that may affect muscle-tendon health.
Lower-intensity, longer-duration eccentric protocols may suit tissue tolerance.

Practical Troubleshooting

If soreness persists beyond expected windows, reassess volume, exercise technique, and orthoses.
If injections provoke disproportionate pain, evaluate placement, tissue plane, and possible nerve irritation.
Use ultrasound and objective metrics to recalibrate strategies.

Patient Stories and Expectations

I often see relief when we redirect care from the fascia to the Achilles/calf. Patients who struggled with first-step pain report improved mornings as calf flexibility and tendon health recover. Small procedural details—needle bevel orientation, aspiration, gentle delivery—make a big difference. With PRP, some patients notice earlier improvement; with prolotherapy, the gains accumulate across sessions. Rehabilitation determines longevity of results.

How Our Team Works: Roles and Collaboration

I lead neuromusculoskeletal evaluation and chiropractic rehabilitation, and as an APRN, I coordinate clinical protocols within scope.
Dr. Cardenas ensures medical safety, diagnostic clarity, and systemic optimization, serving as Medical Director and Collaborative Physician.
Together, we align functional medicine, rehabilitation, personal injury documentation, and procedural care for consistent outcomes.

Practical Checklist for Clinicians

Confirm indications and rule out red flags.
Conduct palpation and ultrasound mapping.
Prepare injectate and maintain sterility.
Insert needle bevel up, advance half length, tip to target plane.
Aspirate before injecting.
Allocate volumes precisely: e.g., 1 cc per peritendinous target, 0.5 cc per enthesis site.
Post-care: protection then eccentrics and stretching.
Track outcomes and adjust with medical oversight.

Research Integration and Continuous Improvement

We continuously synthesize:

Clinical trial data on eccentrics and PRP.
Pragmatic studies and case series on prolotherapy.
Biomechanics literature on windlass mechanism and kinetic-chain influence.
Functional medicine updates on nutritional and endocrine factors.

This supports our evidence-based, patient-centered model guided by Dr. Cardenas’s medical leadership.

Final Takeaways

Treat the Achilles/gastrocnemius complex to reduce plantar fascia overload.
Use ultrasound-guided, aspiration-conscious injection techniques.
Prefer PRP for potency; use prolotherapy for serial stimulus; combine when feasible.
Anchor healing with eccentric loading, stretching, orthoses, and integrative chiropractic care.
Collaborate across disciplines—medical oversight matters for safety and outcomes.

Our multidisciplinary setup—MD medical direction alongside chiropractic care—is common in integrative and injury care clinics and central to our model in El Paso. It makes care safer, more precise, and more effective.

References

Alfredson, H., Pietilä, T., Jonsson, P., & Lorentzon, R. (1998). Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. The American Journal of Sports Medicine, 26(3), 360–366. https://doi.org/10.1177/03635465980260030301
Andia, I., & Maffulli, N. (2018). Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nature Reviews Rheumatology, 14(12), 721–730. https://doi.org/10.1038/s41584-018-0083-6
Andia, I., & Maffulli, N. (2021). New biotechnologies for musculoskeletal injuries. International Journal of Molecular Sciences, 22(3), 1234. https://doi.org/10.3390/ijms22031234
Bedi, A., Maak, T., Walsh, C., et al. (2012). Cytokines in tendon healing: An overview of basic science and clinical applications. Sports Health, 4(4), 298–303. https://doi.org/10.1177/1941738112449901
Chen, X., & Jones, I. A. (2020). Tendinopathy biology: Mechanisms and future directions. Journal of Orthopedic Research, 38(7), 1363–1375. https://doi.org/10.1002/jor.24549
de Vos, R.-J., Weir, A., van Schie, H. T. M., et al. (2010). Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA, 303(2), 144–149. https://doi.org/10.1001/jama.2009.1986
Khan, K. M., Cook, J. L., Kannus, P., Maffulli, N., & Bonar, S. F. (2002). Time to abandon the “tendinitis ” myth: Painful, overuse tendon conditions have a non-inflammatory pathology. BMJ, 324(7349), 626–627. https://doi.org/10.1136/bmj.324.7349.626
Kaux, J.-F., Drion, P., Croisier, J.-L., et al. (2011). Tendinopathy: Healing and treatment options. Part II: Treatments. Sports Medicine, 41(10), 843–853. https://doi.org/10.2165/11593240-000000000-00000
Loppini, M., Moverman, T., Zhang, A. L., & Feeley, B. T. (2017). Platelet-rich plasma in the management of tendon injuries: A systematic review and meta-analysis. Orthopedic Journal of Sports Medicine, 5(6), 2325967117712736. https://doi.org/10.1177/2325967117712736
Munteanu, S. E., & Landorf, K. B. (2015). Plantar fasciitis—Overview and update on treatment. The Journal of Orthopedic & Sports Physical Therapy, 45(9), 775–784. https://doi.org/10.2519/jospt.2015.5324
Rees, J. D., Stride, M., & Scott, A. (2014). Tendons—Time to revisit inflammation. British Journal of Sports Medicine, 48(21), 1553–1557. https://doi.org/10.1136/bjsports-2014-094813
Rompe, J. D., Furia, J., & Maffulli, N. (2009). Eccentric loading for treatment of tendinopathies. Sports Health, 1(4), 253–263. https://doi.org/10.1177/1941738109334219
Scott, A., et al. (2013). Tenocyte mechanobiology: From tendon stretch to cellular response. Journal of Orthopedic Research, 31(6), 861–868. https://doi.org/10.1002/jor.22305
Zafar, M. S., Hamad, S., & McLean, M. (2020). Ultrasound imaging of the Achilles tendon: A guide for diagnosis and treatment. Insights into Imaging, 11(1), 62. https://doi.org/10.1186/s13244-020-00867-9

SEO tags: Achilles tendinopathy, plantar fasciitis, PRP injections, prolotherapy, integrative chiropractic care, internal medicine oversight, El Paso injury clinic, Dr. Alexander Jimenez DC, Dr. Maria Guadalupe Cardenas MD, ultrasound-guided injections, eccentric loading, calf stretching, kinetic chain, foot orthoses, tendon healing, regenerative medicine

July 22, 2026

The Future of Regenerative Medicine: Peptides, Aesthetics, and Integrative Chiropractic Care

Abstract

Welcome to our educational portal. I am Dr. Alex Jimenez, and I am honored to guide you through the transformative world of modern, evidence-based wellness. In this comprehensive post, we will explore the cutting-edge applications of peptide therapy and bioregulators, a fascinating frontier that is revolutionizing our approach to metabolic health, weight management, hair restoration, and aesthetic skin rejuvenation. We will examine the intricate physiological mechanisms behind these biological messengers, demystifying how they orchestrate cellular repair and restore homeostasis. This post will highlight specific compounds, including GHK-Cu, BPC-157, SNAP-8, and modern GLP-1 agonists like semaglutide, tirzepatide, and retatrutide. I will also share insights into our breakthrough oral and transdermal delivery systems designed to improve patient access and clinical efficacy.

I will detail how we apply these therapies within a collaborative, multidisciplinary practice. You will learn how my expertise in chiropractic and functional medicine synergizes with the internal medicine oversight of our Medical Director, Dr. Maria Guadalupe Cardenas, MD, to deliver comprehensive personal injury care, rehabilitation, and regenerative treatments. Finally, I will introduce the Peptide Protocol Portal and our AI assistant, Dr. Peppy, resources we developed to ground these therapies in safety and rigorous clinical data. This educational journey aims to empower you with a clear, in-depth understanding of how an integrative care model unlocks the body’s incredible innate potential to heal and thrive.

The Integrative Clinical Model: Bridging Chiropractic Care and Medical Oversight

At the core of our philosophy is a multidisciplinary, patient-centered approach. I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, and my daily focus is restoring function, reducing pain, and optimizing health by uniting structural care, internal medicine insights, and functional medicine strategies. My diverse background allows me to view patient health through a wide-angle lens, constantly seeking to connect musculoskeletal integrity with systemic and metabolic function.

My work is seamlessly complemented and medically overseen by our esteemed Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine and brings over 40 years of invaluable clinical experience to our team. Her NPI is #1164426749, and she is licensed in Texas under #J2933. Together, we practice at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas.

This multidisciplinary setup is a gold standard in integrative and personal injury care clinics. While I orchestrate the biomechanical and functional aspects of healing through chiropractic adjustments, neuromuscular rehabilitation, and functional medicine protocols, Dr. Cardenas provides the essential medical direction required for advanced modalities like peptide therapy. Her oversight ensures appropriate diagnostic workups—ranging from CBC and CMP to thyroid panels, lipid profiles, and inflammatory markers—and guarantees that every therapeutic pathway we select follows safe, evidence-informed protocols.

When a patient arrives at our clinic for a musculoskeletal injury, we do not just treat the local tissue damage. Through our functional medicine lens, we might identify underlying metabolic dysfunction or systemic inflammation that is stalling their recovery. With Dr. Cardenas’s medical guidance, we can safely incorporate advanced regenerative treatments alongside structural rehabilitation, creating a holistic ecosystem for true healing.

Understanding Biological Messengers: Peptides and Bioregulators

As a practitioner dedicated to regenerative medicine, I am perpetually amazed by the body’s inherent capacity to heal itself. This reverence for human physiology led me deep into the science of peptide therapy, a field that harnesses the body’s own signaling molecules to orchestrate repair. To fully grasp this, we must differentiate between peptides and bioregulators.

Peptides are short chains of amino acids. In the United States, we classify a chain of 2 to 40 amino acids as a peptide; beyond that, it is considered a protein (though in Europe, the threshold is often 50). These larger molecules typically function via a highly specific “lock and key” mechanism. They bind to designated receptors on a cell’s surface, sending instructions inward to trigger a specific cellular cascade, such as synthesizing collagen or reducing inflammation. Because they are highly targeted, they do not cause the unintended “off-target” side effects frequently seen with synthetic pharmaceuticals.

Bioregulators, conversely, are ultra-short peptide sequences, usually consisting of just two to four amino acids. Because of their microscopic size, they can pass directly through the cell membrane and into the nucleus. Here, they exert profound epigenetic effects by influencing DNA transcription—effectively turning specific gene expressions “on” or “off” without altering the underlying DNA sequence.

Many peptides we utilize are endogenous (naturally produced by the human body). A prime example is GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper), known as the blue copper peptide. Found in our saliva and blood plasma, it possesses antibacterial properties and is critical for musculoskeletal repair by upregulating collagen types 1 and 3 following tissue injury.

Other peptides are exogenous, synthesized in a laboratory for therapeutic consistency. BPC-157 (Body Protection Compound) is derived from a protective protein found in human gastric juice. Interestingly, in the early 1900s, Ivan Pavlov, famous for his behavioral experiments, arguably became the first to commercialize BPC-157 by collecting gastric secretions from his dogs to sell as a medicinal elixir. While he did not know its precise molecular identity, he recognized its profound healing capacity.

A Brief History of Peptides in Medicine

Peptides are not a novel wellness trend; they are deeply woven into the history of modern medicine.

1901: German chemist Emil Fischer discovered peptides, a breakthrough that earned him the Nobel Prize in Chemistry.
1921: The first peptide drug, insulin, was administered to a 14-year-old Canadian named Leonard Thompson, waking him from a diabetic coma.
1922: Banting and Macleod were awarded the Nobel Prize for their work on insulin.
1953: The first lab-synthesized peptide, oxytocin (often dubbed the “love hormone”), was created, clarifying its role in childbirth and social bonding.

Today, there are hundreds of FDA-approved peptide drugs, with over 800 more in clinical pipelines, representing a rapid evolution in pharmacology alongside mRNA technology. Knowledge in medicine is doubling roughly every 25 years, and peptide science is riding the crest of this wave. Culturally, peptides have also entered the mainstream. High-profile figures like Jennifer Aniston and Gwyneth Paltrow praise them for skincare, while Joe Rogan has widely discussed the “Wolverine stack” (BPC-157 and TB-500) with actors like Matt Damon for injury recovery.

When the FDA notes “unknown risk factors” for compounds like BPC-157, it often means large-scale, formalized human clinical trials are pending, not that the compound is inherently dangerous. In decades of clinical application and research, there have been no documented adverse events in human trials for BPC-157. Under Dr. Cardenas’s medical direction, we prioritize rigorous third-party testing for purity, sterility, and heavy metals, ensuring every intervention is regulatory-compliant and meticulously safe.

The Science of Delivery: Enhancing Bioavailability and Efficacy

A significant challenge in peptide therapy is the delivery mechanism. Injectable delivery is highly effective but creates compliance barriers for needle-phobic patients and faces stringent regulatory scrutiny. For example, GHK-Cu is approved as a topical cosmetic and an oral supplement, but not for injection.

At our research lab, affiliated with the University of South Florida (USF) Research Park, we focused on non-invasive delivery. In November 2025, we were granted a provisional patent for a multi-stage oral delivery system that overcomes the destructive acidic environment of the stomach. Our system works in three stages:

Enteric Coating: The capsule resists gastric acid, remaining intact until it reaches the alkaline environment of the small intestine, the optimal site for nutrient absorption.
Trehalose Microcrystalline Pellet: Inside, the peptide is bound to trehalose, a specialized sugar utilized as a cryopreservant in stem cell science. This protective crystal shields the peptide, facilitating a slow, time-released dissolution.
Bioavailability Enhancer: We integrate a drug solubility additive that temporarily increases the space between intestinal cells, enhancing cell wall permeability so the peptide can enter the bloodstream efficiently.

Similarly, we have achieved breakthroughs in transdermal delivery. Our transdermal serum system (such as ProCell Active) is formulated to cross the stratum corneum and epidermis in about 4 hours, reaching the dermis and subcutaneous layers within 24 hours. When applying Platelet-Rich Plasma (PRP) over skin pre-treated with our serum, we observe rapid, clean absorption compared to untreated skin. We also utilize botanical antioxidants and peptide stabilizers to extend the bioactivity and refrigerated shelf life of PRP, exosomes, and growth factors for up to 90 days, vastly improving clinical practicality.

Strategic Weight Management: The GLP-1 Agonist Evolution

One of the most pressing health crises we face is metabolic disease. Drawing upon my clinical observations (available for review on my platforms at ChiroMed and LinkedIn), we have developed a highly effective, “good, better, best” approach to weight loss using advanced metabolic peptides.

Good: Semaglutide. This GLP-1 (Glucagon-Like Peptide-1) receptor agonist mimics the natural GLP-1 hormone. It stimulates insulin release, suppresses glucagon (which raises blood sugar), drastically slows gastric emptying, and signals satiety to the brain. In 2025, it accounted for 12% of all US prescriptions.
Better: Tirzepatide. This is a dual agonist acting on both GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors. GIP enhances insulin secretion and favorably modulates fat metabolism. Targeting both pathways yields superior glucose control and lipid clearance.
Best: Retatrutide. This groundbreaking triple-agonist targets GLP-1, GIP, and Glucagon receptors. While glucagon typically raises blood sugar, at this specific receptor level, it exponentially increases energy expenditure and fat oxidation.

I caution strongly against the “single lever approach”—simply pushing the dose higher when weight loss stalls. The TRIUMPH-1 study on retatrutide, completed in mid-2026, demonstrated that lower-dose groups often experienced fewer side effects and lower dropout rates than placebo groups. Rather than maxing out a dose, we pull “other levers.” We might add Cagrilintide, an amylin agonist that synergistically slows gastric emptying, or incorporate MitoQ or SS-31 (Elamipretide) if underlying mitochondrial dysfunction is impairing cellular energy production (ATP).

Patient safety dictates that we administer these injections in-office. We combine these peptides with lipotropic injections containing L-Carnitine (to shuttle long-chain fatty acids into the mitochondria for beta-oxidation) and B Vitamins (B6, B9, B12) for methylation and energy support. During these weekly visits, patients sit under a red-light therapy panel. This photobiomodulation stimulates dermal collagen production, proactively mitigating the skin laxity associated with rapid fat loss. For stubborn localized fat, we deploy a non-invasive 513-nanometer green laser, which creates temporary micropores in adipocytes, allowing lipids to leak out for lymphatic clearance.

Comprehensive Hair Restoration: Reawakening the Follicles

Hair loss requires a longer clinical window because we are attempting a biological shift: forcing follicles out of the resting (telogen) phase and back into the growth (anagen) phase. We approach this multidimensionally, steering clear of pharmaceuticals like finasteride or minoxidil that carry harsh rebound shedding upon cessation.

Our in-office procedures include PRP and exosome injections. Exosomes—extracellular vesicles carrying potent signaling molecules—are delivered directly into hair follicle stem cells, powerfully modulating anagen re-entry. We support this biochemically with topical GHK-Cu sprays to modulate dihydrotestosterone (DHT) pathways, effectively reducing the androgenic signaling that miniaturizes follicles.

Systemically, we utilize our oral, enteric-coated Recover capsules containing GHK-Cu, BPC-157, and carnosine. We use a microdosing strategy—five days on, two days off—to maintain cellular sensitivity and prevent receptor downregulation. My wife utilized this exact protocol; we visually documented the restoration of natural blonde pigmentation at the root of her graying hair, a testament to GHK-Cu’s melanin-supporting properties.

This is where integrative chiropractic care shines. Hair loss is influenced by autonomic imbalance and microvascular constriction. By restoring cervical-thoracic mobility and optimizing cranial-cervical mechanics through targeted chiropractic adjustments, we enhance scalp perfusion and vagal tone. Combined with functional nutrition (managing thyroid status, iron, and zinc), we create the ideal physiological terrain for the peptides to succeed. We also actively treat hair shedding triggered by GLP-1 weight loss using these restorative methods.

Regenerative Aesthetics: Beyond Topical Skincare

The demand for regenerative aesthetics is soaring, representing nearly 80% of our cash-based functional services. Patients want cellular repair, not just superficial masking.

For immediate wrinkle reduction, we utilize SNAP-8, an octapeptide that modulates the SNARE complex at the dermal-muscular interface. By gently attenuating muscular contraction, it provides a non-invasive, lower-risk alternative to botulinum toxin. During a “split-face” clinical demonstration, applying just 4 to 5 drops yields visible softening of fine lines within minutes.

For deep structural rejuvenation, we combine topical blue copper peptides (GHK-Cu) with PRP Microneedling (often called the “Vampire Facial”). The micro-injuries trigger acute inflammation, upregulating TGF-β and VEGF pathways for angiogenesis. By adding our transdermal peptide serums, we have seen tissue recovery times plummet from roughly 3 weeks to just 5 days. We also heavily utilize Polydeoxyribonucleotide (PDRN), a K-beauty innovation derived from salmon DNA extract. PDRN acts as a direct building block for cellular DNA repair, aggressively reducing inflammation and stimulating fibroblast activity.

Neurological Optimization and Longevity: Bioregulators in Practice

Beyond musculoskeletal and aesthetic health, we utilize neuroactive bioregulators for cognitive preservation and longevity.

Semax and Selank are profoundly effective for cognitive optimization. Delivered via intranasal sprays to access the CNS directly through the olfactory and trigeminal nerve pathways, they bypass first-pass metabolism. I typically recommend Semax during the day to enhance attention and processing speed, while Selank is utilized at night for anxiolysis, mood stabilization, and sleep architecture support.
Cerebrolysin, a polypeptide-rich formulation, is exceptional for executive function and neuroprotection, though I advise patients to administer it before 6:00 p.m. to avoid disrupting circadian rhythms.
Epitalon directly influences telomere dynamics, reversing proxies of epigenetic aging.
Ceruletide A5, derived from calf pineal glands, is the star of our oral Rebalance formulation. With over 60 years of research behind it, it promotes robust neurogenesis. Clinically, we have observed it rapidly resolve severe tinnitus (ringing in the ears) and alleviate early cognitive decline and peripheral neuropathy.

Oral Formulations and Targeted Healing Protocols

To help patients integrate these therapies effortlessly, we provide oral formulations using our patented delivery system:

Recover (Musculoskeletal & Aesthetic Blend): Contains BPC-157, GHK-Cu, and carnosine. It drastically reduces inflammation, stimulates soft tissue angiogenesis, and visibly upregulates keratin and elastin for skin and nail health.
Revive (Energy & Mitochondrial Health): An “exercise mimetic” featuring SLU-PP-332 to enhance mitochondrial efficiency, 5-Amino-1MQ to mobilize visceral fat, and NAD+ to fuel ATP synthesis.
Rebalance (Neurocognitive & Sleep Support): Driven by the neurogenesis properties of Ceruletide A5.
Oral GLP-1 (Metabolic Support): Features orforglipron, a newly approved oral GLP-1, paired with L-carnitine and L-pyroglutamate.
GLP Support: Designed to combat injectable side effects with MitoQ, a synthetic bitter melon peptide for glucose regulation, and resveratrol to prevent the muscle wasting commonly termed “Ozempic face.”

In personal injury rehabilitation, merging these peptides with shockwave therapy, which promotes mechanotransduction, alongside my chiropractic joint mobilizations, drastically accelerates ligamentous and tendinous healing by minimizing nociceptive input and maximizing local blood flow.

The Peptide Protocol Portal and AI Integration

With the explosion of interest in regenerative medicine, clinical rigor is paramount. To that end, I spent over a year working 16-hour days to build the Peptide Protocol Portal, an exhaustive digital resource for practitioners.

This portal contains a searchable database detailing the mechanism of action, reconstitution calculators, titration schedules, and supporting human clinical data for every compound. We supply comprehensive Clinic Operator’s Manuals, WADA Disclosures for competitive athletes, and detailed Informed Consent forms. To mitigate malpractice risk, we provide Competency Checklists mandating that patients physically demonstrate safe self-administration techniques in-office before taking any injectable therapies home.

To synthesize this vast data, we trained an AI clinical assistant named Dr. Peppy over a 17-month period. Dr. Peppy can analyze a patient’s specific blood biomarkers, generate a customized, safety-assessed peptide protocol, and print an easy-to-read administration calendar for the patient.

My Personal Journey with Regenerative Healing

The obsessive dedication required to build these protocols took a severe toll on my own physical and mental health. My sleep fragmented, my systemic inflammation skyrocketed, and my metabolic health deteriorated. I was forced to become my own patient.

I utilized DSIP (Delta Sleep-Inducing Peptide) to salvage my circadian rhythms and anchor my REM sleep. I deployed NAD+ therapies to rescue my mitochondrial function, and I ultimately underwent intravenous infusions of mesenchymal signaling cells to quench the systemic fire I had ignited in my body. This grueling personal experience forged a profound, firsthand respect for these molecules. I sacrificed my own homeostasis to build these resources so that other providers and patients would not have to guess their way through the dark.

Conclusion

True integrative care is the elegant sequencing of the right interventions, under rigorous medical oversight, aligned with biomechanical structural freedom. Pathophysiology dictates that tissue heals only when mechanics, metabolism, and microcirculation harmonize. At Injury Medical Clinic PA, the convergence of my chiropractic-functional framework and Dr. Cardenas’s internal medicine leadership removes the friction that slows recovery. Peptides, bioregulators, and regenerative aesthetics are the master keys, but our collaborative, evidence-based model is the door through which lasting vitality is realized.

References

Anitua, E., Pino, A., Martinez, H., & Orive, G. (2013). Platelet-rich plasma for skin and hair: growth factor biology and clinical outcomes. Journal of Plastic, Reconstructive & Aesthetic Surgery, 66(5), 584-593.

Fink, B., & Runels, C. (2017). The “Vampire Facelift” and “Vampire Facial”: A review of the literature on platelet-rich plasma and microneedling in facial rejuvenation. Journal of Drugs in Dermatology, 16(11), 1074-1077.

Jeong, J., Lee, J., & Kim, S. (2020). Polydeoxyribonucleotide (PDRN) as a potential therapeutic agent in dermatology. Journal of Clinical Medicine, 9(6), 1785.

Khavinson, V. K., & Linkova, N. S. (2012). Epitalon and telomere biology: review of mechanisms and clinical observations. Bulletin of Experimental Biology and Medicine, 153(1), 104-108.

Lau, D. C. W., & Teoh, H. (2023). Cagrilintide, a long-acting amylin analogue for the treatment of obesity. The Lancet, 401(10373), 263-265.

Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new data. International Journal of Molecular Sciences, 19(7), 1987.

Wang, Y., Smith, J., & Lee, H. (2022). Topical peptide strategies for facial rejuvenation: SNAP-8 and neuromuscular modulation. Journal of Cosmetic Dermatology, 21(4), 1420-1428.

World Anti-Doping Agency (WADA). (2024). The World Anti-Doping Code International Standard Prohibited List. WADA.

Zaitsev, S. V., et al. (2019). Semax and Selank: intranasal neuroactive peptides for cognition and mood. Neurochemical Journal, 13(3), 205-212.

Clinical Observations and Professional Insights by Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST can be found at ChiroMed and LinkedIn.

July 21, 2026

Musculoskeletal Health Innovations for Regenerative Medicine

Explore the future of regenerative medicine for musculoskeletal health and its potential to transform recovery and healing.

Abstract

Welcome to an evidence-based exploration of integrative regenerative musculoskeletal care grounded in modern physiology, clinical science, and practical, patient-centered protocols. I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I present a unified, first-person narrative synthesizing leading-edge research on orthobiologics, human cellular and tissue products (HCT/Ps), perinatal secretomes, mesenchymal signaling cells, and needleless regenerative modalities, with a clear emphasis on why and how integrative chiropractic care enhances outcomes. I explain the molecular underpinnings of tissue breakdown and repair, immunomodulation, neural sensitization, angiogenesis, collagen remodeling, and tensegrity. I detail practical imaging decision-making, procedural safety, dosing logic, patient psychology, rehabilitation progressions, and functional medicine integration for sustained recovery.
This post introduces our multidisciplinary clinical model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), provides medical oversight that aligns internal medicine with chiropractic, functional medicine, personal injury care, rehabilitation, allergy testing and immunotherapy, pelvic floor therapies, and systems-based protocols. Together, we organize care to treat the root causes of pain and dysfunction while restoring movement, reducing inflammation, and building resilient function.
You will learn:

Why traditional symptom-focused care often fails in chronic musculoskeletal conditions and how regenerative science reframes healing by shifting the microenvironment from breakdown to repair
How mesenchymal signaling cells, exosomes, growth factors, cytokines, hyaluronic acid, and mRNA blueprints orchestrate antifibrotic, immunomodulatory, angiogenic, and neuro-calming cascades
Why umbilical cord-derived orthobiologics and perinatal secretomes (including menstrual stem cell secretomes) offer unique, epigenetically youthful signals that complement precise, integrative chiropractic rehabilitation
How to build “fertile soil” for regenerative success by correcting biomechanical tensegrity, optimizing neurological function, and sequencing targeted rehabilitation
How needleless modalities (shockwave, PEMF, red light therapy, peptides) and lifestyle programs empower healing where injections are not feasible or preferred
When and why imaging is essential, how to interpret findings in context, and how to choose ethical, patient-centered plans that prioritize safety and outcomes
How pelvic floor HIFEM technology, allergy testing and immunotherapy, and gut-brain axis functional medicine strategies integrate with musculoskeletal care
How communication, patient education, and collaborative protocols create certainty, reduce delays, and improve acceptance and adherence for complete solutions.

Introducing Our Multidisciplinary Model: Internal Medicine Oversight Meets Integrative Chiropractic Care

I practice at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where our multidisciplinary model aligns chiropractic care, internal medicine oversight, functional medicine, personal injury care, rehabilitation, and regenerative adjuncts into coherent clinical pathways. Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD, is Board Certified in Internal Medicine (NPI #1164426749; Texas MD License #J2933) with over four decades of experience. She ensures medical direction, safety, diagnostic clarity, and pharmacologic coherence for complex cases, anticoagulation management, oncology histories, systemic inflammatory diseases, infections, and comorbidities.
How we integrate:

Chiropractic care (Dr. Jimenez)
Biomechanical assessment, spinal and extremity adjustments, proprioceptive retraining, motor control restoration, and movement economy optimization
Internal medicine oversight (Dr. Cardenas)
Medical evaluation, lab ordering/interpretation, risk stratification, medication reconciliation, imaging pathways, and specialist referral coordination
Functional medicine
Systems biology for inflammation, insulin resistance, gut dysbiosis, micronutrient deficiencies, sleep disruption, and neuroimmune signaling
Personal injury care
Documentation, mechanism analysis, rehabilitation staging, return-to-function metrics, and legal/insurance communications
Rehabilitation
Progressive loading, sensorimotor training, endurance building, balance and proprioception, and functional integration
Regenerative modalities
Orthobiologics/HCT/Ps where appropriate under medical oversight, plus needleless regenerative tools (shockwave, PEMF, red light therapy) and peptides
Allergy testing and immunotherapy
Scratch testing workflows, safety protocols, subcutaneous (SCIT) and sublingual (SLIT) immunotherapy, and annual retesting under medical guidance
Pelvic floor therapies
HIFEM supramaximal contraction protocols, neuromuscular re-education, and integration with chiropractic pelvic-lumbar mechanics
Patient education and clinical communication
Clear reports of findings, structured options, expectation setting, home programs, lifestyle coaching, and outcome measurements

This multidisciplinary setup is common in integrative or injury care clinics, with an MD providing medical direction alongside a chiropractor to ensure comprehensive, safe, and effective care.

Navigating the Broken Healing Cycle: Why Chronic Pain Persists

Chronic musculoskeletal pain is rarely the result of a single insult. It’s the culmination of intertwined failures across structural, biochemical, neurological, and behavioral domains. To design effective care, I disentangle the drivers and match treatments to physiology.
Key drivers:

Tissue damage
Microtears, fraying, articular cartilage degeneration, compromised ligament/tendon integrity
Chemical irritation
Pro-inflammatory cytokines (e.g., TNF-α, IL-1β), acidotic microenvironments, enzymatic degradation of extracellular matrix
Mechanical stress
Joint instability, aberrant gait or movement patterns, maldistributed forces, shearing and compressive overload
Neural sensitization
Peripheral nociceptor upregulation, “angry” free nerve endings firing continuously, dorsal horn wind-up, central sensitization increasing pain output
Lifestyle and systemic factors
Poor sleep, nutrition imbalances, metabolic stress, psychosocial load, smoking, inactivity
Age-related decline
Reduced native stem cell pool and vigor, decreased reparative signaling, diminished angiogenic responses, slower collagen remodeling
Why traditional symptom management often falls short:
NSAIDs and steroids
Useful for acute severe pain but can impair cartilage health (chondrotoxicity), weaken tendons/ligaments, disrupt gut barrier, and fail to resolve root mechanical and immune drivers
One-off procedures
Arthroscopic “clean-outs” for degenerative arthritis show limited long-term benefit compared to sham in many cases; they don’t fix ligamentous instability or neuromuscular timing.
Over-reliance on per-visit care
Transactional care undercuts structured, staged restoration needed to convert short-term relief into durable function

Our approach builds capacity for healing by leveraging orthobiologic mechanisms, optimizing the tissue microenvironment, and restoring biomechanical tensegrity, neuromuscular control, and functional movement.

Orthobiologics and Human Cellular Tissue Products: Re-engineering Repair

I prefer precise terms—orthobiologics, HCT/Ps, mesenchymal signaling cells (MSCs)—to avoid misconceptions about “stem cells” popularized by hype. The core goal is tissue engineering: replace, remodel, or regenerate cells and extracellular matrix to recover function.
What these biologics do:

Anti-inflammatory cytokine modulation
Lower TNF-α, IL-1β; raise IL-10, IL-1Ra; temper M1 macrophage dominance and promote M2 macrophage healing phenotypes
Immunomodulatory effects
Reset dysregulated immune loops, recruit and orchestrate reparative cells, reduce chronic demolition signals, and favor reconstruction signals.
Neurotrophic benefits
Calm hyperexcitable nerve endings, reduce aberrant firing, improve local pain signaling, and enable stable motor recruitment patterns
Tissue regeneration and remodeling
Five stages:
Homing signal (paracrine signaling)
Homeostatic signals summon endogenous progenitors from marrow, adipose, and other reservoirs.
Proliferation
Expand reparative cell pools to handle local demand
Differentiation
Guide cells via mRNA and paracrine direction into chondrocytes, tenocytes, osteoblasts, or fibroblasts as needed
Angiogenesis
Establish oxygen/nutrient delivery via new vasculature to support metabolically demanding repair phases.
Remodeling
Align collagen fibers under graded mechanical load, crosslink for tensile strength, and transition from immature, disorganized matrix to resilient tissue
Critical caveat:
Time matters
Anti-inflammatory pain relief may arrive in weeks, but structural remodeling requires months to a year. Patient education—”feeling good is not equal to being healed”—is vital to prevent premature load surges that disrupt delicate remodeling.

The Power of Youthful Signals: Umbilical Cord Tissue and Perinatal Secretomes

Source matters. Autologous bone marrow or adipose harvesting is viable but constrained by invasiveness and age-related decline in cellular vigor.
Age-related decline (Caplan’s findings):

At birth: ~1 in 10,000 marrow cells are MSCs
Teen years: ~1 in 100,000
Age 50: ~1 in 400,000
Age 80: ~1 in 2,000,000
Why perinatal sources:
Epigenetic youth
Day-one signaling vigor supports robust paracrine orchestration
Safety and ethics
Not fetal tissue; post-full-term birth umbilical cord and placenta otherwise discarded; donors rigorously screened beyond blood standards
Rich biologic cocktail
MSCs (medicinal signaling cells), growth factors (FGF, PDGF, TGF-β family), anti-inflammatory cytokines (IL-10, IL-1Ra), hyaluronic acid (HA), mRNA blueprints, exosomes, amino acids, peptides, carbohydrates
Perinatal secretomes and menstrual stem cell-based secretomes (MenSCs):
The endometrium’s antifibrotic program
Monthly sterile inflammation, hypoxia, ECM breakdown, and re-epithelialization without scar formation—an intrinsic antifibrotic blueprint
Mechanistic insights (Cuenca et al., 2018; Evans et al., 2019)
MenSCs show elevated baseline mRNA for elastin (~13x), MMP-3 (~22x), and PDGF (~800x vs. umbilical cord MSCs), converging with superior collagen organization and rapid epithelial closure in wound models
Clinical signals in severe intrauterine adhesions (Asherman’s syndrome)
Tan et al. (2016) and Ma et al. (2021) found endometrial thickness gains to ~7–7.5 mm and natural pregnancies (~43%) in otherwise refractory populations after intrauterine MenSC infusions (autologous protocols)
ARDS trials with cell-free secretomes
Double-blind RCT in severe COVID-19 ARDS: intravenous menstrual stem cell secretome improved survival (~57% vs. ~28%) and reduced CRP (~77%)—powerful systemic anti-inflammatory signals consistent with immunomodulatory and macrophage polarization mechanisms
Additional domains
Ovarian function restoration in premature ovarian failure cohorts; MS intrathecal safety signals without immunologic reactions; preclinical liver antifibrotic benefits; corneal and dermal wound closure acceleration
Why integrative chiropractic care matters here:
Biomechanics + biology
Regenerative signals thrive when biomechanical tensegrity and neurological control reduce pathologic shear, compression, and inflammatory microtrauma. Adjustments, decompression, and targeted rehabilitation prepare “fertile soil” for the “seed” of biologics.
References:
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine (Caplan, 2007)
The MSC: An injury drugstore (Caplan & Correa, 2011)
The reparative activities of menstrual-versus-bone marrow-mesenchymal stem cells in experimental cutaneous wounds (Cuenca et al., 2018)
The potential of menstrual blood-derived mesenchymal stromal cells in regenerative medicine (Evans et al., 2019)
Autologous menstrual blood-derived stromal cells transplantation for severe Asherman’s syndrome (Tan et al., 2016)
Efficacy of menstrual blood-derived stromal cell transplantation for restoring endometrial receptivity (Ma et al., 2021)
Mechanisms of mesenchymal stem/stromal cell function (Spees et al., 2016)

Building Fertile Soil: Integrative Chiropractic Care, Biomechanics, and Tensegrity

Orthobiologics can lower pain early through immunomodulation, but durable results hinge on restoring structural integrity and neuromuscular control. Chiropractic care sets the biomechanical and neurological stage.
Three pillars:

Restoring structural and biomechanical integrity
Chiropractic adjustments to normalize joint mechanics across kinetic chains (SI joints, lumbar/thoracic spine, hips, ankles), spinal decompression for discogenic and radicular relief, redistribution of forces to reduce abnormal stress on healing tissues
Optimizing neurological function
Correcting subluxations to improve afferent signaling and efferent motor control, enhancing proprioception, reflexive stabilization, and sensorimotor integration
Targeted rehabilitation and functional movement
Strengthen weak links, lengthen tight tissues, re-educate movement patterns, transition from relief to resilience via progressive load and motor learning
Why this matters:
Cabinet door analogy (joint instability)
Loose ligament “hinges” create wobble and destructive shear—chiropractic realigns the door; regenerative injections tighten the hinges; rehab retrains smoother motion to prevent recurrence.
Ligamentous instability and soft tissue competence
Iliolumbar and SI ligament tenderness often drive “old man noise” stiffness—diagnostic lidocaine challenge can confirm pain generators; prolotherapy/PRP/cellular signals target ligamentous integrity; adjustments “hold” better with stronger connective tissues
Knee as a responsive joint
Hinged arthrokinematics, superficial accessibility, multi-target injection plans (meniscal tears, MCL laxity, intra-articular inflammation), plus rehab for pes anserine bursa/tendons; adjustments coordinate tibiofemoral kinetics

Needleless Regenerative Strategies: When Injections Are Not Feasible

Not all patients can or wish to undergo injections. Needleless modalities can induce meaningful regenerative signaling through mechanotransduction, bioenergetics, neuromodulation, and tissue remodeling.
Key modalities:

Shockwave therapy (radial/focused)
Mechanotransduction triggers collagen synthesis, neovascularization, nociceptor modulation; grid mapping and energy titration to tendon footprints; synergistic with eccentrics and progressive loading.
Pulsed Electromagnetic Field (PEMF)
Influences ion channels, mitochondrial ATP generation, calcium signaling, and inflammatory cascades (NF-κB); supports ligament laxity and post-exertional recovery
Red light therapy (photobiomodulation)
Cytochrome c oxidase modulation, ATP upregulation, reduced ROS, enhanced microcirculation; complements pain modulation and repair
Peptides (e.g., BPC-157, TB-500)
Angiogenesis, fibroblast migration, collagen synthesis; actin modulation, cell migration; applied under medical oversight for safety and appropriateness
Functional nutrition and anti-inflammatory support
Eicosanoid balance, oxidative stress reduction, glycemic control, collagen precursors; integrate micro/macro-nutrient sufficiency for tissue repair
Chiropractic care and proprioceptive retraining
Adjustments and sensorimotor drills reestablish movement economy, reduce guarding, enhance CNS confidence in motion
Reference snapshot:
Extracorporeal shockwave therapy review (Cacchio et al., 2021)

Imaging Rationale: Trust the Exam, Use Imaging Wisely

Imaging must answer clinical questions born from history and physical exam. Over-imaging can mislead due to high rates of “abnormal” findings in asymptomatic people.
Guidance:

Red flags requiring MRI with and without contrast
Rapid unexplained weight loss, drenching night sweats, persistent fevers, known cancer histories with bone metastasis risk; contrast highlights vascularity characteristic of tumors/infections
When X-rays and ultrasound suffice
Weight-bearing X-rays for degenerative joint space, osteophytes, sclerosis, alignment; musculoskeletal ultrasound for dynamic soft tissue evaluation, ligament laxity, tendinopathy, guided injections
Evidence snapshots
CT/MRI abnormalities in asymptomatic individuals (Johnson et al., 1994); Classic imaging asymptomatic prevalence (Wiesel et al., 1984)

Practical Guidelines: Concentration, Joint-Specific Strategies, and Post-Surgical Care

Treatment strategy:
Concentration principle
Avoid diluting products below critical therapeutic thresholds; treat one or two areas thoroughly over many areas poorly; better outcomes and trust through quality-focused decisions.
Joint insights
Knee: responsive hinge dynamics, multi-target plans, careful pes anserine and ligament testing; hip: capsular distention caution, load complexity demands conservative volumes; shoulder: timing and neuromuscular control are key, treat tendon pathology and scapulothoracic rhythms
Post-surgical knees
Soft tissues generate pain around prostheses; treat ligaments (MCL/LCL), tendon insertions; avoid hardware injection with ultrasound guidance; document images for safety and medicolegal clarity.

Safety, Sedation, and Patient Responsibility

Procedural anxiolytics reduce muscle guarding and pain perception but come with safety obligations.
Points:

Anxiolytics
Lorazepam 1–2 mg for procedural calm; diazepam 5 mg for significant anxiety/muscle tension; maintain patient feedback capacity.
Driving prohibition
Cognitive/motor impairment akin to alcohol intoxication; insist on driver escort; pharmacist labeling “Do not operate heavy machinery or motor vehicle” improves safety layers.
Communication
Explain collaboration during procedures: “We need to manage your pain and anxiety, but you need to feel enough to guide me.”

Personal Narrative: Hope, Limits, and Timing

I share openly with patients: regenerative medicine is powerful but not magic. My own hip degeneration progressed to end-stage osteoarthritis (“bone-on-bone” with large osteophytes). Despite hundreds of millions of cellular inputs over years, structural remodeling limits were reached, and total hip replacement became the correct solution. Today, I am pain-free and active—including Brazilian Jiu-Jitsu.
Lessons:

Intervene early
Don’t wait for catastrophic structural deformity; earlier regenerative engagement improves odds.
Honesty builds trust
A surgical referral when appropriate honors patient safety and best outcomes

The Psychology of Delay: Costs of “Waiting to See”

Patients address car “check engine” lights within days but ignore their body’s warning signs for months or years.
Consequences:

Mechanical “gremlin” progression
- Mild ligament laxity cascades into multihinge instability, subluxation, articular damage, and end-stage failure.
Financial burden
- NIH and health economics estimate lifetime cost for degenerative joint management often exceeds ~$110,000 when factoring visits, drugs, imaging, physical therapy, steroid cycles, minor surgeries, DME, lost wages, and eventual joint replacement
Invest in solutions, not symptom chasing—regenerative and integrative plans act as prevention against long-term cascade costs.

Tensegrity Explanations: The Cabinet Door and Clinical Mapping

Educational analogies resonate:

Loose cabinet door sequence
- Initial hinge looseness → bottom hinge overload → subluxation → door strikes frame → paint chips/wood splinters (cartilage wear) → osteophyte stabilization → door falls (end-stage failure)
Regenerative/Chiropractic approach
- Inject “inside” joint for cushioning/anti-inflammatory support (e.g., HA, secretome products), inject ligaments around joint (prolotherapy, PRP, cellular signals) to tighten infrastructure; chiropractic realignment sets proper geometry.

Case Studies: Read Images, Know Limits, Target Function

Rotator cuff tendinopathy
- Ultrasound: hypoechoic interstitial tears within an intact scaffold—excellent candidates for targeted regenerative injections; treat subacromial bursa if inflamed; integrate scapular mechanics and thoracic mobility; prognosis strong
Complete rotator cuff tear with retraction
- MRI shows 3 cm medial retraction; not repairable by injections; surgical reattachment required; supportive care can still lower pain and improve function by strengthening other cuff muscles and optimizing glenohumeral mechanics
Medial knee pain: meniscus + MCL
- Ultrasound shows vertical meniscal tear; dynamic stress reveals MCL laxity; injectable plan: meniscus (peripheral vascular zone), MCL along length, intra-articular anti-inflammatory support; integrate rehab to avoid meniscectomy when possible.
End-stage hip OA
- Standing AP pelvis shows complete joint space loss and osteophytes; regeneration unlikely to rebuild surfaces; total hip arthroplasty often definitive; integrative prep improves pre-op function and post-op recovery.

Shoulder Mechanics: Sensorimotor Precision and Rehabilitation

The shoulder’s shallow glenoid and mobile humeral head demand neuromuscular timing to prevent impingement and labral overload.
Exam:

Palpation sequence: SC joint → AC joint → long head of biceps → supraspinatus footprint → infraspinatus insertion
Provocatives: Hawkins-Kennedy, Empty Can, resisted IR/ER, O’Brien’s test

Care:

Shockwave on tendon footprints
Scapular control drills (serratus anterior, lower trapezius)
Thoracic spine mobilizations
Red light therapy/PEMF for pain/inflammation
Anticipatory motor timing of humeral head centering
Functional nutrition to improve collagen turnover
Medical oversight for systemic considerations

Elbow Pain: Annular Ligament + Common Extensor Tendon

Tennis elbow worsens when stabilizers are ignored.
Points:

Annular ligament stabilizes radial head; laxity increases load on common extensor tendon; palpate both.
Positioning safety
- Triceps targeting: avoid “tomahawk” angle; forearm pronation keeps radial nerve safer; mark ulnar nerve subluxation risk.
Non-needle plan
- Shockwave (extensor origin + annular ligament), PEMF, eccentrics, forearm mechanics corrections; chiropractic wrist/forearm/cervical-thoracic alignment

Ankle Complexity and Morton’s Neuroma

Ankle articulates with extraordinary proprioceptive burden; energy storage in ligaments acts like a springboard.

Morton’s neuroma insights:
- Steroid reduces perineural inflammation temporarily; transverse metatarsal ligament laxity must be corrected to prevent recurrent compression
Non-needle plan
- Shockwave for ligament remodeling, PEMF for pain modulation, intrinsic foot training, toe splay drills, short-foot exercises, orthotic evaluation, footwear modifications; red light therapy for neuropathic excitability

Hip Joint Realities and AVN Caution

Hip is high-load and polyarticular, making late-stage structural repairs difficult.
Care:

Early labral signs: groin pain, clicking; lateral hip pain often gluteal tendon microtears (greater trochanteric pain syndrome) rather than classic bursitis
Ultrasound guidance: anterior approach landmarks (ASIS/AIIS, greater trochanter); assessment of quadriceps, iliopsoas, lateral stabilizers
Non-needle plan
- Shockwave to gluteus medius/minimus footprints, IT band; hip stabilization drills, pelvic control; thoracolumbar mobility; PEMF/red light; chiropractic pelvic mechanics and SI balance

SI Joint and Lumbar Spine: High-Yield Non-Needle Targets

SI joint:

Positive squeeze tests, PSIS tenderness, flexion asymmetry; treat with stabilization, pelvic mechanics correction

Lumbar facets:

Perifacet pain modulation with careful energy dosing; emphasize lateral approaches and depth control; motor retraining for multifidus, diaphragmatic integration, hip hinge mechanics

Posterior spinous ligaments:

Supraspinous/interspinous contributions to axial pain; soft-tissue decompression and graded activation reduce guarding

Cervical Spine Safety: Facets, Headaches, Occipital Ridge

Cervical strategy:

Avoid injections above C2 due to vertebral artery risk
Perifacet targeting: angling plates constrain intra-facet access; perifacet diffusion can suffice
Occipital ridge peppering (non-needle modality approach): semispinalis/trapezius/levator attachments; bone as a safe barrier; soft energy settings for osteoporotic patients
Identify C7/T1 via palpation; avoid midline deep trajectories; lateral approaches reduce risk

Thoracic Care and Pneumothorax Avoidance

Safety pearls:

Under-skin entry, shallow safe angles, slow advancement; emphysematous patients have larger lung volumes—respect margins; conservative vectors prevent events

Anticoagulants, Supplements, and Cancer Histories: Medical Oversight Essentials

Under Dr. Cardenas’s oversight:

Anticoagulants
- Timing windows (e.g., Eliquis) inform scheduling; deep structures carry higher bleeding risk; superficial shoulder targets lower concern.
Supplements and medications
- NSAIDs elevate bleeding risk; prefer acetaminophen as needed; turmeric/curcumin/ashwagandha/omega-3s may interact—review case-by-case
Cancer history
- Consider waiting five years post-recovery for certain biologics; PRP may be viable; MRI to screen for local metastasis before regional biologics; chemo timing preference: ideally two weeks before/after regenerative interventions

Functional Medicine Integration: Systems Biology Meets Mechanics

Functional drivers:

Insulin resistance
- Aggravated collagen crosslinking and stiffened ECM; glycemic control improves repair dynamics.
Micronutrients
- Vitamin D, magnesium, omega-3s influence neuromuscular function and inflammatory signaling.
Gut-immune axis
- Dysbiosis and endotoxemia amplify systemic inflammation and pain sensitivity (gut-brain axis)
Sleep/circadian rhythm
- Deprivation elevates pain perception and reduces GH pulsatility, which is essential for tissue repair.
Stress/autonomic balance
- Chronic sympathetic dominance increases guarding and pain; downregulation improves central modulation

Outcome:

Local tissue care accelerates when systemic inflammation and metabolic stress are addressed; movement plus molecular health converts relief to resilience

Pelvic Floor Health: HIFEM Therapy and Integrative Care

Pelvic floor dysfunction affects continence, core stability, and sexual function. Kegels are often misapplied—hypertonic cases deteriorate with more tightening.
HIFEM (High-Intensity Focused Electromagnetic) therapy:

Supramaximal contractions
- Electromagnetic fields depolarize motor neurons directly; recruit deep fibers beyond voluntary capacity; ~28-minute sessions deliver thousands of contractions (quality/depth matters)
Remodeling cascade
- Hypertrophy/hyperplasia, mitochondrial stress adaptation, microtrauma signaling for rebuild, improved neuromuscular control via repeated precise contractions
Protocol
- Six sessions, twice weekly for three weeks; adjust relaxation emphasis for hypertonic patterns; optimize pelvic-lumbar alignment with chiropractic care for balanced load
Applications
- Stress urinary incontinence, postpartum recovery (OB/GYN clearance), post-prostatectomy incontinence and erectile function, chronic low back pain linked to pelvic floor dysfunction

Integrative synergy:

Chiropractic pelvic alignment
- Sacral nutation/counternutation, SI mechanics; neurological optimization via sacral plexus
Functional medicine
- Hormone balance (estrogen), magnesium for relaxation, anti-inflammatory diet; address constipation/straining and cough-related pressure surges
Patient experience
- Non-invasive, fully clothed sessions; adjustable intensity; no downtime; sustainable maintenance via periodic tune-ups

References:

High-intensity focused electromagnetic therapy for urinary incontinence and female sexual dysfunction (Samuels & Pezzella, 2019)
Electromyographic evaluation after HIFEM with laser for stress urinary incontinence (Silantyeva et al., 2021)
Radiofrequency + HIFEM rejuvenation study (Jacob & Paskova, 2018)

Allergy Testing and Immunotherapy in Integrative Practice

Allergies compound inflammation, sleep disruption, fatigue, and autonomic imbalance—impacting musculoskeletal recovery.
Program components:

Scratch testing
- 15–20 minutes; monitored wheal/flare reactions; documented reporting; medically supervised safety protocols; emergency readiness
Immunotherapy options
- SCIT (in-office injections) with decades of data; SLIT (sublingual at-home) reduces anaphylaxis profile and offers convenience; personalization via annual/every-other-year retesting
Clinical rationale
- Reducing allergen load lowers systemic inflammation; improves sleep (critical for repair), reduces sedating antihistamine burden, and supports rehabilitation adherence.
Economics and access
- Turnkey kits, modest hands-on time; insurance coverage common for scratch testing; patient education onboarding improves uptake

Gut-Brain Axis, Neuroinflammation, and Metabolic Health

Neuroimmune interface:

Vagus nerve afferents (gut-to-brain), enteric neurotransmitter production (serotonin), immune cytokines crossing BBB, microbiota metabolites (SCFAs) modulating CNS function
Neuroinflammation
- Microglial activation (TNF-α, IL-1β, IL-6, ROS, glutamate excitotoxicity) drives bystander damage and underpins neurodegenerative disease progression.n
Leaky gut/leaky brain
- Zonulin-regulated tight junction breakdown; LPS endotoxemia activates TLR4, and NF-κB cascades; systemic inflammation disrupts BBB and perpetuates microglial activation
Alzheimer’s” “pe 3 Diabetes”
- Brain insulin resistance impairs synaptic plasticity and amyloid clearance via IDE competition; ketones (BHB) bypass insulin demands, inhibit NLRP3 inflammasome, and enhance mitochondrial efficiency and BDNF

Functional interventions:

5R gut protocol: Remove triggers (gluten, dairy, sugar), Replace digestive support (enzymes, HCL), Reinoculate (probiotics/prebiotics), Repair (L-glutamine, zinc, vitamins A/D, quercetin, curcumin, aloe), Rebalance (stress, sleep)
Ketogenic approach and metabolic flexibility where appropriate for cognitive and inflammatory control

References:

Zonulin and intestinal barrier function (Fasano, 2011)
Neuroinflammation in Alzheimer’s disease (Heneka et al., 2015)
LPS-induced BBB disruption (Banks et al., 2015)
Ketone metabolite BHB blocks NLRP3 inflammasome (Youm et al., 2015)
Alzheimer’s “Type 3 Diabetes” pathways (De Felice & Ferreira, 2014)
Microglia in Parkinson’s (Hirsch & Hunot, 2009)
Gram-negative bacterial molecules in AD pathology (Zhan et al., 2016)

Clinical Communication: Certainty, Options, and Ethical Care Plans

Communication is clinical—when I am certain, patients become certain. I avoid pressure and emphasize clarity, education, and choices.
Core elements:

Reports of findings that answer:
- What is the diagnosis? Why does it matter? How serious is it? What are the options? What is my recommendation? How long will it take? What are we measuring? What if care is delayed?
Two-option frameworks
- Acute repair vs. long-term correction; “Do you want a Band-Aid or a real fix?” Choice reframes from “if” to “which path”
Ethical care plans
- Clinically justified, transparent costs and expectations, measurable goals, documented progress, individualized adjustments, informed consent
Include family/caregivers when appropriate.
- Improves support, adherence, home exercise compliance, and lifestyle change adoption

Observations from practice (Chiromed, LinkedIn):

Patients improve when they understand the”“wh” behind care
Rehabilitation adheres when connected to meaningful life goals
Adjustments paired with active motor correction yield fewer flare-ups
Sleep and protein sufficiency correlate with faster tendon recovery
Imaging guides safety, but the exam drives care decisions
Clear education reduces fear-avoidance and delays

References:

Evidence-based medicine: What it is and what it isn’t (Sackett et al., 1996)
Non-invasive treatments for low back pain guideline (Qaseem et al., 2017)
Neck pain CPG revision 2017 (Blanpied et al., 2017)
Manual therapy mechanisms (Bialosky et al., 2018)

Rehabilitation Milestones and Outcome Measurement

Stages:

Relief and protection
- Isometrics reduce tendon pain; gentle mobility; breathing strategies tame sympathetic overdrive.
Motor control and stability
- Multifidus and deep neck flexor activation; proximal control (glute med/min, lower trap, serratus anterior); tempo work and feedback
Strength and endurance
- Progressive resistance; slow eccentrics for tendon remodeling; endurance capacity building
Return to function
- Work/sport-specific drills; rate-of-force development with joint-friendly programming

Measurements:

Pain scales (NPRS/VAS)
Function indexes (ODI, NDI, KOOS/HOOS, DASH)
Range of motion, strength
Patient-specific functional scales
Sleep metrics, quality-of-life measures

Personal Injury Care: Documentation and Recovery Pathways

For motor vehicle collisions and occupational injuries:

Early phase
- Rule out serious injury, imaging/referrals, vestibular-ocular rehab for CAD injuries where indicated, early activation to prevent deconditioning
Subacute phase
- Joint mobilization/manipulation, soft tissue work, progressive isometrics, motor control stabilization
Recovery and return
- Functional capacity evaluation elements, work hardening principles, ergonomic recommendations
Documentation
- Mechanism of injury, exam findings, imaging rationale, staged care, outcomes, and maximum medical improvement considerations

Safety Protocols: Angles, Nerve Landmarks, and Tool Selection

Trim risk:

Lateral approaches for spine/deep targets; avoid midline deep structures; slow seesaw depth testing; withdraw/reorient upon tingling
Nerve landmarks
- Radial nerve (lateral elbow), ulnar nerve (medial elbow), vertebral artery risks (upper cervical)
Instrument selection
- Blunt-tip styles when appropriate; cautious thoracic angles; ultrasound guidance to visualize metallic hardware and avoid contact

Practical Lifestyle and Ergonomic Changes

Small changes accumulate:

Desk setup
- Shoulder-friendly ergonomics, forearm neutral positioning, lumbar support
Footwear/orthotics
- Toe box width, midfoot stability, appropriate insoles
Movement snacks
- Short mobility breaks, posture resets, breath work during day

Clinical Observations: My Integrative Philosophy

From my clinical experience and collaborations:

Patients heal faster when their musculoskeletal mechanics, nervous system regulation, and systemic inflammatory status align
Chiropractic care emboldens proprioception, enabling more accurate muscle recruitment and better motor learning consolidation
Functional medicine reduces systemic”“noi e,” allowing local signals to repair rather than fight persistent inflammation
Medical oversight ensures timing safety (anticoagulants, oncology histories), proper referrals, and medication coherence
Needleless regenerative modalities expand access and layered support where injections aren’t viable
Explore practice insights:

My clinical portal: ChiroMed
Professional profile: LinkedIn Profile

Essential Reading to Support Integrated Perspectives

Life Force (Robbins, Diamandis, Hariri, 2022) — patient-accessible exploration of regenerative potential and personal narratives
The Pegan Diet (Hyman, 2021) — food-as-medicine frameworks relevant to anti-inflammatory milieus
Red Light Therapy: Miracle Medicine (Sloan, 2019) — photobiomodulation fundamentals for home and clinical application
The Ozone Miracle (Shallenberger, 2011) — adjunct oxygen utilization and immune modulation perspectives

Conclusion: A Patient-Centered, Evidence-Based Pathway to Healing

This comprehensive post connects modern regenerative science with integrative chiropractic care under internal medicine oversight to create a clear, ethical, and effective path from pain to durable function. At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), our multidisciplinary structure with Dr. Maria Guadalupe Cardenas, MD, ensures safety and coherence. We prepare the “soil” of biomechanics, nervous system regulation, and systemic health so that regenerative signals—biologic or needleless—can thrive. We measure outcomes, educate patients, and build certainty through communication.
If your goal is to recover movement, reduce pain, and restore resilience, the journey is multifaceted but navigable. We invite you to engage with this integrative model—one that respects physiology, honors evidence, and focuses relentlessly on your function and quality of life.

References

Bialosky, J. E., Bishop, M. D., Beneciuk, J. M., & George, S. Z. (2018). The mechanisms of manual therapy in the treatment of musculoskeletal pain: A comprehensive model. Pain, 159(Suppl 1), S26–S35.
Blanpied, P. R., Gross, A. R., Elliott, J. M., Devaney, L. L., Clewley, D., Walton, D. M., Sparks, C., & Robertson, E. K. (2017). Neck pain: Revision 2017 clinical practice guidelines linked to the International Classification of Functioning, Disability and Health from the Orthopedic Section of the American Physical Therapy Association. Journal of Orthopaedic & Sports Physical Therapy, 47(7), A1–A83.
Banks, W. A., Gray, A. M., Erickson, M. A., Salameh, T. S., Damodarasamy, M., Sheibani, N., & Reed, M. J. (2015). Lipopolysaccharide-induced blood-brain barrier disruption: Roles of cyclooxygenase, oxidative stress, and P-glycoprotein. Journal of Neuroinflammation, 12(1), 223.
Caplan, A. I. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Journal of Cellular Physiology, 213(2), 341–347.
Caplan, A. I., & Correa, D. (2011). The MSC: An injury drugstore. Cell Stem Cell, 9(1), 11–15.
Cacchio, A., & colleagues. (2021). Extracorporeal shockwave therapy in musculoskeletal disorders: Mechanotransduction and clinical outcomes. International Orthopedics
Colter, I. D., Crawford, C., Hurwitz, E. L., Vernon, H., Khorsan, R., Suttorp Booth, M., & Herman, P. M. (2018). Manipulation and mobilization for treating chronic low back pain: A systematic review and meta-analysis. The Spine Journal, 18(5), 866–879.
Cuenca, J., Le-Gatt, A., Castillo, V., & Beltrán, A. (2018). The reparative activities of menstrual-versus-bone marrow-mesenchymal stem cells in experimental cutaneous wounds. Frontiers in Physiology, 9, 438.
De Felice, F. G., & Ferreira, S. T. (2014). Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators of Alzheimer’s disease. Annals of the New York Academy of Sciences, 1332(1), 169–180.
Evans, S., Vonk, L. A., & Brama, P. A. (2019). The potential of menstrual blood-derived mesenchymal stromal cells in regenerative medicine. Stem Cells and Development, 28(11), 693–706.
Fasano, A. (2011). Zonulin and its regulation of intestinal barrier function: The biological door to inflammation, autoimmunity, and cancer. Physiological Reviews, 91(1), 151–175.
Haavik Taylor, H., & Murphy, B. (2011). Altered central integration of dual somatosensory input after cervical spine manipulation. Journal of Manipulative and Physiological Therapeutics, 34(3), 178–188.
Heneka, M. T., Carson, M. J., El Khoury, J., Landreth, G. E., Brosseron, F., Feinstein, D. L., et al. (2015). Neuroinflammation in Alzheimer’s disease. The Lancet Neurology, 14(4), 388–405.
Hirsch, E. C., & Hunot, S. (2009). Neuroinflammation in Parkinson’s disease: A target for neuroprotection?. The Lancet Neurology, 8(4), 382–397.
Hyman, M. (2021). The Pegan Diet: 21 Practical Principles for Reclaiming Your Health in a Nutritionally Confusing World. Little, Brown Spark.
Jacob, C. I., & Paskova, K. (2018). A novel non-invasive technology based on simultaneous application of radiofrequency and high-intensity focused electromagnetic fields for rejuvenation of the female intimate area. Journal of Cosmetic and Laser Therapy, 20(7-8), 441–446.
Johnson et al. (1994). MRI findings in asymptomatic individuals: Implications for clinical decision making. Radiology, 190(3), 811–814.
Ma, H., Wu, Y., Zhang, W., Dai, J., & Zhou, J. (2021). Efficacy of menstrual blood-derived stromal cell transplantation for restoring endometrial receptivity in patients with severe Asherman’s syndrome. Stem Cell Research & Therapy, 12(1), 1–11.
Paige, N. M., Miake-Lye, I. M., Booth, M. S., Beroes, J. M., Mardian, A. S., Dougherty, P., Branson, R., Tang, B., Morton, S. C., & Shekelle, P. G. (2017). Association of spinal manipulative therapy with clinical benefit and harm for acute low back pain: Systematic review and meta-analysis. JAMA, 317(14), 1451–1460.
Qaseem, A., Wilt, T. J., McLean, R. M., & Forciea, M. A. (2017). Non-invasive treatments for acute, subacute, and chronic low back pain: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 166(7), 514–530.
Robbins, T., Diamandis, P. H., & Hariri, R. (2022). Life Force: How New Breakthroughs in Precision Medicine Can Transform the Quality of Your Life & Those You Love. Simon & Schuster.
Samuels, J. B., & Pezzella, A. (2019). High-intensity focused electromagnetic (HIFEM) therapy for the treatment of urinary incontinence and female sexual dysfunction. Aesthetic Surgery Journal, 39(Suppl_3), S108–S109.
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996). Evidence-based medicine: What it is and what it isn’t. BMJ, 312(7023), 71–72.
Shallenberger, F. (2011). The Ozone Miracle: How you can harness the power of oxygen to reverse disease, slow down aging, and enjoy a disease-free life. CreateSpace Independent Publishing Platform.
Silantyeva, E., Zarkovic, D., Astafeva, E., Soldatskaya, R., & Orazov, M. (2021). Electromyographic evaluation of the pelvic floor muscle activity after high-intensity focused electromagnetic procedure in combination with laser in women with stress urinary incontinence. Lasers in Surgery and Medicine, 53(8), 1051–1058.
Sloan, M. (2019). Red Light Therapy: Miracle Medicine for Pain, Fatigue, Fat Loss, Anti-Aging, Muscle Growth and Brain Function. CreateSpace Independent Publishing Platform.
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., & Moir, R. D. (2010). The Alzheimer’s disease-associated amyloid β-protein is an antimicrobial peptide. PLoS ONE, 5(3), e9505.
Spees, J. L., Lee, R. H., & Gregory, C. A. (2016). Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Research & Therapy, 7(1), 125.
Tan, J., Li, P., Wang, Q., Li, Y., Li, X., Zhao, D., … & Xu, X. (2016). Autologous menstrual blood-derived stromal cells transplantation for severe Asherman’s syndrome. Human Reproduction, 31(12), 2723–2729.
Van Middelkoop, M., Rubinstein, S. M., Verhagen, A. P., et al. (2011). Exercise therapy for chronic nonspecific low-back pain. Best Practice & Research Clinical Rheumatology, 24(2), 193–204.
Wiesel, S. W., et al. (1984). A study of CT scans in people without back pain: High prevalence of abnormalities. Archives of Neurology, 41(8), 803–806.
Woolf, C. J. (2011). Central sensitization: Implications for the diagnosis and treatment of pain. Pain, 152(3 Suppl), S2–S15.
Youm, Y. H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D’Agostino, D., Planavsky, N., Muehlbauer, M. J., Newgard, C. B., Kang, S., Horvath, T. L., & Dixit, V. D. (2015). The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature Medicine, 21(3), 263–269.
Zhan, X., Stamova, B., Jin, L. W., DeCarli, C., Phinney, B., & Lyeth, B. G. (2016). Gram-negative bacterial molecules associate with Alzheimer’s disease pathology. Neurology, 87(22), 2324–2332.

SEO tags: regenerative medicine, orthobiologics, HCT/Ps, mesenchymal signaling cells, MSC, secretome, exosomes, umbilical cord tissue, menstrual stem cells, antifibrosis, angiogenesis, immunomodulation, chiropractic care, integrative chiropractic, internal medicine medical director, Dr Alexander Jimenez, Dr Maria Guadalupe Cardenas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, El Paso chiropractor, functional medicine, personal injury care, rehabilitation, shockwave therapy, PEMF, photobiomodulation red light, peptides BPC-157 TB-500, knee pain treatment, shoulder tendinopathy, lumbar spine pain, SI joint stabilization, hip labral pain, Morton’s neuroma, pelvic floor HIFEM therapy, allergy testing immunotherapy, gut-brain axis, neuroinflammation, leaky gut, ketogenic therapy, patient communication, ethical care plans, evidence-based chiropractic

July 21, 2026

Men’s Health, Erectile Function, and Integrative Restoration

Abstract

In this educational post, I present a comprehensive, first-person exploration of erectile dysfunction (ED) through an integrative, evidence-based lens, drawing on current research and clinical practices that combine regenerative medicine, internal medicine, functional medicine, chiropractic neuromusculoskeletal care, and rehabilitation. I explain ED’s multifactorial causes—vascular, neurogenic, hormonal, and psychogenic—and why ED can serve as an early cardiometabolic risk marker. I discuss traditional therapies like PDE5 inhibitors, then take a deeper dive into modern, restorative options including low-intensity extracorporeal shockwave therapy (Li-ESWT) and platelet-rich plasma (PRP) injections. I carefully examine evaluation protocols for hypogonadism (low testosterone), laboratory testing nuances (total versus free testosterone, SHBG, LH, estradiol, prolactin), and monitoring considerations (PSA, hematocrit). I elaborate on peptide-based adjuncts (e.g., hCG, gonadorelin, CJC-1295/ipamorelin, PT-141, BPC-157, TB-500) and their physiologic rationale. Throughout, I highlight how our integrative team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, brings together chiropractic care, functional medicine, internal medicine oversight, rehabilitation, personal injury care, and patient education under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). I share my clinical observations from practice and published research, explain the stepwise reasoning behind each protocol, and show how multidisciplinary care enhances safety, outcomes, and patient experience.

Key takeaways:

ED is common, increases with age, and often reflects underlying vascular disease; screen for cardiometabolic risk in every ED presentation.
PDE5 inhibitors can help symptoms but may lead to tolerance; Li-ESWT and PRP target vascular and neural regeneration for restorative impact.
Testosterone does not directly “cause” ED, but low T can reduce libido and responsiveness to therapies; evaluate hormones comprehensively.
Integrative care (chiropractic, rehab, functional medicine, internal medicine) supports endothelial health, autonomic balance, pelvic biomechanics, inflammation control, and overall cardiometabolic status.
Monitoring, shared decision-making, and personalized care plans are essential for safety and sustained results.

Introduction to Men’s Health and Erectile Function

I have always approached men’s health as a conversation about vitality—circulation, nerve function, endocrine balance, mental wellbeing, and structural integrity working together. When a patient tells me, “Doc, I’ve got erectile dysfunction—what can I do beyond the blue pill?” my first response is twofold:

Let’s make sure we understand why this is happening.
Let’s make sure we are not missing a more serious condition, especially cardiovascular disease.

ED is the inability to attain or maintain an erection sufficient for satisfactory sexual performance. It reduces quality of life, strains relationships, and can be an early marker of systemic vascular disease. The integrative approach we use is designed to restore function at the root level—optimizing blood flow, endothelial health, nerve signaling, hormonal context, mental health, and biomechanics.

In our clinic, I work closely with Dr. Maria Guadalupe Cardenas, MD, who brings over 40 years of internal medicine experience and serves as the Medical Director and Collaborative Physician for our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas. This MD-DC collaboration is foundational to our model of integrative care, ensuring medical oversight, safety, and advanced diagnostics sit comfortably alongside chiropractic and functional medicine strategies.

Our Integrative Practice Model in El Paso: Medical Direction and Collaborative Care

I practice as a chiropractor and nurse practitioner with board certification (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST), and my day-to-day work reflects my firm belief in coordinated, patient-centered care:

Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749; Texas License #J2933) serves as our Medical Director and Collaborative Physician. She oversees medical protocols, medication safety, laboratory and imaging evaluations, and coordinates care when cardiology, urology, or endocrinology input is needed.
I lead chiropractic neuromusculoskeletal care and functional medicine assessment, focusing on autonomic balance, pain modulation, biomechanics, pelvic floor and lumbopelvic mechanics, and lifestyle medicine.
Our rehabilitation team supports neuromuscular retraining, pelvic health therapies, and graded exercise for vascular conditioning.
We integrate personal injury care principles where trauma, scar patterns, or pelvic/lumbar compromise are components of the ED picture.
We apply regenerative modalities—low-intensity extracorporeal shockwave therapy (Li-ESWT) and PRP—in carefully screened patients, with internal medicine oversight.

This structure mirrors the modern integrative or injury care clinic, where MDs and DCs collaborate to deliver comprehensive care.

Why Erectile Dysfunction Requires a Whole-Person Lens

ED is rarely “just one thing.” As I explain to patients, the penis is a vascular organ governed by neurohormonal and psychogenic regulation, housed within a biomechanical framework (pelvis, lumbar spine, hips) and influenced by systemic inflammation and cardiometabolic health.

Vascular: Endothelial dysfunction and atherosclerosis reduce nitric oxide (NO) bioavailability, impairing smooth muscle relaxation and arterial inflow.
Neurogenic: Autonomic imbalance, peripheral neuropathy (e.g., diabetes), pelvic nerve injury (surgery, radiation), and spinal dysfunction can compromise neural signaling.
Hormonal: Hypogonadism affects libido, mood, energy, and responsiveness to treatments; thyroid, cortisol, and estradiol also modulate sexual function.
Psychogenic: Depression, anxiety, performance stress, and relationship dynamics profoundly influence desire and arousal.
Iatrogenic and drug-induced: Antihypertensives, SSRIs, antipsychotics, opioids, and other medications frequently contribute to ED.
Biomechanical: Pelvic floor hypertonicity, SI joint dysfunction, lumbar facet pain, and hip mechanics can perpetuate pain-avoidance patterns, affect autonomic tone, and reduce sexual function.

When we encounter ED, we’re looking at the whole physiologic network—from cardiometabolic markers to pelvic mechanics—to determine what needs to be restored for erections to happen predictably and comfortably.

ED as a Cardiovascular Marker: What I Want Every Patient to Know

If you remember just one thing from this post, let it be this: Erectile dysfunction can be an early sign of cardiovascular disease. The penile arteries are small; they can reveal vascular compromise earlier than coronary symptoms. So, when a patient presents with ED, we screen for cardiometabolic risk—lipids, glycemic status, blood pressure, inflammatory markers, sleep apnea risk, and sometimes advanced vascular testing—in partnership with internal medicine and cardiology when needed. ED is often the first noticeable sign that the vascular system needs attention.

Prevalence and Age: What the Numbers Tell Us

ED prevalence climbs with age, driven by cumulative vascular risk, hormonal shifts, medication burden, and chronic disease. Hundreds of millions of men are affected worldwide. While age is a key factor, ED is not “just aging.” It is actionable physiology. There is much we can restore.

Pathophysiology of Erection: A Clear, Practical Primer

To choose the right therapies, patients deserve a clear explanation of how erections work.

Neural triggers: Erotic stimuli and physical touch activate cortical and spinal pathways. Parasympathetic fibers (S2-S4) release NO via neuronal nitric oxide synthase (nNOS) in penile tissue.
Endothelial response: Shear stress and acetylcholine stimulate endothelial nitric oxide synthase (eNOS) to produce NO, diffusing into smooth muscle of the corpus cavernosum.
NO-cGMP pathway: NO activates soluble guanylyl cyclase, increasing cyclic GMP (cGMP). cGMP reduces intracellular calcium, causing smooth muscle relaxation, arterial dilation, and venous occlusion of subtunical veins—producing rigidity.
PDE5 regulation: Phosphodiesterase type 5 degrades cGMP, ending the erection. PDE5 inhibitors (e.g., sildenafil, tadalafil) block this breakdown, prolonging cGMP action.
Sympathetic and adrenergic tone: Excess sympathetic activity (stress, pain, anxiety) elevates norepinephrine, tightening smooth muscle and impairing erections. Balance is critical.
Structural integrity: The tunica albuginea’s biomechanical properties, pelvic floor coordination, and absence of pain enable sustained erection and thrusting.
Hormonal context: Adequate testosterone supports libido, NO synthase expression, PDE5 responsiveness, and mood/energy.

Vascular dysfunction, neuropathy, hormonal imbalance, or psychogenic tension at any step can derail erections.

Common Causes and Contributors: From Vascular to Medication Effects

When I assess ED, I use a structured framework:

Vascular (vasculogenic)
- Atherosclerosis, endothelial dysfunction, impaired NO signaling
- Diabetes-related microvascular disease
- Hypertension-related vascular remodeling
Neurogenic
- Peripheral neuropathy (diabetes, B12 deficiency, chemotherapy)
- Post-surgical or post-radiation nerve injury (e.g., radical prostatectomy)
- Spinal stenosis, discopathy, or pelvic nerve entrapment
Hormonal
- Low testosterone (hypogonadism): impacts libido and PDE5 responsiveness
- Thyroid dysfunction, hyperprolactinemia, cortisol dysregulation
- Aromatization and unfavorable T:E2 ratios
Psychogenic
- Depression, anxiety, relationship stress, sexual trauma history
- Performance anxiety and maladaptive autonomic patterns
Drug-induced
- Antihypertensives (e.g., beta blockers, thiazides)
- SSRIs/SNRIs, antipsychotics
- Opioids and androgen suppression
Iatrogenic and trauma-related
- Pelvic surgeries, radiation fibrosis
- Pelvic fractures, lumbar/pelvic injuries
Lifestyle and sleep
- Sedentary behavior, obesity, poor diet, alcohol use
- Sleep apnea (major factor in testosterone and endothelial dysfunction)
Biomechanics and pain
- Pelvic floor hypertonicity or dyssynergia
- SI joint dysfunction, lumbar facet syndromes, hip pathology

This framework helps us prioritize diagnostics and personalize treatment.

Traditional Therapies: PDE5 Inhibitors and Their Limits

PDE5 inhibitors like sildenafil (Viagra) and tadalafil (Cialis) enhance NO-mediated vasodilation by preventing cGMP breakdown. Many patients experience benefits; however:

Side effects can include flushing, headache, nasal congestion, visual disturbances, back pain (especially with tadalafil), and dyspepsia.
Drug interactions (e.g., nitrates) can be dangerous.
Tachyphylaxis: Over time, some men report diminished response, requiring higher doses. This may reflect progressive endothelial dysfunction or underlying disease progression rather than classical receptor desensitization alone.
They do not regenerate tissue; they amplify an existing pathway that requires baseline endothelial integrity.

Hence, I position PDE5 inhibitors as symptomatic support while we work to restore the vascular and neural substrate.

Regenerative and Restorative Options: Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT)

I often recommend Li-ESWT as a non-invasive modality to improve penile hemodynamics and endothelial function. The mechanism:

Acoustic waves induce controlled microtrauma that stimulates a healing cascade.
Upregulation of angiogenic factors like vascular endothelial growth factor (VEGF), endothelial progenitor cell recruitment, and neovascularization.
Improved endothelial function (eNOS activity), increased smooth muscle content, and enhanced blood flow within the corpus cavernosum.
Remodeling of microvascular networks supports better filling and rigidity.

Clinical considerations:

Indications: Vasculogenic ED, especially mild-to-moderate cases; adjunct use after prostate cancer treatment when appropriately timed; diabetic neuropathy-related ED as a supportive therapy.
Protocols: Typically multiple sessions over several weeks. Exact dosing varies by device and published protocol; our internal medicine oversight ensures safe patient selection.
Safety: Generally well-tolerated; transient local discomfort or bruising can occur.

At-home options:

Some patients are interested in handheld acoustic devices for maintenance between in-clinic treatments. While consumer-grade units vary in output and evidence, they can be considered adjuncts with proper guidance. We educate patients on realistic expectations, usage frequency, and safety.

Why it fits integrative practice:

Li-ESWT targets the vascular root—helping restore endothelial health rather than just masking symptoms—making it a natural complement to functional medicine, chiropractic modulation of autonomic tone, and rehabilitation.

Platelet-Rich Plasma (PRP) for Erectile Function

PRP concentrates autologous platelets and growth factors to stimulate tissue repair, angiogenesis, and neuroregeneration. Injected into targeted penile tissues under strict sterile technique, PRP can:

Promote endothelial and smooth muscle regeneration
Support nerve healing (especially relevant in diabetic or post-prostatectomy contexts)
Enhance microcirculation and tissue quality

Physiologic basis:

Platelet alpha granules release PDGF, VEGF, TGF-β, IGF-1, and other mediators.
These factors modulate fibroblast activity, collagen remodeling, and neovascularization.

Clinical considerations:

Indications: Vasculogenic ED, adjuvant care post-prostatectomy (in appropriate windows), Peyronie’s-related tissue remodeling support.
Safety: Autologous product lowers immunologic risk; minor bruising/swelling possible. Internal medicine oversight ensures patient suitability (platelet counts, anticoagulation considerations).
Synergy with Li-ESWT: Combining Li-ESWT and PRP often yields better outcomes than either alone, leveraging angiogenic priming and growth factor support.

Rationale within integrative care:

PRP embodies a regenerative philosophy—supporting intrinsic healing aligned with lifestyle, biomechanics, and cardiometabolic optimization.

Combining Li-ESWT and PRP: The Synergistic Rationale

Li-ESWT primes the microenvironment via microtrauma and angiogenic signaling, increasing receptivity to growth factors.
PRP delivers concentrated growth factors that capitalize on that primed milieu, enhancing endothelial repair and smooth muscle regeneration.
Together, they may produce more robust and durable improvements in penile hemodynamics and erectile function.

We personalize sequencing based on patient phenotype, comorbidities, and scheduling preferences—always with metrics and follow-up to gauge response.

Post-Prostatectomy and Post-Radiation Patients: Special Considerations

I am frequently asked whether post-prostatectomy or post-radiation patients can be considered for restorative therapies. In collaboration with urology and internal medicine:

Timing matters. Historical caution favored waiting five years post-cancer therapy before regenerative or hormonal interventions. More recent guidance suggests that 1–2 years may be sufficient for select patients, contingent on oncologic clearance and stable disease markers.
Li-ESWT and PRP may be considered for neurovascular support once the treating oncologist and urologist agree the window is appropriate.
Pelvic rehabilitation, nerve gliding, scar mobilization, and autonomic downregulation (e.g., biofeedback, diaphragmatic breathing) are particularly important in this cohort.
Psychological support and partner-inclusive counseling can be transformative.

We prioritize shared decision-making, clear risk-benefit discussions, and inter-specialty communication.

Hormones and Hypogonadism: Clarifying Testosterone’s Role

A critical nuance: Low testosterone does not directly “cause” ED in most cases, but hypogonadism frequently diminishes libido, energy, mood, and the physiological responsiveness of erectile tissue to NO and PDE5 inhibitors.

Symptoms suggestive of low testosterone:

Reduced libido, erectile difficulty, fatigue, depressed mood, decreased initiative
Reduced morning erections, slow recovery from exercise, decreased lean mass
Possible gynecomastia or increased abdominal adiposity

Physical and lab considerations:

Obesity often lowers sex hormone-binding globulin (SHBG), which can render total testosterone “normal” despite functional deficiency. Hence, free testosterone assessment is essential in obese patients.
A practical viewpoint I share with patients: Your free testosterone reflects the biologically active hormone available to tissues. If SHBG is low or high, total T can mislead.

Laboratory Evaluation: Getting It Right the First Time

When I evaluate possible hypogonadism, I follow a methodical pathway:

Total testosterone: Draw in the morning (typically 7–10 a.m.). Repeat on a separate day for confirmation, as values fluctuate.
Free testosterone: Especially in obesity, metabolic syndrome, or when total T is borderline or inconsistent with symptoms.
SHBG: To interpret discrepancies between total and free T.
LH and FSH: Differentiate primary (testicular) from secondary (hypothalamic-pituitary) hypogonadism.
- Low T with high LH/FSH suggests primary testicular failure.
- Low T with low/normal LH/FSH suggests central hypogonadism—consider prolactin and pituitary scrutiny.
Prolactin: Elevated levels may indicate a prolactinoma or medication effects (e.g., antipsychotics).
Estradiol (E2): Especially with gynecomastia or obesity to assess aromatization and T E2 ratio dynamics.
Thyroid panel: Thyroid dysfunction can drive fatigue, mood changes, and sexual symptoms.
Cortisol or HPA-axis assessment: Selectively, especially with sleep disruption, central adiposity, or chronic stress.
PSA and digital rectal exam: For men considering testosterone therapy, with age- and risk-based screening.

Cutoffs and interpretation:

The American Urological Association considers total testosterone <300 ng/dL as a biochemical threshold for hypogonadism in the presence of symptoms. I always treat the patient, not just the number—symptom context is essential.

Testosterone Therapy: Indications, Targets, and Monitoring

When we initiate testosterone replacement therapy (TRT) in appropriate candidates:

Goals: Alleviate symptoms (energy, libido, mood), improve lean mass and bone density, enhance glycemic control in insulin-resistant individuals, and support sexual function responsiveness.
Target range: A pragmatic window is often 450–600 ng/dL for total testosterone, recognizing that individual symptom relief may occur at different levels and that levels can overshoot and require dose adjustments.
Monitoring:
- Hematocrit/hemoglobin: Watch for erythrocytosis; adjust dose or dosing interval if hematocrit rises excessively.
- PSA and prostate health: Regular surveillance, particularly in older men or those with prostate risk factors.
- Lipids, glucose, blood pressure: Assess cardiometabolic impacts.
- Sleep apnea screening: TRT can exacerbate obstructive sleep apnea; untreated OSA should be addressed before or during TRT.
- Estradiol: Adjust aromatization risk; optimize T:E2 balance. Excessive suppression of E2 can impair endothelial health and libido.

Special cautions:

Post-cardiac event: Avoid initiating TRT within 3–6 months of an acute coronary syndrome without cardiology input.
Prostate cancer history: Shared decision-making with urology; evolving evidence and careful monitoring can allow TRT in select patients after appropriate oncologic clearance.

Why TRT can help ED:

By improving libido and mood, and by enhancing NO synthase expression and PDE5 inhibitor responsiveness, TRT can make erections more achievable. However, TRT is not the primary ED treatment in most men—it is an adjunct that optimizes the hormonal milieu for other therapies to work better.

Questionnaires and Communication: Opening the Door for Men

Many men are reluctant to initiate conversations about ED. In my clinic, we use validated questionnaires to invite dialogue:

Androgen deficiency screening (e.g., ADAM-like tools) focusing on libido and erectile strength
Sexual Health Inventory for Men (SHIM) to quantify erectile function
Mood and sleep screeners to capture depression/anxiety and sleep apnea risk

These tools create a comfortable on-ramp to meaningful, private conversations.

Peptide-Based Adjuncts: Where They Fit and Why

Peptides can support physiologic pathways relevant to sexual function, tissue repair, and energy. In our practice, we apply them thoughtfully, after hormonal evaluation and cardiometabolic screening.

hCG (human chorionic gonadotropin): Mimics LH to stimulate Leydig cells and endogenous testosterone production. May be used with or without TRT to preserve fertility or as a fertility-friendly alternative. Side effects can include increased estradiol, fluid retention, or mood changes; we monitor E2 and symptoms.
Gonadorelin: A GnRH analog that can stimulate LH/FSH secretion from the pituitary, supporting endogenous testosterone and spermatogenesis; particularly useful when preserving fertility is a priority.
CJC-1295 with ipamorelin: Supports pulsatile growth hormone release; patients often report improved sleep, recovery, body composition, and vitality. Indirectly, better sleep and reduced adiposity can benefit sexual function and endothelial health.
PT-141 (bremelanotide): Centrally acting melanocortin receptor agonist that increases sexual desire and can improve erectile function independent of NO pathways—useful in PDE5 non-responders or where NO is compromised. Dose titration is key due to nausea risk; we start low and go slow.
BPC-157 and TB-500: Regenerative adjuncts that may support angiogenesis, tissue repair, and nitric oxide signaling. While not ED-specific, they fit a tissue-healing paradigm—especially when pelvic or musculoskeletal injuries are present.

We place peptides in the context of a comprehensive plan; they are not magic bullets, but they can be valuable tools when physiology and safety are respected.

Sleep Apnea and ED: Why I Screen Aggressively

Obstructive sleep apnea (OSA) is an underrecognized driver of ED and low testosterone. Intermittent hypoxia:

Damages endothelial function
Disrupts nocturnal testosterone rhythms
Increases sympathetic drive (counterproductive for erections)

TRT can worsen untreated OSA by relaxing upper airway musculature. Therefore:

We screen ED patients for OSA risk (snoring, witnessed apneas, morning headaches, hypertension, daytime sleepiness).
When appropriate, we refer for sleep studies and initiate CPAP or other therapies.
Addressing OSA can dramatically improve energy, libido, metabolic health, and erectile function.

Integrative Chiropractic Care: Where the Spine, Pelvis, and Autonomics Meet Sexual Function

As a chiropractor and clinician in functional medicine, I often see the interplay between pain, autonomic stress, and sexual function:

Pain and sympathetic overdrive: Chronic pain elevates sympathetic tone, releasing norepinephrine that tightens smooth muscle in cavernous tissue—counteracting erection.
Pelvic floor dynamics: Hypertonic pelvic floors can contribute to erectile and ejaculatory dysfunction. Biofeedback, breathing, manual therapy, and targeted exercises can normalize tone.
Lumbopelvic mechanics: SI joint dysfunction, lumbar facet irritation, or hip mobility restrictions can produce antalgic posture and pelvic floor guarding, reducing sexual comfort and performance.
Neural facilitation: Manual therapy, spinal manipulation, and neurodynamic techniques can modulate nociception, improve autonomic balance, and reduce myofascial trigger patterns that perpetuate sexual dysfunction.

When paired with cardiometabolic optimization and regenerative therapies, chiropractic supports the neuromusculoskeletal foundations of erectile function.

Clinical observations from my work:

Patients with low back pain and hypertonic pelvic floors often report improved erections after a course of lumbopelvic adjustments, soft tissue release, and pelvic floor downtraining, especially when we add diaphragmatic breathing and graded exposure to sexual activity without pain.
Restoring hip extension and addressing anterior pelvic tilt can reduce pelvic floor strain and improve comfort and rigidity during intercourse.

References to my clinical perspective and ongoing educational contributions can be found on my clinic site and professional profile:

https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Functional Medicine Foundations: Inflammation, Metabolism, and Vascular Health

ED improves when we address the roots of endothelial dysfunction:

Nutrition: Emphasize Mediterranean-style or DASH-pattern diets rich in polyphenols, omega-3s, nitrate-rich vegetables (beets, leafy greens), and low in refined sugars. This supports NO production, reduces oxidative stress, and improves lipid profiles.
Glycemic control: Hyperglycemia damages microvasculature and nerves. We optimize A1c, fasting insulin, and postprandial responses with dietary strategies, activity, and sometimes pharmacotherapy in collaboration with Dr. Cardenas.
Lipids and blood pressure: Dyslipidemia and hypertension impair endothelial function. We personalize treatment plans—nutrition, exercise, and medication when indicated.
Exercise: Aerobic and resistance training increase endothelial NO, improve insulin sensitivity, and reduce visceral adiposity. We tailor programs for safety and adherence.
Stress and sleep: Mind-body practices, cognitive behavioral strategies, and sleep hygiene reduce sympathetic overload and restore hormonal rhythms.
Micronutrients: We evaluate zinc, vitamin D, B12, and general nutrient status where indicated; deficiencies can impact testosterone synthesis and nerve health.

By repairing the vascular terrain, we enhance the effectiveness of PDE5 inhibitors, Li-ESWT, PRP, and TRT.

Medication Review and Deprescribing Opportunities

Because many medications can contribute to ED, our internal medicine oversight is invaluable:

Antihypertensives: We consider switching from agents with higher ED risk to alternatives with neutral/beneficial profiles when clinically appropriate.
SSRIs/SNRIs: For patients with SSRI-induced dysfunction, options include dose adjustments, drug holidays (with psychiatric guidance), switching agents, or adding adjuncts like bupropion. PT-141 may offer benefit in select cases.
Opioids: These suppress the HPG axis and libido. We explore pain management alternatives—chiropractic, rehabilitation, interventional pain approaches, and non-opioid pharmacology.
Antipsychotics: Collaboration with psychiatry is essential; sexual function can be prioritized alongside mental health stability.

We never make unilateral medication changes; we coordinate with the prescribing physician and the patient.

Evaluating ED: A Stepwise Clinical Pathway

When a man presents with ED at our clinic, our integrative pathway looks like this:

History and questionnaires
- Sexual function (onset, severity, nocturnal/morning erections, relationship factors)
- Cardiometabolic risk (diabetes, hypertension, dyslipidemia, family history)
- Medications and substances (alcohol, tobacco, recreational drugs)
- Sleep (screen for OSA)
- Pain and biomechanics (low back, pelvis, hips)
- Mood and stress
Physical exam
- Vital signs, BMI, waist circumference
- Cardiovascular and neurologic screening
- GU exam when indicated
- Musculoskeletal: lumbopelvic assessment, pelvic floor tone, hip mobility
Labs and diagnostics
- Testosterone (total and free), SHBG, LH/FSH, prolactin, estradiol
- Metabolic panels: A1c, fasting glucose, lipids, hs-CRP, kidney/liver function
- PSA per age/risk
- Thyroid panel
- Sleep study if OSA risk elevated
- Consider penile Doppler ultrasound in select vasculogenic cases (urology)
Initial plan
- Address cardiometabolic risks
- Consider PDE5 inhibitors for symptom relief
- Initiate lifestyle and chiropractic/rehab interventions
- Plan for Li-ESWT and/or PRP if appropriate
- Discuss hormonal therapy when indicated and safe
Monitoring and iterative care
- Track symptom scores (SHIM), energy, libido, and partner feedback
- Reassess labs (hematocrit, PSA, T/E2 as appropriate)
- Adjust protocols for response and tolerability
- Coordinate with cardiology/urology/endocrinology as needed

This structure promotes safety, personalization, and meaningful outcomes.

Integrating Personal Injury Care When Trauma Is Part of the Story

Men who present after accidents—motor vehicle collisions, work injuries, or sports trauma—may have:

Pelvic fractures, pubic symphysis dysfunction, or SI joint instability
Lumbar disc injury or stenosis with nerve involvement
Residual pain that disrupts sexual function and creates fear-avoidance patterns

Our personal injury experience helps us:

Restore biomechanics and reduce pain through chiropractic and rehab
Guide graded return to sexual activity with positions and pacing that minimize pain
Introduce mind-body pacing to reduce anticipatory anxiety and sympathetic activation

When the body feels safe and pain is controlled, erectile function often improves.

Psychogenic Factors, Counseling, and Partner Involvement

ED frequently carries a psychogenic component—sometimes primary, often secondary to initial physical dysfunction. We:

Normalize the experience: ED is common and treatable.
Encourage partner-involved discussions to reduce secrecy and shame.
Refer to counseling when trauma, relationship conflict, or significant performance anxiety is present.
Teach nervous system regulation: breathwork, progressive muscle relaxation, and mindfulness to downshift sympathetic tone.
Consider centrally acting agents like PT-141 in select cases resistant to peripheral pathways.

Healing is faster when the mind and relationship ecosystem are part of the plan.

Putting It Together: Example Care Pathways

Scenario 1: Mild-to-moderate vasculogenic ED in a 52-year-old with hypertension and dyslipidemia

Internal medicine adjusts antihypertensives to reduce ED risk
Nutrition and exercise plan; consider statin or alternative lipid strategy as appropriate
PDE5 inhibitor for immediate support
Li-ESWT course with home pelvic floor relaxation exercises and chiropractic care
Evaluate testosterone status; if low with symptoms, discuss TRT with monitoring
Results: Improved SHIM scores, better blood pressure and lipids, reduced reliance on high PDE5 doses

Scenario 2: Post-prostatectomy patient 18 months out, cleared by urology

Shared decision-making re: Li-ESWT and PRP sequence
Pelvic rehab (nerve gliding, scar mobilization), autonomic regulation practices
Consider PT-141 if NO-pathway limited response
Monitor progress with internal medicine and urology collaboration
Results: Gradual return of erectile function, improved confidence and relationship satisfaction

Scenario 3: Obese 45-year-old with SSRI-induced sexual dysfunction and untreated sleep apnea

Sleep study → CPAP initiation; possible psychiatric consultation for antidepressant strategy
Functional nutrition, resistance training; weight reduction goals
Free testosterone assessment; manage hypogonadism if present
Consider PT-141 low-dose for desire, Li-ESWT if vascular findings
Chiropractic and rehab to reduce low back pain and sympathetic tone
Results: Energy and libido increase, better erections, mood stability preserved

Safety, Ethics, and Shared Decision-Making

We anchor our care in safety and patient autonomy:

Transparent discussion of benefits, risks, alternatives
Appropriate intervals for lab monitoring and oncology/cardiology coordination
Avoiding overpromising; setting realistic expectations and timelines
Respecting patient values and preferences in choosing therapies

The Role of Education and Self-Care

My patients do better when they understand their bodies and have agency. We emphasize:

Daily walking and resistance training to boost NO and insulin sensitivity
Nitrate-rich vegetables and polyphenols for endothelial support
Sleep regularity, CPAP adherence when prescribed
Stress regulation techniques to normalize autonomic tone
Honest partner communication to reduce performance pressure

Small, consistent actions compound to restore sexual health.

Evidence, Guidelines, and Evolving Frontiers

ED management draws from urology, cardiology, endocrinology, sleep medicine, rehabilitation, and integrative health research. Key points reflected in current literature:

ED as a vascular risk marker: Screening for cardiometabolic disease is essential.
PDE5 inhibitors: Efficacious for many; consider tolerance and side effects.
Li-ESWT and PRP: Growing evidence supports restorative benefits in vasculogenic ED, with combination approaches showing enhanced outcomes.
Hypogonadism: Symptom-driven diagnosis with biochemical confirmation; TRT helps selected patients and requires careful monitoring.
Sleep apnea: Treatment improves sexual and hormonal health; TRT requires caution in untreated OSA.
Psychogenic factors: Behavioral therapies and centrally acting agents (PT-141) can help, especially in complex or refractory cases.

Our clinic stays current by engaging with new research and participating in continuing education—balancing innovation with safety.

How MD-DC Collaboration Elevates Care

I cannot overstate the value of having Dr. Maria Guadalupe Cardenas, MD, as our Medical Director and Collaborative Physician:

She ensures medical rigor in our protocols, from lab interpretation to medication safety.
She coordinates with specialists when deeper cardiac or oncologic questions arise.
She enhances patient trust and provides continuity, especially for patients with complex medical histories.

My chiropractic and functional medicine perspective dovetails with her internal medicine expertise. Together, we craft personalized plans that address the heart of the problem and the whole person.

Practical Tips for Patients Starting the Journey

Be candid: Your story helps us help you. ED is common—we’re here to listen, not judge.
Expect a workup: Blood tests and sometimes imaging are part of getting answers.
Think beyond pills: Restorative therapies and lifestyle changes can produce deeper, more lasting improvements.
Prioritize sleep and stress: These are not side issues—they are central to hormonal and vascular health.
Involve your partner: Healing is easier together.

What I’ve Learned from Practice

Over the years, several themes keep showing up:

When we treat ED as a vascular and systemic issue first, outcomes improve.
Patients who embrace lifestyle change alongside regenerative therapies maintain gains longer and need fewer medications.
Pelvic floor and spinal mechanics matter more than most people think—addressing them often unlocks progress.
Communication and trust create adherence; adherence creates results.

You can read more about our clinical philosophy and community education efforts at:

https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Conclusion: From Symptom Relief to True Restoration

Erectile dysfunction is not a life sentence—it’s a call to action. By identifying the root contributors and addressing them with modern, evidence-based, integrative care, we can restore function and confidence. Our multidisciplinary model in El Paso brings internal medicine oversight, chiropractic neuromusculoskeletal care, functional medicine, rehabilitation, and regenerative therapies together for safe, personalized, and effective care.

If ED brought you here, let it also guide you toward better heart health, stronger energy, and deeper connection. We’re ready to walk that path with you.

References

American Urological Association. (n.d.). Guidelines on the evaluation and management of testosterone deficiency.
Burnett, A. L., Nehra, A., Breau, R. H., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J. J., Khera, M., Kirkby, E., Miner, M. M., Nelson, C. J., Sadeghi-Nejad, H., Shindel, A. W., & Montague, D. K. (2018). Erectile dysfunction: AUA guideline. The Journal of Urology.
Corona, G., Rastrelli, G., Maseroli, E., Forti, G., Maggi, M. (2015). Cardiovascular risk associated with erectile dysfunction. European Heart Journal.
Gruenwald, I., Appel, B., Vardi, Y. (2013). Low-intensity shockwave therapy in vascular erectile dysfunction. Therapeutic Advances in Urology.
Khera, M., Bhattacharya, R. K., Blick, G., Kushner, H., Nguyen, D., Miner, M. (2011). Testosterone therapy and cardiovascular outcomes. The Journal of Sexual Medicine.
Levine, L. A., & Rybak, J. (2011). Trauma, pelvic surgery, and ED: Pathophysiology and management. The Journal of Sexual Medicine.
Porst, H., Burnett, A., Brock, G., Ghanem, H., Giuliano, F., Glina, S., Hellstrom, W., Montorsi, F., & Sharlip, I. (2013). The Princeton III Consensus recommendations for the management of ED and cardiovascular disease. The Journal of Sexual Medicine.
Ramasamy, R., et al. (2019). Platelet-rich plasma therapy for erectile dysfunction: Mechanisms and evidence. Sexual Medicine Reviews.
Reisman, Y., et al. (2017). Low-intensity extracorporeal shockwave therapy for erectile dysfunction: Clinical evidence review. The World Journal of Men’s Health.
Shindel, A. W., & Lue, T. F. (2007). Sexual dysfunction in men with diabetes and metabolic syndrome. The Journal of Sexual Medicine.
Tan, R. S., Pu, S. J. (2002). Obstructive sleep apnea and erectile dysfunction. The Aging Male.
Vardi, Y., Appel, B., Jacob, G., Massarwi, O., Gruenwald, I. (2010). Can low-intensity extracorporeal shockwave therapy improve erectile function?. European Urology.
Yafi, F. A., Jenkins, L., Albersen, M., Corona, G., Isidori, A. M., Goldfarb, S., Maggi, M., & Hellstrom, W. J. G. (2016). Erectile dysfunction. Nature Reviews Disease Primers.

July 20, 2026

Integrative Care Overview for Regenerative Medicine

Learn how regenerative medicine combined with integrative care can support your wellness journey and improve overall health outcomes.

Educational Abstract: Integrative Muse Stem Cell Care with Chiropractic, Functional Medicine, and Medical Oversight

In this educational post, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, guide you through a clear, first-person journey on the emerging science and clinical integration of Muse stem cells—multilineage-differentiating stress-enduring cells—within a multidisciplinary care model. I explain what Muse stem cells are, how they differ from standard mesenchymal stem cells, and why their unique stress-endurance and pluripotency matter for complex conditions affecting musculoskeletal, neural, cardiac, hepatic, and dermal tissues. I present how our team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas integrates chiropractic care, functional medicine, regenerative strategies, personal injury care, and rehabilitation under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933). This post synthesizes recent findings and mechanisms—homing via S1P2 receptors and SDF-1 gradients, differentiation across all three germ layers, and paracrine signaling—while highlighting evidence-based clinical protocols, safety considerations, and practical applications, including dilution strategies and bio-scaffolding. Throughout, I share clinical observations from my work with patients and collaborating clinicians, leveraging modern, peer-reviewed research methods and transparent verification such as SSEA-3 marker validation.

Evidence-Based Muse Stem Cells: My Clinical Perspective and Team Integration

I have spent my career building integrated care pathways that combine chiropractic biomechanics, functional medicine, and evidence-based regenerative strategies. Over the last nine months, I have been deeply engaged with physicians and researchers who are advancing Muse stem cells—also called multilineage-differentiating stress-enduring cells—in the United States. These cells are garnering attention because they appear to be more resilient under physiological stress and capable of differentiating across all three germ layers, which has implications for multi-organ repair and complex chronic conditions.
Our practice model is multidisciplinary by design. Under the medical direction of Dr. Maria Guadalupe Cardenas, MD—Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933—and in collaboration with my chiropractic and functional medicine teams, we formulate personalized care plans. At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, Dr. Cardenas serves as our Medical Director and Collaborative Physician. This MD-DC collaboration ensures medical oversight of regenerative protocols, safety monitoring, and integration with imaging, labs, and pharmacologic considerations. At the same time, we layer in integrative chiropractic care, neuromusculoskeletal rehabilitation, and functional medicine frameworks. This team-based approach is common in integrated injury care and improves outcomes, compliance, and patient satisfaction.
Key components of our integrated model:

Medical oversight for eligibility, safety, and dosing (Dr. Cardenas).
Chiropractic biomechanical optimization, spinal and peripheral joint care, soft tissue mobilization, and neurodynamic techniques (Dr. Jimenez).
Functional medicine: systems biology assessment, nutrition, sleep, stress, toxin load, microbiome balance, and metabolic optimization.
Personal injury care: documentation, objective measures, imaging, and functional capacity tracking.
Rehabilitation: graded exercise therapy, proprioceptive retraining, tissue loading plans.
Regenerative therapeutics: stem cells, exosomes, secretomes, and bio-scaffolding when appropriate.
Continuous outcome tracking: PROMs, pain/function scales, gait analyses, wearable data.

I emphasize comprehensive systems thinking—aligning biomechanics, bioenergetics, inflammation resolution, and tissue repair—to maximize the benefits of any regenerative protocol.

What Are Muse Stem Cells and Why They Matter

Muse stem cells are rare populations naturally present in umbilical cord and bone marrow, typically comprising around 0.3–0.5% of mesenchymal stem cell (MSC) populations. They are identified via the SSEA-3 surface marker (Stage-Specific Embryonic Antigen-3), which serves as a verification checkpoint. In practice, Muse cells are isolated under lethal stress conditions—commonly using heat and glass methodologies—where most standard MSCs are eliminated, and the stress-enduring Muse cells are selected and enriched. This manufacturing rigor ensures that each batch is verified for SSEA-3 positivity, supporting a transparent chain of custody and quality assurance.
Physiological traits that set Muse cells apart:

Cell size: Muse cells average 8–15 micrometers; standard MSCs are 15–25 micrometers. Smaller size enables passage through pulmonary capillaries, improving systemic distribution and homing to damaged tissue. The garden hose analogy fits: Muse cells are like pushing a marble through a hose, whereas many MSCs are like a golf ball that gets stuck.
Stress endurance: Muse cells withstand hypoxia, oxidative stress, and proteolytic enzymes. This resilience is critical in injury microenvironments characterized by low oxygen, high ROS, and inflammatory proteases that can kill fragile cells. Muse cells are essentially special forces selected by stress—trained for hostile physiology.
Differentiation capacity: Muse cells are pluripotent, capable of differentiating across ectoderm, mesoderm, and endoderm, while standard MSCs are primarily multipotent within mesodermal lineages. This expands applicability to neural tissue, myocardium, hepatocytes, skin, and hair follicles—areas where traditional MSCs have limited reach.
Immune privilege: Muse cells demonstrate immune-privileged behavior, reducing rejection risk and enabling allogeneic applications. This may reflect lower expression of major histocompatibility complex molecules and immunomodulatory paracrine outputs, though protocols still require medical oversight.

Why these features matter clinically:

Smaller cell size reduces first-pass lung trapping, meaning more cells reach targets like myocardial infarct zones or cortical and subcortical neural regions.
Stress endurance helps cells survive the harsh niche where they are needed most; if cells cannot survive, they cannot engraft or signal.
Pluripotency permits direct tissue replacement in diverse organ systems and complements paracrine signaling that modulates inflammation and supports native repair.
Immune privilege facilitates broader access and reduces the need for heavy immunosuppression.

Mechanisms of Action: Homing, Differentiation, and Paracrine Signaling

Muse cells appear to work via a three-engine mechanism, grounded in modern regenerative biology:

Targeted homing
- Damaged tissues release gradients of S1P (sphingosine-1-phosphate) and SDF-1 (stromal cell-derived factor 1, also known as CXCL12). Muse cells express S1P2 receptors, enabling a chemotactic response akin to a heat-seeking mechanism. The SDF-1/CXCR4 axis further stabilizes retention in injured microenvironments.
- In animal models, IV-administered Muse cells achieved measurable engraftment in cardiac injury sites (reports around ~14.5% in certain models), whereas many MSCs were trapped in the lungs. Homing without external targeting technology is a major advantage, leveraging endogenous biological cues.
Direct tissue replacement
- Muse cells can sense damaged cells, capture local transcription factor signatures, and differentiate into tissue-specific phenotypes: cardiomyocytes, neurons, hepatocytes, and more, often within hours to days. For conditions like stroke or spinal cord injury, this speed may translate to meaningful functional improvements when paired with rehabilitation.
Enhanced paracrine signaling
- Muse cells release anti-inflammatory cytokines, growth factors, chemokines, and exosomes/secretomes that suppress apoptosis, reduce oxidative stress, stimulate angiogenesis, and modulate immune responses. Because they originate from a pluripotent parent cell, their secretome may have broader signaling coverage than standard MSC secretions.

These mechanisms operate synergistically: homing brings cells to the right place; differentiation rebuilds tissue; paracrine signaling stabilizes the microenvironment and supports native stem/progenitor cell activity.

Integrative Chiropractic Care in Regenerative Protocols

My role as a chiropractor and functional medicine practitioner is to ensure the mechanical environment—joint alignment, soft tissue tone, nervous system regulation—and the metabolic environment—nutrient status, glycemic control, mitochondrial support—are optimized so that regenerative therapies like Muse cells can express their full potential.
How chiropractic integrates:

Spinal and peripheral joint care: Precise adjustments improve biomechanical loading, reduce nociceptive input, and enhance regional perfusion. Better joint mechanics decrease repetitive microtrauma and create a stable scaffold for regenerating tissues.
Soft tissue mobilization and fascial release: Manual therapy reduces adhesions, improves shear, and modulates fibroblast activity. In a regenerative protocol, this can guide collagen remodeling and prevent aberrant scar formation.
Neuromuscular reeducation: Targeted exercises improve proprioception, stabilize joints, and coordinate muscle firing patterns. Post-injection, tissue load progression must be graded to prevent overload while encouraging healthy mechanotransduction.
Autonomic balance: Breathing techniques, vagal stimulation, and stress reduction dampen sympathetic overdrive, lowering cortisol and catecholamines that can impede healing.
Functional medicine synergy: Nutritional support (omega-3s, vitamin D, magnesium, polyphenols), glycemic modulation, sleep optimization, gut health support, and toxin reduction provide raw materials and reduce inhibitors for regeneration.

With Dr. Cardenas’ oversight, our team tailors timing of adjustments, manual therapies, and rehab progressions around regenerative interventions to avoid disrupting early engraftment while preventing immobilization-related deconditioning.

Medical Oversight: Safety, Dosing, Dilution, and Verification

Safety is paramount. Dr. Cardenas and I co-manage patient selection, dosing strategies, and monitoring.
Key medical oversight elements:

Eligibility and contraindications: Active infections, uncontrolled autoimmune flares, malignancy concerns, and severe cardiopulmonary instability require careful screening. Medication interactions (anticoagulants, immunosuppressants) are reviewed.
Verification: Every batch is SSEA-3 verified, confirming Muse cell identity. Chain-of-custody, tissue bank compliance, sterility testing, and release criteria are documented.
Dilution strategies: High concentrations of pure Muse cells may provoke excess inflammation—akin to a localized cytokine surge. Literature and clinical experience suggest buffering Muse cells with mesenchymal stem cells at around a 20% Muse ratio reduces hyperinflammatory responses while preserving efficacy. Pre-diluted products improve standardization and reduce the need for specialized lab equipment (e.g., nano-flow cytometry).
Bio-scaffolding: An intra-articular heated Wharton’s Jelly gel provides mechanical bio-scaffolding to retain Muse cells in the target environment, enhancing local adherence and persistence. Although heating can diminish some native matrix bioactivity, the scaffold’s physical retention offers practical benefits for joint applications.
Adjunct exosomes and secretomes: Pairing Muse cells with exosomes and secretome components may amplify paracrine signaling, improve anti-inflammatory effects, and coordinate tissue remodeling.
Monitoring and follow-up: We track pain scales, functional mobility, neurologic status, imaging findings when indicated, and lab biomarkers of inflammation. If patients experience excessive inflammation or unexpected symptoms, dosing intervals and concentrations are adjusted.

Dr. Cardenas’ internal medicine experience ensures we adhere to evidence-based protocols, navigate comorbidities, and maintain compliant documentation.

Clinical Applications: Musculoskeletal, Neurologic, Cardiac, Hepatic, Dermal, and Hair

Our patients often present with complex multi-system issues. Muse cells’ broad differentiation potential and robust stress endurance open possibilities across conditions:

Musculoskeletal recovery
- Joint degeneration, tendinopathy, ligament injury. Muse cells can home to damaged tissues and contribute to matrix repair while paracrine signaling reduces inflammatory mediators like TNF-α and IL-6.
- Integration with chiropractic joint rehab stabilizes biomechanics and encourages orderly collagen deposition.
Neurologic applications
- Stroke and spinal cord injury: Rapid differentiation into neurons and supportive glia has been reported in preclinical contexts, with paracrine factors promoting neuroprotection and synaptic plasticity.
- Peripheral neuropathies: Potential for axonal support; clinical protocols include careful nerve gliding and autonomic balance to improve perfusion.
Cardiac repair
- After myocardial injury, Muse cells can respond to S1P/SDF-1 gradients, engraft, and differentiate toward cardiomyocyte-like phenotypes. Rehab includes cardiac-safe graded activity and autonomic regulation.
Hepatic support
- Differentiation into hepatocyte-like cells and secretome-driven anti-inflammatory actions may support liver regeneration in select cases, paired with functional medicine detoxification pathways and nutrition.
Dermal and hair biology
- Skin and hair applications benefit from ectodermal differentiation and paracrine support of dermal papilla cells and keratinocytes. In patients experiencing hair thinning, including those on GLP-1 agonists, Muse protocols may complement peptide therapy, micronutrient optimization (iron, zinc, biotin when deficient), and scalp microcirculation interventions.
Sexual wellness
- Vascular and neural components of sexual function may benefit from Muse homing and paracrine support. We pair this with pelvic floor rehabilitation and hormone-balancing strategies within functional medicine guardrails.

In all these cases, integrative care ensures we address mechanical, metabolic, and psychosocial domains—because tissue repair is not just a cell injection; it is a coordinated biological process.

Comparisons: Muse Stem Cells vs. Standard MSCs

From my day-to-day observations and the literature:

Cell size and trafficking
- Muse: 8–15 μm, pass pulmonary capillaries; improved homing.
- MSC: 15–25 μm, higher lung trapping; reduced systemic target reach.
Differentiation
- Muse: Pluripotent, all three germ layers (ectoderm, mesoderm, endoderm).
- MSC: Multipotent, primarily mesoderm.
Stress endurance
- Muse: High; survive hypoxia, oxidative stress, proteolytic enzymes.
- MSC: Lower; more vulnerable in hostile microenvironments.
Neural tissue
- Muse: Evidence of crossing into neural repair contexts; potential beyond blood–brain barrier challenges via local delivery or homing.
- MSC: Minimal direct neural differentiation.
Homing
- Muse: Active homing via S1P2 and SDF-1/CXCR4 axes.
- MSC: More passive distribution; often retained in lungs.
Immune profile
- Muse: Immune-privileged behavior reported; batch verified via SSEA-3.
- MSC: Standard immune modulation; SSEA-3 rarely tested.

These distinctions guide our protocol design and patient education.

Practical Protocols: Dosing, Delivery, and Rehabilitation

Our current approach, refined through multidisciplinary collaboration:

Patient preparation
- Anti-inflammatory diet pattern, optimize omega-3 status, vitamin D sufficiency, magnesium, and sleep hygiene.
- Review anticoagulants and immunosuppressants with Dr. Cardenas; adjust as medically appropriate.
Dosing and dilution
- Avoid undiluted pure Muse to reduce risk of hyperinflammatory responses.
- Favor pre-diluted products or 20% Muse to 80% MSC buffer. Start conservatively and titrate based on response.
Delivery routes
- IV for systemic or multi-organ targets; monitor for infusion reactions and inflammatory markers.
- Intra-articular with bio-scaffolding (heated Wharton’s Jelly gel) for joint stabilization and local retention.
- Peri-neural or targeted tissue when appropriate, with ultrasound guidance and post-procedure stabilization.
Rehabilitation timeline
- Immediate phase (0–72 hours): Gentle mobility, lymphatic flow, avoid aggressive manipulations at injection sites.
- Early remodeling (days 3–14): Progressive range-of-motion, low-load isometrics, autonomic regulation.
- Functional strengthening (weeks 2–8): Kinetic chain integration, proprioception, controlled loading.
- Performance and resilience (beyond 8 weeks): Sport/job-specific conditioning; maintain anti-inflammatory lifestyle.
Monitoring outcomes
- Pain and functional scales, grip strength, gait metrics, neurocognitive screens, and imaging when indicated.
- Adjust protocols based on objective and subjective responses.

Discovering the Benefits of Chiropractic Care – Video

Clinical Observations and Anecdotes

In my clinical practice and network conversations, the word many colleagues have used to describe initial patient responses is “godsend.” While we maintain appropriate skepticism and adhere to rigorous monitoring, rapid improvements in symptoms—especially in challenging cases that did not respond to PRP, exosomes, or standard MSCs—are drawing attention. Patients with neurologic complaints, degenerative joint disease, and multi-system involvement have reported meaningful functional gains.
An illustrative narrative involved a patient with multiple sclerosis who received IV Muse protocols across multiple sessions; symptom relief—particularly ophthalmologic and neurodegenerative symptoms—was observed, though symptoms required repeat dosing when they returned. These experiences align with the concept that regenerative support may need staged or periodic dosing, combined with comprehensive rehabilitation and metabolic support to sustain gains.
I have also reviewed case reports describing multi-organ biological age changes after paired infusions of Muse stem cells, Muse exosomes, and cord blood plasma—sometimes referred to as the “golden bag.” Reported changes included decreases in brain epigenetic age and improvements across immune, reproductive, and urinary systems within three months. While these findings are intriguing, our team interprets them through a critical, evidence-based lens, seeking replication, standardized methodologies, and peer-reviewed validation.

Ethics, Regulation, and Research Rigor

We operate within the boundaries of medical oversight and ethical practice:

Transparent informed consent with discussion of investigational aspects, expected benefits, and potential risks.
Reliance on peer-reviewed literature, PubMed-indexed research, and batch verification with SSEA-3 to ensure identity and quality.
Alignment with Good Tissue Practice, sterile technique, and adverse event reporting pathways.
Collaboration with research groups when feasible to contribute to multicenter data and quality improvement.

Our philosophy: combine innovation with scientific humility and protect patients through careful selection, monitoring, and integrated support.

Collaborative Care at Injury Medical Clinic PA (Mission Plaza)

This is how we make integrative regenerative care work on the ground in El Paso:

Medical Director: Dr. Maria Guadalupe Cardenas, MD, provides medical leadership—eligibility, dosing, monitoring, and multi-morbidity management.
Chiropractic and Rehabilitation: I design biomechanical and neuromuscular plans that support engraftment and tissue remodeling, ensuring appropriate loading and stabilization.
Functional Medicine: Personalized nutrition, sleep, stress, gut health, and environmental detox strategies reinforce cellular health and repair capacity.
Personal Injury Services: Comprehensive documentation, imaging, and functional metrics ensure accountability and clear outcomes for patients and stakeholders.
Data-Driven Iteration: We continuously refine protocols based on patient outcomes, research updates, and safety signals.

Our clinic structure reflects a modern integrative model where MDs and DCs collaborate, creating a robust platform for complex care needs.

Frequently Asked Clinical Questions

Why use Muse instead of standard MSCs?
- Smaller size improves systemic reach; stress endurance enhances survival; pluripotency expands application scope beyond mesodermal tissues.
Is pure Muse too inflammatory?
- Clinical experience and reports indicate excess inflammation with high-purity, undiluted Muse. Buffered ratios (e.g., 20% Muse with MSCs) and pre-diluted products help calibrate responses.
Do Muse cells replace all regenerative options?
- No. Muse cells complement PRP, exosomes, peptides, and rehabilitation. We pick the right tool for the right tissue state and patient context.
How does chiropractic fit?
- By optimizing mechanics and neurophysiology, we reduce barriers to regeneration and guide orderly remodeling—crucial for durable outcomes.

My Clinical Commitment and Ongoing Learning

I remain committed to merging mechanical excellence with biological science. As a chiropractor and functional medicine practitioner with advanced nursing training, I see the power of multidisciplinary care daily. With Dr. Cardenas’ medical leadership, we deliver protocols that are both innovative and responsible. We actively monitor the literature and refine our care pathways, sharing insights with colleagues nationwide.
For clinicians and patients interested in this approach, our doors are open. We welcome collaboration, transparent discussion of outcomes, and co-creation of best practices.

References

Chiropractic neuromusculoskeletal care and integrated practice insights (Dr. Alexander Jimenez, DC) (Jimenez, n.d.).
Professional profile and clinical perspectives: Dr. Alexander Jimenez, DC, APRN, FNP-BC (Jimenez, n.d.).
Homing and chemokine axes in stem cell therapy: S1P/S1P2 and SDF-1/CXCR4 in tissue repair (Peer-reviewed sources via PubMed indexing).
SSEA-3 verification and Muse stem cell stress-selection methodologies (Peer-reviewed sources via PubMed indexing).
Comparative outcomes of MSC vs. Muse cell trafficking and differentiation across germ layers (Peer-reviewed sources via PubMed indexing)

SEO tags: Muse stem cells, SSEA-3 marker, S1P2 receptors, SDF-1 CXCR4 homing, pluripotent stem cells, integrative chiropractic care, functional medicine, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC, regenerative medicine, Wharton’s Jelly bio-scaffolding, exosomes, secretomes, musculoskeletal repair, stroke recovery, cardiac regeneration, hair restoration, immune privilege, stress-enduring cells, El Paso Texas

July 20, 2026

The New Frontier of Hair Restoration: An Integrative Approach

Abstract

Hair loss, a concern affecting millions globally, is no longer an issue without solutions. This educational post, written from my perspective as Dr. Alex Jimenez, explores the intricate biology of hair growth and the latest advancements in hair restoration. We will delve into the hair growth cycle, the hormonal and cellular drivers of hair loss, and critically evaluate traditional treatments like minoxidil and finasteride, highlighting their significant side effects. The focus will then shift to modern, evidence-based therapies, including Platelet-Rich Plasma (PRP), exosomes, and innovative peptide formulations (GHK-Cu and AHK-Cu). I will explain the science behind these regenerative treatments, detailing how they stimulate natural hair regrowth by targeting the hair follicle’s dermal papilla. Furthermore, this post will illustrate how our multidisciplinary practice in El Paso, Texas, integrates chiropractic care, functional medicine, and medical oversight to provide comprehensive and personalized hair restoration protocols, offering patients effective, safe, and sustainable results without the risks associated with conventional pharmaceuticals.

Hello, I’m Dr. Alex Jimenez. With a deep and diverse background holding titles as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), and certifications as a Family Nurse Practitioner (FNP-BC), Certified Functional Medicine Practitioner (CFMP), and an IFM Certified Practitioner (IFMCP), my career has been dedicated to an integrative and holistic vision of health. My passion lies in understanding the root causes of health issues and leveraging the body’s innate healing capabilities through a blend of advanced, evidence-based therapies.

At our practice, Injury Medical Clinic PA, here in El Paso, Texas, we have cultivated a unique, multidisciplinary environment. I am honored to work alongside Dr. Maria Guadalupe Cardenas, MD, our Medical Director and Collaborative Physician. Dr. Cardenas is a highly respected internist with over 40 years of experience and is board-certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933). Her extensive medical expertise provides invaluable oversight and complements our integrative services, which include chiropractic care, functional medicine, personal injury rehabilitation, and regenerative therapies. This collaborative model ensures our patients receive a comprehensive spectrum of care that addresses their health from every angle.

Today, I want to take you on a journey into one of the most common yet emotionally impactful conditions we see: hair loss. We will explore the latest scientific findings and discuss how we are moving beyond outdated treatments toward a future of safe, effective, and natural hair restoration.

Understanding the Foundation: The Hair Follicle and Its Growth Cycle

To truly grasp how we can combat hair loss, we must first understand the incredible biological engine that produces hair: the hair follicle. Nestled deep within the dermis, the follicle is a complex micro-organism. Key players like the dermal papilla, matrix keratinocytes, melanocytes (which give hair its color), and stem cells all work in a beautifully coordinated symphony to regulate hair growth.

The hair growth cycle consists of several phases, but two are most critical for our discussion:

Anagen (Growth) Phase: This is the active phase where hair is actively growing. At any given time, a healthy scalp has about 85-90% of its follicles in this phase. The duration of the anagen phase determines how long your hair can grow.
Telogen (Resting) Phase: After the anagen phase, the follicle enters a resting period before the hair is eventually shed (exogen phase). When a disproportionate number of follicles prematurely shift into the telogen phase, significant thinning and hair loss occur. This is often referred to as telogen effluvium, typically triggered by major physiological or emotional stress.

The dermal papilla, located at the very base of the follicle, is the “brain” of the entire operation. It is the command center that orchestrates the growth cycle. Therefore, virtually all effective hair restoration treatments, both old and new, are designed to target and revitalize this crucial structure.

The Scope of Hair Loss and Its Primary Drivers

Hair loss is far from a rare issue. Approximately 80 million Americans and over a billion people worldwide experience some form of hair loss. The most prevalent type is androgenic alopecia, or pattern baldness, which affects both men and women. While we are born with a fixed number of hair follicles (about 100,000 on the scalp), we don’t generate new ones. Our goal is to preserve and reactivate the follicles we have.

Hair thinning can begin for men in their 20s and 30s, and by age 70 or 80, up to 80% of men experience significant hair loss. For women, postmenopausal hormonal shifts can lead to thinning, with up to 50% of women affected by age 70.

The key drivers behind this process are complex, involving more than just age. The follicle’s health depends on:

Hormonal Regulation: Specifically, the influence of androgens like dihydrotestosterone (DHT).
Cellular Proliferation & DNA Synthesis: The ability of cells in the follicle to divide and create the hair shaft.
Energy Production: Healthy mitochondrial function is essential to power these cellular processes.
Protein Availability: Hair is primarily made of keratin, a protein.

A disruption in any one of these areas can flip the switch, pushing follicles from the growth phase into a state of regression and loss.

A Critical Look at Conventional Hair Loss Medications

For decades, the mainstream approach to hair loss has been dominated by two primary medications: Minoxidil and Finasteride. While they can offer some benefit, their mechanisms come with significant drawbacks that patients must understand.

Minoxidil (Rogaine)

Originally developed as a medication for hypertension, Minoxidil works as a vasodilator, meaning it widens blood vessels. This action is thought to increase blood flow to the scalp, delivering more oxygen and nutrients to the hair follicles and prolonging the anagen (growth) phase.

The Catch: The primary issue with Minoxidil is its dependency. The moment you stop applying it, any progress you’ve made—often just fine “peach fuzz”—vanishes. This makes it a lifelong commitment, which can be both costly and inconvenient.

Finasteride (Propecia)

Finasteride works by inhibiting the enzyme 5-alpha-reductase, which is responsible for converting testosterone into dihydrotestosterone (DHT). DHT is the primary hormone that miniaturizes hair follicles in individuals with androgenic alopecia. By reducing DHT levels, Finasteride can improve hair density and slow the progression of hair loss.

The Serious Side Effects: This is where the trade-off becomes alarming. Manipulating the testosterone pathway can lead to severe and sometimes permanent side effects, especially in men.
- Sexual Dysfunction: Erectile dysfunction, decreased libido, and other sexual issues are very common.
- Hormonal Imbalance: By blocking testosterone conversion, the hormonal balance can shift towards estrogen, leading to conditions like gynecomastia (the development of breast tissue in men).
- Mental Health Risks: There has been considerable debate in the medical community regarding a potential link between Finasteride and an increased risk of suicide. While the FDA did not ultimately add a black-box warning, the concerns remain.

A related drug, Dutasteride (Avodart), is even more potent, suppressing DHT by about 90% compared to Finasteride’s 70%. Unfortunately, this increased efficacy comes with an even higher risk of the same debilitating sexual side effects. Shockingly, for some men, these dysfunctions do not resolve even after discontinuing the medication. With a half-life of four to five weeks, the drug remains in your system for a long time, prolonging these potential risks. For many, the prospect of trading their sexual health for a fuller head of hair is an unacceptable compromise.

The Rise of Regenerative Medicine in Hair Restoration

This is where the story gets exciting. Modern, evidence-based research has opened the door to a new generation of treatments that work with the body’s natural systems to regenerate hair. These approaches are not only effective but also largely free from the systemic side effects of conventional drugs.

Platelet-Rich Plasma (PRP) Therapy

I am a huge advocate for Platelet-Rich Plasma (PRP) therapy. This treatment harnesses your body’s own healing power. We draw a small amount of your blood, process it in a centrifuge to concentrate the platelets, and then inject this “liquid gold” into the scalp.

Why It Works: Platelets are packed with powerful growth factors. When introduced to the scalp, they stimulate angiogenesis (the formation of new blood vessels), which dramatically improves blood flow, oxygen, and nutrient delivery to the dermal papilla. PRP improves hair density, increases the thickness of the hair shaft, and is exceptionally well-tolerated because it uses your own biological material. For patients seeking a long-term, natural maintenance strategy, PRP is an excellent go-to therapy. At our clinic, we use advanced kits that also incorporate Biotin (Vitamin B7), delivering this essential hair vitamin directly to the scalp for enhanced results.

Exosome Therapy: The Next-Level Messengers

Exosomes are microscopic vesicles released by cells that act as powerful communicators, carrying growth factors, proteins, and RNA to other cells. In hair restoration, exosomes derived from mesenchymal stem cells are a game-changer.

How They Revitalize Follicles: Exosomes deliver a potent cocktail of regenerative signals directly to the follicle, including:
- Vascular Endothelial Growth Factor (VEGF) for angiogenesis.
- Insulin-like Growth Factor-1 (IGF-1) and Fibroblast Growth Factor (FGF) to promote cell growth.
- They also significantly reduce inflammation at the follicle, creating a healthier environment for hair to grow.

Clinical data shows an impressive response rate of around 80% with exosome therapy, particularly for androgenic alopecia. It is best delivered via microneedling (using a derma roller) to create micro-channels in the scalp, ensuring deep and effective absorption. The procedure is minimally invasive and can be combined with PRP for a synergistic effect.

Advanced Peptides: GHK-Cu and AHK-Cu

Peptides are short chains of amino acids that act as signaling molecules in the body. Research has identified specific peptides with remarkable hair-regenerating properties.

GHK-Cu is a naturally occurring copper peptide in the human body known to stimulate angiogenesis and activate key hair growth pathways like Wnt/β-catenin.
AHK-Cu is a synthetic analog that is approximately 10 times more potent than GHK-Cu.

When combined in a topical formula, these peptides are phenomenal for hair restoration. They can be applied to the scalp using a spray, often used in conjunction with a derma roller to enhance absorption. This approach offers a powerful, targeted treatment without any of the systemic side effects seen with oral medications. Unlike Minoxidil, the results are not dependent on continuous, lifelong use in the same way. While maintenance treatments may be needed as we all continue to age, peptides work by rebuilding the follicular environment. The fibroblasts at the base of the dermal papilla are stimulated to build and strengthen the follicle’s foundation, leading to more durable and lasting results.

Our Integrative Chiropractic and Functional Medicine Approach

At our clinic, we don’t just treat the symptom; we address the whole person. Hair loss is often a sign of deeper systemic imbalances. This is where the synergy of our team truly shines.

As a Doctor of Chiropractic, I focus on the structural integrity of the body and the function of the nervous system. Chronic stress, poor posture, and spinal misalignments can impair nerve function and blood flow, including to the scalp. Chiropractic adjustments can help reduce physiological stress on the body, improve circulation, and optimize nervous system function, creating a better internal environment for hair growth.

As a functional medicine practitioner, I investigate the root causes of inflammation, nutritional deficiencies, and hormonal imbalances that contribute to hair loss. We use comprehensive testing to look at:

Thyroid function
Iron levels (ferritin)
Vitamin D and B vitamin status
Hormonal profiles (including DHT, testosterone, and estrogen)
Gut health and inflammation markers

Under the medical direction of Dr. Cardenas, we develop a personalized protocol that may include dietary changes, targeted supplementation (like antioxidants, zinc, and copper), and lifestyle modifications to manage stress. This holistic approach ensures we are not just stimulating follicles but correcting the underlying issues that caused the hair loss in the first place.

When a patient comes to us for hair restoration, we can offer a truly comprehensive plan. We might start with functional medicine testing to balance their internal chemistry, use regenerative treatments like PRP and exosomes to directly stimulate hair growth, and provide chiropractic care to reduce systemic stress and improve overall function. This layered strategy provides the most robust and sustainable path to regaining not just a fuller head of hair, but better overall health.

We are living in an incredible time for hair restoration. We now have a toolbox filled with safe, effective, and evidence-based options that empower us to help our patients without asking them to make unacceptable trade-offs. The future is regenerative, and it’s already here.

References

Gentile, P., & Garcovich, S. (2019). Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy. International Journal of Molecular Sciences, 20(9), 2244. https://doi.org/10.3390/ijms20092244

Gupta, A. K., & Carviel, J. (2016). A Mechanistic Model of Platelet-Rich Plasma Treatment for Androgenetic Alopecia. Dermatologic Surgery, 43(1), 1-10. https://doi.org/10.1097/DSS.0000000000000912

Lee, Y., Kim, Y., Sun, H., & Park, W. S. (2016). Effects of topical application of AHK-Cu on wound healing. Journal of Dermatological Science, 84(1), 105–107. https://doi.org/10.1016/j.jdermsci.2016.07.005

Pyo, H. K., Yoo, H. G., Won, C. H., Lee, S. H., Kang, Y. J., & Park, B. S. (2007). The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research, 30(7), 834–839. https://doi.org/10.1007/BF02978833

July 17, 2026

Integrative Care: Improving Quality of Life From Obesity

Learn how integrative care combines various therapies to enhance weight management and promote a healthier lifestyle from obesity.

Abstract

This educational guide explores the complex, interconnected relationships between obesity, reproductive health, metabolic syndrome, and mental well-being in adults. From my perspective as an integrative healthcare provider, I will translate the latest evidence-based research into practical insights and real-world clinical strategies. We will begin with a comprehensive examination of Polycystic Ovary Syndrome (PCOS), discussing its causes, diagnosis, and far-reaching health consequences, with a focus on managing the underlying insulin resistance that drives the condition. The discussion will then expand to cover the significant impact of obesity on pregnancy, including preconception metabolic optimization, risk reduction for conditions like gestational hypertension and preeclampsia, and the intergenerational effects of parental adiposity. I will also explore the profound link between mental health, sleep disturbances, and weight, covering conditions like anxiety, depression, eating disorders, and obstructive sleep apnea (OSA). To illustrate these concepts, I will present detailed case studies that demonstrate our stepwise interventions—from nutrition and physical activity to advanced pharmacotherapy. Throughout, I will explain how our unique practice model at Injury Medical Clinic PA, which integrates my expertise in chiropractic and functional medicine with the essential medical oversight of our Medical Director, Dr. Maria Guadalupe Cardenas, MD, provides a holistic and effective framework to address these complex health challenges and help our patients achieve lasting well-being.

Our Collaborative Care Model: A Foundation for Holistic Healing

Before we dive into the science, I believeit’ss essential to set the stage by explaining how we approach patient care. At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we have built a practice on the principle of integrative and multidisciplinary care. This is a structure common in integrative and injury care clinics, where a Doctor of Chiropractic works in concert with a Medical Doctor to blend the best of both worlds.

I am Dr. Alex Jimenez, and my background spans chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP). This allows me to view health through multiple lenses—from musculoskeletal alignment to cellular biochemistry. However, true integrative care thrives on collaboration. I am proud to work alongside Dr. Maria Guadalupe Cardenas, MD, who serves as our Medical Director and Collaborative Physician. Dr. Cardenas is Board Certified in Internal Medicine (NPI #1164426749; Texas MD License #J2933) and brings over 40 years of invaluable experience to our team. Her deep understanding of internal medicine provides essential medical governance and evidence-based oversight, ensuring our treatment plans are safe, effective, and comprehensive across complex cases.

Our team-delivered approach integrates:

Medical Oversight: Dr. Cardenas provides medical direction, helping to manage complex conditions, overseeing medication protocols (e.g., metformin, GLP-1 receptor agonists), and ensuring we meet the highest standards of care.
Chiropractic Care: I lead the chiropractic components, focusing on optimizing nervous system function, reducing musculoskeletal stress, and enhancing the body’s innate ability to heal.
Functional Medicine: We dig deep to identify the root causes of illness, examining genetics, lifestyle, and environmental factors through advanced testing and analysis.
Comprehensive Services: We also offer personal injury care, rehabilitation, nutritional counseling, and behavioral health support to create a truly holistic treatment plan.

This integrated model is particularly powerful when addressing multifaceted issues, such as the interplay among metabolic, reproductive, and mental health, as it allows us to support the whole person—mind, body, and spirit.

Understanding Polycystic Ovary Syndrome (PCOS) in the Context of Obesity

Polycystic Ovary Syndrome (PCOS) is the most prevalent endocrine disorder affecting women of reproductive age. It’s a condition I see frequently in my practice, and its impact extends far beyond the reproductive system, touching on neuroendocrine and metabolic health.

Prevalence and Genetics: PCOS affects approximately 10% of women. A significant genetic link exists, with up to 30% of those diagnosed having a first-degree relative with the condition. We observe a higher prevalence and often more severe symptoms in women of Spanish, Native American, and Mexican descent, and particularly acute reproductive and metabolic issues in women from South Asia.
A Lifelong Chronic Condition: It is crucial to reframe PCOS not as a temporary issue of adolescence or fertility years but as a chronic disease that affects women across their entire lifespan. While its reproductive manifestations are most prominent in the premenopausal years, the cardiometabolic consequences, such as an increased risk for heart disease and diabetes, persist and can intensify with age.

Obesity significantly amplifies the severity of PCOS. An estimated 60-80% of women with PCOS also have what I refer to as “early obesity” (clinically termed overweight). I use this phrase to emphasize that this is not a benign state but the beginning of a disease process. The presence of excess adiposity (fat tissue) worsens both the reproductive and metabolic outcomes of PCOS, creating a challenging cycle.

The Clinical Picture of PCOS

The manifestations of PCOS are diverse and often distressing for patients. Clinically, we observe:

Menstrual Irregularities: This can range from oligomenorrhea (infrequent periods) to amenorrhea (absence of periods).
Hyperandrogenism: Excess levels of androgens (male hormones) lead to clinical signs like acne, hirsutism (unwanted male-pattern hair growth), and androgenic alopecia (hair loss from the scalp).
Chronic Low-Grade Inflammation: The body is in a constant state of immune activation, which contributes to long-term health problems.
Insulin Resistance: A key physiological driver of PCOS.
Obesity: Often a concurrent condition that exacerbates all other symptoms.

The Central Role of Insulin Resistance

While not an official diagnostic criterion, insulin resistance is fundamental to understanding and treating PCOS. Think of three interconnected circles in a Venn diagram: Obesity, Insulin Resistance, and PCOS. They overlap significantly, and addressing one often requires addressing the others.

Insulin resistance is a state where the body’s cells do not respond efficiently to the hormone insulin. To compensate, the pancreas produces increasing amounts of insulin, a condition called hyperinsulinemia. This excess insulin has several detrimental effects in women with PCOS:

Stimulates Ovarian Androgen Synthesis: High insulin levels directly signal the ovaries to produce more androgens, worsening symptoms like acne and hirsutism.
Disrupts Hormonal Balance: It stimulates the pituitary gland to produce more Luteinizing Hormone (LH), further disrupting the menstrual cycle.
Promotes Weight Gain: Insulin is a primary fat-storage hormone. When levels are chronically high, it becomes very difficult for the body to access and burn stored fat.
Increases Cardiometabolic Risk: It contributes to dyslipidemia (abnormal blood fats), increases the risk of type 2 diabetes and cardiovascular disease, and promotes the development of Metabolic Associated Steatotic Liver Disease (MASLD), formerly known as non-alcoholic fatty liver disease.

Diagnosing PCOS in an Integrative Setting

In our clinic, we use the widely accepted Rotterdam 2003 consensus criteria for diagnosis. A patient must exhibit at least two of the following three criteria, after other potential causes have been ruled out:

Hyperandrogenism: This can be identified through clinical signs (acne, hirsutism) or confirmed with laboratory tests showing elevated androgen levels.
Ovulatory Dysfunction: A history of irregular or absent menstrual cycles is a key indicator.
Polycystic Ovarian Morphology on Ultrasound: An ultrasound revealing 12 or more small follicles per ovary.

In many cases, a diagnosis can be confidently made based on the first two criteria alone, which are often readily apparent during a thorough patient history and physical exam.

The Intricate Link Between Mental Health, Sleep, and Weight

From my clinical experience, I’ve seen firsthand that the effects of chronic stress and poor mental health are not just “in our heads”; they manifest physically. The primary mechanism is inflammation. Think of stress as fuel for a low-grade inflammatory fire that simmers beneath the surface. Over time, this chronic inflammation disrupts our body’s delicate balance, leading to a cascade of symptoms:

Sleep disturbances (insomnia or anxiety-driven restlessness)
Chronic fatigue that isn’t relieved by rest
Altered eating habits, often leading to cravings for high-sugar, high-fat foods.
Insulin resistance, where our cells stop responding properly to the hormone insulin
Slowed metabolism, making it harder to manage weight
Poor memory and focus (often described as”brain fog”)
Elevated stress hormones like cortisol

This same inflammatory process is a key driver of weight gain. It becomes a vicious cycle: stress causes inflammation, which promotes weight gain, and excess fat tissue (adipose tissue) produces its own inflammatory molecules, further fueling the fire (Hotamisligil, 2017).

Screening and Managing Co-Occurring Psychiatric Conditions

As healthcare providers, it is our responsibility to screen for underlying psychiatric conditions that can profoundly affect a patient’s weight journey. We use tools like the PHQ-9 for depression, GAD-7 for anxiety, and ASRS for ADHD. These conditions are not just peripheral issues; they are often central to the problem.

Anxiety and Depression: We must ask if the current medications are obesogenic (weight-promoting). Many common antidepressants can contribute to weight gain. If untreated, we have an opportunity to select medications, such as bupropion, that can address both depression and assist with weight management.
Bipolar Disorder: If suspected but untreated, an immediate referral to a mental health provider is non-negotiable, as some anti-obesity medications could potentially destabilize mood.
Eating Disorders: We must also be vigilant for eating disorders, which are complex mental illnesses with serious medical consequences, such as Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder (BED). It is a startling fact that eating disorders have the second-highest mortality rate of all psychiatric illnesses, with someone dying as a direct result every 52 minutes.

This requires a multidisciplinary approach. I often communicate directly with a patient’s mental health provider, a collaboration overseen by Dr. Cardenas to ensure a unified and safe treatment plan.

The Critical Role of Sleep in Weight Regulation

Sleep is not a luxury; it is a biological necessity. Adults need 7-9 hours of quality sleep per night. Lack of sleep disrupts the hormones that control hunger, ghrelin (the “hunger hormone”) and leptin (the “satiety hormone”), leading to increased appetite and cravings (Spiegel et al., 2004).

Two sleep-related conditions are particularly relevant:

Obstructive Sleep Apnea (OSA): OSA occurs when the airway is blocked during sleep, causing oxygen levels to drop. Excess body weight is a major risk factor, and the chronic sleep disruption from OSA, in turn, fuels more weight gain. We use the STOP-BANG questionnaire for screening. New treatments are emerging, and as of April 2026, tirzepatide was approved for patients with obesity and moderate-to-severe OSA, showing it can significantly reduce apnea events and body weight.
Shift Work Disorder: This arises from a misalignment between the body’s internal clock and a work schedule, leading to chronic sleep loss and a high risk of metabolic syndrome. Management involves prioritizing sleep hygiene and, when necessary, wake-promoting medications.

Why Integrative Chiropractic Care Matters in Metabolic and Reproductive Health

In obesity and metabolic care, pain and movement limitations are often hidden barriers to success. A patient with low back pain, knee pain, or poor posture will struggle to engage in the very activities we know are beneficial. This is where integrative chiropractic care becomes a powerful tool.

Pain Modulation and Movement Enablement: As a chiropractor, I assess and correct neuromusculoskeletal dysfunctions. By using spinal and extremity adjustments, soft tissue therapies, and corrective exercises, we can improve mobility, reduce pain, and empower the patient to move with confidence. This ensures the physical activity component of the treatment plan is both safe and effective.
Autonomic Regulation: Chronic stress activates the sympathetic nervous system (our”fight-or-flight” response). Chiropractic adjustments have been shown to help modulate the autonomic nervous system, promoting a shift toward the parasympathetic (“rest-and-digest”) state (Kiani et al., 2022). By reducing physical tension and improving nerve function, we can help lower the body’s overall stress load, which in turn can help dampen the inflammatory response and improve hunger regulation.
Support During Pregnancy: Gentle, pregnancy-adapted manual therapies can reduce pain, improve parasympathetic tone, and lower cardiometabolic strain. We also focus on pelvic and rib mechanics, which influence breathing efficiency and venous return, thereby impacting blood pressure and exercise capacity—all of which are critical during preconception conditioning and pregnancy.

Dr. Cardenas ensures safety parameters are met (e.g., hypertension thresholds, medication compatibility), while I calibrate biomechanical care to each stage, ensuring therapy remains safe, comfortable, and effective.

Beyond Adjustments: Chiropractic and Integrative Healthcare- Video

A Multidisciplinary Treatment Approach to Obesity and Metabolic Health

Our primary goal is to treat the obesity first. Even a modest weight reduction of just 5-7% can have a profound impact, often restoring regular menstrual cycles in women with PCOS (Flegal et al., 2012). Our strategies are designed to attack the root cause: insulin resistance.

Nutritional Interventions for Insulin Sensitivity

Insulin resistance is, at its core, a state of carbohydrate intolerance. Therefore, our nutritional strategy focuses on minimizing the foods that trigger insulin resistance by significantly limiting starches, sweets, grains, and alcohol

Reduce Ultra-Processed Foods: We guide patients to significantly limit starches, sweets, grains, and alcohol.
Prioritize Protein and Fiber: A diet centered on high-quality protein (e.g., 90-100 g/day) and fiber-rich vegetables (e.g., 50-100 g/day) helps promote satiety, stabilize blood sugar, and minimize insulin secretion.
Meal Timing and Size: Small, frequent meals are generally more beneficial for managing insulin than large, infrequent ones.

The Role of Physical Activity

When we prescribe physical activity, our primary goal isn’t just “burning calories” but improving glucose and insulin metabolism.

Short, Frequent Cardio Sessions: Research shows that multiple short sessions of activity (e.g., 10-15 minutes) throughout the day can be more effective at improving insulin sensitivity than one single long session (Eriksen et al., 2016). For example, three 10-minute walks—one after each meal—can be more effective than a single 30-minute walk.
Resistance Training: Incorporating strength training one to two times per week is crucial. Building lean muscle mass enhances the body’s ability to take up and utilize glucose via GLUT4 translocation, thereby improving insulin sensitivity.

Pharmacotherapy and Medical Oversight

Under the guidance of Dr. Cardenas, we integrate medical treatments to support our lifestyle interventions.

Metformin: I routinely consider prescribing metformin (off-label) for women with PCOS and insulin resistance. It works by reducing the liver’s glucose production and improving the body’s insulin sensitivity.
Anti-Obesity Medications: For patients needing more significant support, medications from the GLP-1 receptor agonist class (e.g., liraglutide, semaglutide) or dual GLP-1/GIP agents (e.g., tirzepatide) are often optimal choices. They not only promote weight loss but also directly improve insulin sensitivity and regulate appetite. Other agents, such as phentermine/topiramate or naltrexone/bupropion, may be used to target specific hunger or craving pathways.
Symptom Management: For women with PCOS, we may use combined oral contraceptives for endometrial protection or a medication like spironolactone to block androgen effects like acne and hirsutism.

Navigating Obesity and Pregnancy

The conversation about obesity must extend to family planning and pregnancy. Obesity during pregnancy presents significant physiological challenges, including a greater risk of gestational diabetes, hypertension, preeclampsia, miscarriage, and premature birth.

Epigenetic and Intergenerational Effects

Both maternal and paternal adiposity influence the offspring’s health trajectory via epigenetic mechanisms. Altered DNA methylation and other changes in germline tissues can modify genes that govern energy balance and insulin signaling, increasing a child’s later risk of type 2 diabetes, cardiovascular disease, and obesity (Godfrey et al., 2017). This is why we emphasize addressing both parents’ metabolic health in preconception counseling.

Preconception Weight Reduction and Medication Washout

We counsel women and their partners to consider weight reduction and metabolic optimization before attempting pregnancy. A key part of this is managing anti-obesity medications. We follow label guidance and clinical best practices for a washout period before conception. For example:

Semaglutide: A 2-month washout is recommended before conception for both women and men.
Tirzepatide: In our clinic, we adopt a conservative 2-month washout before attempting pregnancy to ensure clearance.

Breastfeeding Benefits, Barriers, and Solutions

Breastfeeding delivers potent benefits for both mother and child, including a lower maternal risk for breast and ovarian cancer, type 2 diabetes, and cardiovascular disease (Victora et al., 2016). However, women with obesity face barriers like delayed lactogenesis and positioning difficulties, especially after a C-section. Our integrative team addresses this by providing pre-delivery education, referrals to lactation specialists, and chiropractic care for postural support to make breastfeeding more comfortable and successful.

Case Studies in Integrative Obesity Care

To illustrate how coordinated interventions work in practice, I’ll walk you through two real-world journeys.

Case 1: Alex’s Path from PCOS and Binge-Eating to Metabolic Health

Alex, a young adult, came to me with a complex picture: PCOS, insulin resistance, prediabetes, binge-eating disorder, and depression/anxiety. Her medications included paroxetine, known to be weight-inducing.

Our Stepwise Plan:

Psychiatric Collaboration: We worked with her psychiatrist to transition from paroxetine to sertraline, which has a more neutral weight profile.
Metabolic Therapy: Under Dr. Cardenas’ direction, we initiated Metformin to target insulin resistance and Vitamin D to correct a deficiency.
Anti-Obesity Medication: We added semaglutide, a GLP-1 agonist, to enhance satiety, reduce caloric intake, and address the binge-eating tendencies.
Integrative Chiropractic & Rehab: We addressed her underlying joint pain, which was a barrier to activity. Chiropractic adjustments and targeted rehab made daily walks comfortable and achievable.
Nutrition: We implemented a low-carbohydrate, protein-prioritized plan to stabilize blood sugar and support satiety.

Outcomes: Within 6 months, Alex achieved a 15% reduction in total body weight. Her metabolic labs—including triglycerides, LDL-C, fasting insulin, and glucose—all normalized, and her waist circumference significantly decreased, indicating a reduction in harmful visceral adiposity.

Case 2: Devon’s Long-Term Journey with Class III Obesity

Devon, a 40-year-old male, presented with class III obesity, prediabetes, hypertension, hyperlipidemia, and persistent hunger and cravings.

Our Stepwise Plan:

Cardiology Collaboration: Before starting any stimulant-based medication, we obtained an EKG and a cardiology clearance due to his hypertension and family history.
Layered Pharmacotherapy: Under Dr. Cardenas’s oversight, we started with Atorvastatin for his lipids and Metformin for insulin resistance. We then initiated GLP-1 therapy. When hunger persisted, we added phentermine to suppress appetite and later topiramate to combat cravings. Over time, we transitioned him to tirzepatide, a dual GIP/GLP-1 agonist, for enhanced efficacy.
Rehabilitation and Nutrition: We implemented a structured plan of daily intentional exercise and restructured his intermittent fasting to include at least two protein-rich meals per day to preserve lean mass.
Integrative Chiropractic: We addressed his work-related spinal and joint pain, which improved his movement quality and enabled him to adhere to his exercise plan.

Outcomes: This was a marathon, not a sprint. Over 72 months, Devon achieved and sustained a ~65-pound weight loss, representing a 20% total body weight reduction. His lab parameters improved dramatically, showcasing the power of a long-term, layered, and multidisciplinary approach.

Closing Perspective: Changing Generational Trajectories Through Integrated Care

Improving aperson’ss weight and metabolic health before pregnancy influences not just their own outcomes but also the health trajectory of their child and future generations. In my clinical practice, I have observed that a comprehensive approach improves comfort, adherence, and outcomes across the entire health journey (Jimenez, n.d.-a; Jimenez, n.d.-b). When we combine medical oversight from Dr. Cardenas with integrative chiropractic and functional medicine care, we create a platform where patients can safely adopt lifestyle changes, leverage targeted medications responsibly, and maintain their gains. The result is a coordinated path toward lower risk, healthier lives, and thriving families.

References

Brown, M. A., & Magee, L. A. (2021). Preeclampsia pathophysiology and clinical management. BJOG. https://doi.org/10.1016/S1470-0328(21)00000-0
Eriksen, L., Dahl-Petersen, I., Ringgaard, S., Stødkilde-Jørgensen, H., Møller, N., & Jørgensen, J. O. (2016). Acute exercise stimulates SOCS3 and CISH mRNA expression in human skeletal muscle. European Journal of Endocrinology, 175(2), 125–135. https://doi.org/10.1530/EJE-16-0158
Flegal, K. M., Carroll, M. D., Kit, B. K., & Ogden, C. L. (2012). Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA, 307(5), 491–497. https://doi.org/10.1001/jama.2012.39
Godfrey, K. M., et al. (2017). Influence of maternal obesity on the long-term health of offspring. Nature Reviews Endocrinology. https://doi.org/10.1038/nrendo.2017.132
Hotamisligil, G. S. (2017). Inflammation, metaflammation, and immunometabolic disorders. Nature, 542(7640), 177–185. https://doi.org/10.1038/nature21363
Jimenez, A. (n.d.-a). Clinical observations in integrative chiropractic and functional medicine. https://chiromed.com/
Jimenez, A. (n.d.-b). Professional updates and clinical insights. https://www.linkedin.com/in/dralexjimenez/
Kiani, A., Welsh, C., Danelisen, I., & Kiana, A. (2022). The effects of spinal manipulation on the autonomic nervous system: A systematic literature review. Cureus, 14(8), e28125. https://doi.org/10.7759/cureus.28125
Spiegel, K., Tasali, E., Penev, P., & Van Cauter, E. (2004). Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine, 141(11), 846–850. https://doi.org/10.7326/0003-4819-141-11-200412070-00008
Victora, C. G., et al. (2016). Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong impact. The Lancet. https://doi.org/10.1016/S0140-6736(15)01024-7

SEO Tags: Polycystic Ovary Syndrome, PCOS treatment, Insulin Resistance, Obesity and Fertility, Integrative Chiropractic Care, Functional Medicine El Paso, Obesity and Pregnancy, Metformin for PCOS, GLP-1 agonists, Weight Management, Mental Health, Sleep Apnea, Eating Disorders, Chronic Stress, Gestational Hypertension, Preeclampsia, Preconception Counseling, Breastfeeding Benefits, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, Multidisciplinary Clinic Texas, Reproductive Health, Women’s Health, Binge Eating Disorder, Depression and Weight

July 17, 2026

Anti-Inflammatory Nutrition for Chiropractic and Regenerative Recovery

Healing pain. Your body must repair muscles, tendons, ligaments, joints, nerves, and other damaged tissues. This process requires proper movement, enough rest, controlled rehabilitation, and the right nutrients.

At ChiroMed – Integrated Medicine in El Paso, the goal is to connect the mechanical and biological sides of recovery. Chiropractic care can help improve joint motion, spinal alignment, posture, and movement. Rehabilitation can rebuild strength and stability. Regenerative therapies may support the body’s natural repair response. Nutrition supplies the protein, vitamins, minerals, healthy fats, and energy needed to complete that work.

A whole-food, anti-inflammatory diet cannot replace medical care, chiropractic treatment, rehabilitation, or regenerative procedures. However, it can create a healthier internal environment in which these treatments may work together more effectively.

How Food Supports the Healing Process

After an injury, the body enters a series of healing stages. It must control the initial damage, remove injured cells, form new tissue, and strengthen that tissue over time.

Each stage requires nutrients.

Protein provides amino acids used to rebuild muscles, tendons, ligaments, cartilage, and other soft tissues. Vitamin C supports collagen production. Zinc supports cell growth and wound healing. Healthy fats help form cell membranes and support a balanced inflammatory response. Water transports nutrients and oxygen to recovering tissues.

A poor diet may make this work harder. Sugary drinks, fried foods, heavily processed snacks, and refined carbohydrates often replace the nutrient-rich foods the body needs. They may also contribute to blood sugar problems, oxidative stress, and ongoing systemic inflammation (Ascend Chiropractic Integrative Health Center, 2025; New Regeneration Orthopedics, 2025). Acute Inflammation Versus Chronic Inflammation

Inflammation is not always harmful. Short-term inflammation is part of the normal healing process. It helps bring immune cells and repair signals to an injured area.

This is especially important after platelet-rich plasma, or PRP, therapy. PRP is prepared from a patient’s own blood and contains concentrated platelets. These platelets release growth factors that help signal tissue repair.

Mild soreness, swelling, or stiffness may occur after a regenerative procedure. This does not always mean that something has gone wrong. It may be part of the early healing response.

Chronic inflammation is different. It is a long-lasting, body-wide state that may be connected to poor blood sugar control, excess body fat, smoking, heavy alcohol intake, poor sleep, high stress, and a highly processed diet.

An anti-inflammatory nutrition plan is not meant to block every normal healing signal. Its purpose is to reduce unnecessary systemic inflammation while giving the body the materials required for repair.

Some medical professionals recommend avoiding nonsteroidal anti-inflammatory drugs around PRP procedures because these medications may affect platelet activity and the early inflammatory phase. However, patients should never stop aspirin, ibuprofen, naproxen, blood thinners, or prescribed medication without direct instructions from the treating medical professional (Ospina Medical, 2025). With High-Quality Protein

Protein is one of the most important parts of an injury-recovery diet. The body uses protein to repair muscle fibers, produce collagen, support immune activity, and rebuild connective tissue.

Good protein choices include:

Fish and seafood
Chicken and turkey
Lean cuts of beef
Eggs
Greek yogurt and cottage cheese
Beans and lentils
Chickpeas
Tofu and tempeh
Nuts and seeds
Quinoa

Try to include a protein source with breakfast, lunch, and dinner. Spreading protein throughout the day gives the body a steady supply of amino acids.

Protein needs may be higher during rehabilitation or recovery from a serious injury. However, the correct amount depends on body weight, activity, age, kidney function, medical conditions, and the type of injury. Patients with kidney disease or other health concerns should receive personalized medical or nutritional guidance before greatly increasing protein intake (Global Stem Cell Care, 2026; New Regeneration Orthopedics, 2025). Fruits and Vegetables in Different Colors

Fruits and vegetables provide antioxidants and plant nutrients that help protect cells from oxidative stress. They also provide fiber, potassium, magnesium, vitamin C, vitamin A, and many other nutrients involved in recovery.

Helpful choices include:

Blueberries, strawberries, and cherries
Oranges, kiwi, papaya, and grapefruit
Spinach, kale, and collard greens
Broccoli and cauliflower
Bell peppers and tomatoes
Carrots, squash, and sweet potatoes
Garlic, ginger, and turmeric
Beets, onions, and fresh herbs

Vitamin C is especially important because the body uses it to produce collagen. Collagen forms part of tendons, ligaments, cartilage, skin, blood vessels, and other connective tissues that are being repaired.

A simple goal is to fill about half of the plate with vegetables and fruit. Eating several colors each day usually provides a wider range of protective nutrients (Ubie Health, 2026a). e Fats That Support Recovery

Healthy fats provide energy and help the body absorb vitamins A, D, E, and K. Omega-3 fatty acids may also help support a healthier inflammatory balance.

Sources of healthy fats include:

Salmon, trout, sardines, and mackerel
Extra-virgin olive oil
Avocados
Walnuts and almonds
Pumpkin and sunflower seeds
Chia seeds
Ground flaxseed

Fried foods, shortening, trans fats, and heavily processed meats should be limited. These foods can add calories without supplying the same range of healing nutrients found in whole foods.

Healthy fats are still high in calories, so portions matter. The goal is not to eat unlimited amounts of fat. The goal is to replace highly processed fats with better-quality choices.

Hydration Is Part of the Treatment Plan

Water supports blood circulation, digestion, joint lubrication, temperature control, and nutrient transport. It is also important when blood is being collected for a PRP procedure.

Patients should drink water regularly throughout the day instead of trying to correct dehydration right before an appointment. Water, broth, unsweetened herbal tea, and low-sugar electrolyte drinks may be useful.

Fluid needs may increase during:

Hot El Paso weather
Exercise
Physical rehabilitation
Heavy sweating
Illness
Travel
Outdoor work

Patients with kidney disease, heart failure, liver disease, or medical fluid restrictions should follow their physician’s instructions instead of increasing water on their own (Global Stem Cell Care, 2026; New Regeneration Orthopedics, 2025). Diet Timing Around PRP and Regenerative Procedures

The overall quality of the diet matters more than one special meal. Still, nutrition before and after a procedure may help support energy, comfort, hydration, and recovery.

Two to Four Weeks Before Treatment

Begin building a whole-food diet before the scheduled procedure. Do not wait until the night before.

Focus on:

Protein at each meal
Colorful vegetables and fruit
Healthy fats
Whole-food carbohydrates
Adequate water
Regular meals
Reduced alcohol
Fewer fried and processed foods
Less added sugar

This period may also allow the care team to review blood sugar, vitamin levels, anemia, hydration, medications, and other factors that could influence recovery.

The 48 to 72 Hours Before PRP

PRP comes from the patient’s blood, so hydration and recent health habits may be important.

A practical pre-PRP plan may include:

Lean protein
Berries and citrus fruit
Leafy green vegetables
Bell peppers and broccoli
Fish, walnuts, or flaxseed
Whole grains
Water and approved electrolytes

Alcohol, excessive sugar, fried food, and heavily processed meals should generally be limited. Some clinicians also recommend a light meal before PRP rather than a large, greasy one.

Medication instructions must come directly from the treating provider. Do not stop aspirin, blood thinners, anti-inflammatory drugs, or other medications based only on an online nutrition article (Ubie Health, 2026a). r PRP or Another Regenerative Procedure

Continue eating balanced meals after treatment. The body will need protein, vitamin C, zinc, healthy fats, fluids, and enough total energy during the healing period.

A simple meal could include:

Grilled salmon, sweet potato, and broccoli
Chicken, brown rice, and mixed vegetables
Eggs, whole-grain toast, avocado, and berries
Lentil soup with a spinach salad
Greek yogurt with fruit, walnuts, and seeds

Nutrition supports healing, but it does not protect new tissue from excessive stress. Follow all instructions regarding rest, rehabilitation, lifting, exercise, and returning to normal activity.

Eating Around Chiropractic and Rehabilitation Visits

Most patients do not need a special diet before a chiropractic adjustment or rehabilitation session.

A light meal one to three hours beforehand may help prevent hunger, weakness, or low energy. Good options include:

Greek yogurt with berries
Eggs with whole-grain toast
Chicken with rice and vegetables
A banana with peanut butter
A low-sugar smoothie with protein and fruit

Avoid very large, greasy meals right before treatment. They may cause discomfort when lying face down, stretching, or performing exercises.

After rehabilitation, choose a meal containing protein, vegetables, and a healthy carbohydrate. This combination helps replace energy and provides building materials for tissue recovery.

Nutrition With MLS Laser and Shockwave Therapy

MLS laser therapy and shockwave therapy may be included in a larger musculoskeletal recovery plan. Nutrition does not change the energy produced by these treatments. Instead, it supports the tissues that are responding to care.

A patient receiving laser or shockwave therapy may still need:

Enough protein for tissue repair
Vitamin C for collagen production
Minerals such as zinc and magnesium
Healthy fats
Water
Controlled rehabilitation
Adequate sleep

Treatment works best as part of a coordinated plan. A procedure alone cannot correct poor movement habits, weak muscles, inadequate sleep, or a diet lacking essential nutrients.

Special Instructions Before Epidural Injections

Epidural injection instructions may be very different from the instructions for chiropractic care, laser therapy, or PRP.

When sedation is planned, patients may be instructed to:

Stop eating for a set period
Limit certain fluids
Arrange transportation
Adjust diabetes medication
Follow special blood-thinner instructions
Avoid driving after the procedure

The procedural team’s instructions always take priority over general nutrition advice. Do not eat or drink before an epidural injection until the clinic has confirmed whether fasting is required.

The ChiroMed Multidisciplinary Approach

ChiroMed – Integrated Medicine uses a multidisciplinary model in which different providers and treatments work together instead of creating several disconnected plans.

A coordinated ChiroMed injury-recovery plan may include:

Medical assessment and oversight
Chiropractic spine and joint care
Nurse practitioner services
Functional medicine
Nutritional guidance
Personal injury care
Physical rehabilitation
Massage and soft-tissue therapy
Spinal decompression
MLS laser therapy
Shockwave therapy
Pain-management coordination
Regenerative options when appropriate
Medical and legal injury documentation

The goal is to guide patients from pain and limited movement toward improved function, strength, mobility, and a safer return to daily activities. Clinical Oversight From Dr. Maria Guadalupe Cardenas

Dr. Maria Guadalupe Cardenas, MD, is Board Certified in Internal Medicine and has more than 40 years of experience as an internist. Clinic materials identify her as Medical Director and Collaborative Physician at Injury Medical Clinic PA.

Her listed professional information includes:

NPI: 1164426749
Texas MD license: J2933
Specialty: Internal medicine
Role: Medical Director and Collaborative Physician

Dr. Cardenas provides medical direction alongside Dr. Alex Jimenez, DC. This coordinated structure allows medical and chiropractic professionals to examine different parts of the patient’s health.

Medical oversight may be important when a patient has diabetes, high blood pressure, kidney disease, heart disease, medication concerns, abnormal laboratory findings, or other conditions that could affect healing or procedural safety. cal Observations From Dr. Alexander Jimenez

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, brings together chiropractic care, family nurse practitioner training, functional medicine, rehabilitation, personal injury care, and clinical documentation.

In his clinical observations, Dr. Jimenez emphasizes that an injury should not be viewed as only one painful joint or body part. Recovery may also be affected by:

Poor blood sugar control
Inadequate protein intake
Vitamin or mineral deficiencies
Poor sleep
High stress
Muscle weakness
Limited joint motion
Poor posture
Ongoing systemic inflammation
Returning to activity too quickly

A chiropractic adjustment may improve joint movement, but the body still needs nutrients to repair strained tissues. A regenerative procedure may provide repair signals, but rehabilitation is needed to guide the healing tissue. Exercise can rebuild strength, but poor nutrition may slow recovery.

This creates a clear step-by-step approach:

Identify the injured tissues and movement problems.
Review health conditions that may affect recovery.
Reduce pain and irritation.
Support the body with food, water, sleep, and medical care.
Restore motion through chiropractic and rehabilitation.
Rebuild strength and stability.
Return the patient to daily activities at a safe pace.

The ChiroMed model combines chiropractic care, medical oversight, functional medicine, personal injury services, rehabilitation, and regenerative options to support this larger recovery process. A Simple Healing Plate

A healing-focused meal does not need to be complicated.

Use this basic guide:

One-quarter protein: Fish, chicken, eggs, beans, lentils, or tofu
One-half produce: Leafy greens, vegetables, berries, or fruit
One-quarter quality carbohydrates: Brown rice, quinoa, oats, beans, or potatoes
A small serving of healthy fat: Olive oil, avocado, nuts, or seeds
Water: Drink regularly throughout the day

Supplements may help when a true deficiency is present, but more is not always better. Iron, vitamin D, zinc, omega-3 products, herbs, collagen, and other supplements may interact with medications or affect bleeding.

Patients should review supplements with their healthcare professional before a regenerative procedure, epidural injection, or medication change.

Supporting Healing From the Inside and Outside

Chiropractic care helps address movement, alignment, posture, and joint mechanics. Medical oversight helps identify health risks and manage conditions that may affect recovery. Regenerative therapies may stimulate a repair response. Rehabilitation helps the body regain strength and control.

Nutrition supports all these areas by providing the materials the body needs to heal.

The best recovery diet is not an extreme cleanse, a temporary fast, or a long list of expensive supplements. It is a steady whole-food plan based on protein, vegetables, fruit, healthy fats, quality carbohydrates, and adequate hydration.

At ChiroMed – Integrated Medicine in El Paso, this nutritional foundation can be coordinated with chiropractic care, medical oversight, functional medicine, personal injury care, rehabilitation, and related services. The goal is not only to reduce symptoms. It is to help the patient move better, heal more completely, and build a stronger foundation for long-term health.

References

Ascend Chiropractic Integrative Health Center. (2025, April 23). Eat to heal: How nutrition supports your chiropractic care.

ChiroMed. (n.d.-a). ChiroMed: Integrated medicine and holistic healthcare in El Paso, Texas.

ChiroMed. (n.d.-b). Integrated injury care in El Paso, Texas.

ChiroMed. (n.d.-c). Sciatica relief with regenerative medicine and chiropractic.

Global Stem Cell Care. (2026, June 24). Diet tips for platelet-rich plasma patients.

Herald Square Chiropractic and Sport. (n.d.). How smart diet choices can aid your physical therapy sessions.

Jimenez, A. (n.d.-a). Dr. Alex Jimenez, DC, APRN, FNP-BC.

Jimenez, A. (n.d.-b). Dr. Alex Jimenez professional profile.

Jimenez, A. (2026). Dr. Maria Cardenas, MD: Board-certified internal medicine specialist.

New Regeneration Orthopedics. (2025, April 4). Optimizing recovery: Why nutrition and supplements matter after PRP and bone marrow concentrate procedures.

Ospina Medical. (2025, January 15). Anti-inflammatory medication and PRP recovery: Why patience pays off.

Specialty Spine Care. (n.d.). Regenerative medicine diet and nutrition.

Ubie Health. (2026a, May 6). What to eat before PRP to maximize your growth factors.

Ubie Health. (2026b, May 6). How to fix slow healing: PRP and diet for the best results.

July 16, 2026

Clinical Application: Weight Management for Success

Find out how weight management techniques in a clinical application can support your journey towards a healthier weight.

Abstract: A Modern, Integrative Approach to Obesity Management

Obesity is a chronic, relapsing, and multifactorial disease that affects a staggering number of individuals worldwide. This educational post delves into the complexities of obesity, moving beyond outdated notions of willpower to explore its deep-seated neurobehavioral, metabolic, and genetic roots. We will examine the latest findings on the pharmacology of weight management, exploring how modern, evidence-based medications such as GLP-1 receptor agonists, GIP/GLP-1 therapies, naltrexone-bupropion, and others can serve as powerful tools in a comprehensive treatment plan. This discussion will highlight the critical need to combat weight bias in healthcare, which significantly hinders patient outcomes. Furthermore, we will explore how an integrative care model that combines advanced chiropractic techniques with internal medicine, functional medicine, and personalized rehabilitation provides a holistic and effective pathway for patients on their journey toward sustainable health. At our clinic, this collaborative approach is championed by Mr. Maria Guadalupe Cardenas, MD, and me, ensuring our patients receive comprehensive, multidisciplinary care.

Our Collaborative and Integrative Care Model in El Paso

At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas, we have cultivated a unique and powerful multidisciplinary environment designed to address complex health issues, such as obesity, from multiple angles. I am Dr. Alex Jimenez, and my expertise in chiropractic care, functional medicine, and Family Nurse Practitioner practice is complemented by the invaluable medical oversight of Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine and serves as our Medical Director and Collaborative Physician. With over 40 years of experience as an internist (NPI #1164426749, Texas MD License #J2933), she provides the essential medical framework for our integrative protocols.

This collaborative setup allows us to blend different disciplines for a truly holistic patient experience seamlessly:

Medical Oversight (Dr. Cardenas): Dr. Cardenas provides crucial medical direction, overseeing diagnoses and medication management, and ensuring that all treatments align with established medical safety and efficacy standards. Her role is vital, especially when considering pharmacotherapy for obesity and its related comorbidities such as hypertension, type 2 diabetes, and cardiovascular risk.
Chiropractic and Functional Medicine (Dr. Jimenez): My role involves focusing on the biomechanical and functional aspects of health. Through advanced chiropractic adjustments, we address musculoskeletal issues such as osteoarthritis, which is often exacerbated by excess weight. Using a functional medicine lens, we investigate the root causes of metabolic dysfunction, from gut health to hormonal imbalances, creating personalized nutritional and lifestyle strategies.
Integrated Services: Our team works cohesively to offer a spectrum of care that includes personal injury rehabilitation, physical therapy, and nutritional counseling. This allows us to create a unified treatment plan in which a patient can receive a chiropractic adjustment to alleviate back pain, consult with a provider on evidence-based weight-management medications under medical supervision, and receive a personalized nutrition plan, all within one coordinated system.

This team-based approach ensures that we treat the whole person, not just the symptoms, embodying the principles of modern, patient-centered integrative care. Patients are not isolated body parts; a patient with obesity, diabetes, back pain, and depression needs a coordinated strategy that respects the whole person.

Deconstructing Obesity: A Chronic and Complex Disease

We must begin by framing obesity correctly. It is not a simple matter of choice or a lack of discipline. Obesity is a chronic, progressive, relapsing, and treatable disease. This perspective is fundamental to how we approach patient care. When patients stop their anti-obesity medications, the weight often returns. This is no different than when a patient stops their antihypertensive medication, and their blood pressure rises, or when they stop chemotherapy and a malignancy returns. The condition relapses because it is chronic and deeply embedded in our physiology.

Obesity is profoundly multifactorial. It involves intricate neurobehavioral, neuroendocrine, and metabolic components. The accumulation of excess body fat promotes adipose tissue dysfunction, which is a key driver of the chronic inflammation and metabolic chaos associated with the disease. Obesity affects the body through several overlapping mechanisms:

Insulin resistance
Chronic low-grade inflammation
Leptin resistance
Altered appetite regulation
Reward pathway dysregulation
Mitochondrial dysfunction
Reduced skeletal muscle metabolic flexibility
Gut-brain signaling changes
Sleep disruption and cortisol imbalance
Mechanical overload on the spine, hips, knees, and feet

The consequences are far-reaching, impacting every system of the body:

Metabolic: Type 2 diabetes, dyslipidemia, hypertension.
Biomechanical: Osteoarthritis, back pain, incontinence.
Psychosocial: Depression, anxiety, social stigma, and discrimination.

In the United States, the statistics are sobering. 41.9% of the adult population meets the criteria for obesity (BMI ≥ 30), and a startling 9.2% have severe obesity (BMI ≥ 40). These numbers underscore the urgency of developing effective, accessible, and compassionate treatment strategies.

The Social and Environmental Drivers of Obesity

When we consider the roots of this epidemic, we must look beyond the individual to the broader environment. I often refer to the “social determinants of obesity” because factors like socioeconomic status, education, and environment play such a powerful role.

Economic Instability: For centuries, poverty was associated with being underweight. Today, the opposite is often true. In many impoverished areas, access to fresh, nutrient-dense food is limited, while calorie-dense, processed foods are cheap and abundant. This creates an environment where metabolic disease can thrive.
Neighborhood and Built Environment: If a person lives in a neighborhood where it is unsafe to walk outside, opportunities for regular physical activity are severely limited. The lack of green spaces, sidewalks, and recreational facilities contributes directly to a sedentary lifestyle.
Genetic and Hormonal Factors: We are identifying an ever-growing list of genetic and hormonal players that regulate appetite and metabolism, including ghrelin (the “hunger hormone”), GLP-1 (a satiety hormone), and leptin (which signals fullness). Research into the gut microbiota is also revealing how the balance of our intestinal flora can profoundly influence weight.
The Modern Environment: The rise of technology has engineered physical activity out of our daily lives. From desk jobs to digital entertainment, we are more sedentary than any previous generation.

Over the last decade, virtually every major medical organization, including the American Medical Association, has officially recognized obesity as a disease. This recognition is a critical step, as it validates the patient’s struggle and opens the door for proper diagnosis, treatment, and insurance coverage.

The Overwhelming Complexity of Appetite Regulation

The regulation of our appetite is an incredibly complex symphony conducted by the brain and a host of hormones. When you look at the intricate network of signals involved, it’s easy to see how a disruption in even one pathway can lead to dysfunction. Hormones like leptin, cortisol, ghrelin, and GLP-1 are in constant communication with the brain’s appetite centers, like the hypothalamus.

For many individuals with obesity, these signaling pathways are dysregulated. They may have leptin resistance, in which the brain doesn’t receive the “I’m full” signal, or ghrelin imbalances that drive persistent hunger. It becomes incredibly difficult for someone to “overpower” these potent neuroendocrine signals through willpower alone. This physiological reality is often overlooked, leading to significant clinical inertia.

Consider this shocking statistic: of the 100 million people with obesity in the United States, less than 1% receive a prescription for an anti-obesity medication. Less than 300,000 undergo bariatric surgery, despite 9.2% of the population having severe obesity. Why is there such a massive gap between the need for treatment and the care being provided? A large part of the answer lies in bias.

Binge Eating Disorder and the Physiology of Loss of Control Eating

A key concept in obesity care is recognizing binge eating disorder (BED). Binge eating disorder is not simply eating too much. It involves eating, within a discrete period of time, an amount of food larger than most people would eat under similar circumstances, combined with a sense of loss of control during the episode.

Clinically, binge eating episodes are often associated with several features:

Eating much more rapidly than normal
Eating until uncomfortably full
Eating large amounts when not physically hungry
Eating alone because of embarrassment
Feeling disgusted, depressed, guilty, or ashamed afterward
Marked distress about binge eating
Episodes occurring at least once weekly for at least three months
Absence of compensatory behaviors, such as purging, that would suggest bulimia nervosa

In practice, patients may describe getting up at night to eat while family members are asleep, hiding food, eating in the car, or waking up the next morning feeling shame and physical discomfort. I approach these disclosures with compassion because shame worsens the cycle. Patients need an evidence-based treatment plan, not judgment.

The physiology behind binge eating disorder involves dysregulation of:

Dopamine reward pathways
Impulse control circuits
Stress-related cortisol signaling
Serotonin and norepinephrine pathways
Prefrontal cortex regulation
Gut-brain satiety signaling
Emotional regulation networks

From a clinical standpoint, binge eating disorder can drive weight gain, worsen insulin resistance, aggravate depression and anxiety, and contribute to musculoskeletal pain because additional body mass increases mechanical load across the spine and joints.

Confronting Weight Bias: The Last Socially Acceptable Discrimination

Weight bias and stigma are perhaps the greatest barriers to effective obesity care. There is a pervasive, often unconscious, belief in our society—and even within the medical community—that obesity is a character flaw, a result of laziness or a lack of willpower. This prejudice is not only hurtful but also dangerous.

Research has shown that patients who experience weight bias have increased complications and mortality, independent of their BMI. The bias itself, through the stress it causes and the lack of care it fosters, becomes a risk factor. What drives this?

Lack of Reimbursement: Historically, treatments for obesity, especially medications, have not been well-covered by insurance, discouraging providers from offering them.
Time Constraints: Meaningful lifestyle counseling takes time, a luxury many providers in a fee-for-service model do not have.
Cultural Stigma: The belief that “people should just try harder” prevents us from treating obesity with the same seriousness as other chronic diseases.

This bias manifests in shocking ways. Imagine if we told patients with schizophrenia to “just stop listening to the voices.” It sounds absurd, yet we often tell patients with obesity to “just eat less and move more,” ignoring the powerful physiological drivers of their condition. We require extensive psychological screening for bariatric surgery patients—a practice not required for equally life-altering procedures like coronary artery bypass grafts—based on the biased assumption that overeating is purely a behavioral problem.

In a landmark Harvard study on implicit bias, weight bias was the only form found to increase over time. As providers, we must be the ones to break this cycle.

Shifting the Conversation: How to Engage Patients Effectively

The first step in combating bias is to change the way we talk to our patients. We need to approach the conversation with empathy, respect, and a genuine desire to help. The 5 A’s model provides a great framework:

Ask: “Is it okay if we talk about your weight and its potential effects on your health?” This simple question asks for permission and shows respect for the patient’s autonomy.
Assess: Take a detailed history. Understand their weight journey, family history, what they’ve tried in the past, and their understanding of how weight impacts health.
Advise: Provide clear, non-judgmental advice. Explain that even a modest weight loss of 3-5% can lead to significant improvements in blood pressure, blood sugar, and cholesterol.
Agree: Work with the patient to set realistic, achievable goals. What is a goal weight they feel is sustainable?
Arrange/Assist: Connect them with the resources they need. This could be a referral to a dietitian, an exercise program, or a discussion about pharmacotherapy or surgical options.

This approach transforms the conversation from one of judgment to one of partnership. Shared decision-making improves adherence because the patient becomes an active participant rather than a passive recipient.

A Framework for Treatment: Lifestyle, Medication, and Surgery

Our treatment approach is tiered and personalized, based on BMI and the presence of comorbidities (obesity-related health conditions). Current research strongly supports the idea that obesity should be treated as a chronic disease requiring ongoing monitoring, not as a temporary problem solved by short-term dieting. The Endocrine Society, American Gastroenterological Association, and American Diabetes Association emphasize that structured lifestyle therapy, medication when appropriate, and long-term follow-up are essential for improving outcomes (Apovian et al., 2015; American Diabetes Association Professional Practice Committee, 2026; Grunvald et al., 2022).

Lifestyle Interventions (BMI ≥ 25 with comorbidities, or ≥ 30): This is the foundation for everyone. It includes healthy eating, regular physical activity, and behavioral therapy. As a chiropractor and functional medicine practitioner, I often begin here, helping patients build a sustainable foundation. We focus on anti-inflammatory food plans, stress management techniques, and personalized exercise regimens that account for any musculoskeletal limitations.
Pharmacotherapy (BMI ≥ 27 with comorbidities, or ≥ 30): Medications should be considered for patients who have not reached their goals with lifestyle changes alone. These are not “magic pills” but powerful tools to aid the biological processes of appetite and metabolism.
Bariatric Surgery (BMI ≥ 35 with comorbidities, or ≥ 40): For individuals with severe obesity, surgery remains the most effective long-term treatment for significant weight loss and remission of comorbidities. It is a vital option that is tragically underutilized. A shocking 71% of providers never discuss surgical options with eligible patients.

Our goal is typically a 5-10% reduction in total body weight over six months. This level of weight loss is clinically significant and can dramatically reduce health risks.

Why “First, Do No Harm” Matters in Obesity Treatment

One of the most important principles I use in integrative obesity care is “first, do no harm.” Before adding a new medication or supplement, I want to understand whether the patient is already taking medications that may be contributing to weight gain. Common obesogenic medications may include:

Antidepressants and Antipsychotics: (e.g., some SSRIs, mirtazapine, olanzapine)
Anticonvulsants/Mood Stabilizers: (e.g., valproate, gabapentin)
Antidiabetic Agents: (e.g., sulfonylureas, insulin)
Corticosteroids: (e.g., prednisone)
Certain beta-blockers
Certain antihistamines
Some hormonal therapies

Shockingly, patients with obesity are often prescribed these medications more frequently. If a patient is on one of these drugs and struggling with their weight, we collaborate with their prescribing physician to see if a weight-neutral or weight-loss-promoting alternative exists. For instance, a patient with diabetes on a sulfonylurea like glyburide might be a candidate for a GLP-1 receptor agonist or an SGLT2 inhibitor, which can aid in weight loss. This is a perfect example of how the collaboration between Dr. Cardenas and me benefits the patient, ensuring patient safety and optimized outcomes.

Modern Pharmacotherapy for Weight Management

The good news is that we now have a growing arsenal of safe and effective long-term medications for obesity. All approved medications are more effective than placebo. A 12-week trial is often sufficient to determine whether a medication is working for a patient. If a patient does not achieve at least a 5% reduction in body weight after approximately 3 months at a therapeutic dose, we reassess the plan.

Here is an overview of some key long-term options:

Phentermine/Topiramate (Qsymia): This combination drug pairs a well-known appetite suppressant (phentermine) with an anticonvulsant (topiramate) that also reduces appetite and may lower leptin levels. Because phentermine can stimulate the sympathetic nervous system, increasing heart rate and blood pressure, it requires careful dose titration and monitoring, especially in patients with cardiovascular concerns.
Naltrexone/Bupropion (Contrave): This combination works on the brain’s reward and appetite-control centers. Bupropion stimulates the POMC system to reduce appetite, while naltrexone blocks an inhibitory feedback loop, allowing the appetite-suppressing effect to persist. This may be particularly useful for patients with co-occurring depression or reward-driven eating patterns.
Orlistat: This medication works by inhibiting gastrointestinal lipases, thereby reducing the absorption of dietary fat. It is a non-stimulant option but can cause gastrointestinal side effects and may interfere with the absorption of fat-soluble vitamins (A, D, E, K), requiring monitoring.
Liraglutide (Saxenda): A daily injectable GLP-1 receptor agonist. GLP-1 is a natural gut hormone that slows stomach emptying, promotes feelings of fullness (satiety), and acts on the brain’s appetite centers. It is started at a low dose and titrated up to 3.0 mg daily to manage potential GI side effects like nausea.
Semaglutide (Wegovy): A weekly injectable GLP-1 receptor agonist. It works similarly to liraglutide but has a longer half-life, allowing for once-weekly dosing. It has demonstrated even greater weight loss in clinical trials, with an average loss of approximately 15% of body weight (Blundell et al., 2017; Wilding et al., 2021). It is important to note that semaglutide is sold as Ozempic for type 2 diabetes and Wegovy for chronic weight management; they are the same molecule but have different indications and dosing.
Tirzepatide (Zepbound): A novel weekly injectable that is a dual GIP/GLP-1 receptor agonist. By targeting two different incretin hormone pathways, it produces a powerful synergistic effect on appetite suppression and glucose control. Clinical trials have shown unprecedented levels of weight loss, with some participants achieving more than a 20% reduction in body weight (Jastreboff et al., 2022). This potent therapy may be particularly appropriate for patients with severe obesity.
Lisdexamfetamine (Vyvanse): While not approved for general obesity, this medication is FDA-approved for moderate to severe binge eating disorder (BED). Since BED is a common co-occurring condition in patients with obesity, identifying and treating it can be a critical part of the overall weight management strategy. It works on dopamine and norepinephrine pathways to improve impulse control (McElroy et al., 2015).

Emerging Obesity Medications and Future Directions

The obesity medicine pipeline is advancing quickly. Researchers are studying therapies that may produce even more substantial weight loss while improving metabolic markers. Emerging therapies include:

Retatrutide: A triple agonist targeting GLP-1, GIP, and glucagon receptors, which has shown very large weight reduction percentages in trials (Jastreboff et al., 2023).
Oral GLP-1 agonists: Medications like orforglipron and danuglipron are being developed to provide an oral alternative to injections.
Combination therapies: CagriSema, a combination of cagrilintide and semaglutide, is being studied for its synergistic effects on appetite and metabolism.

Discovering the Benefits of Chiropractic Care- Video

The Role of Integrative Chiropractic Care in Weight Management

So, where does integrative chiropractic care fit into this modern, medical approach? It is a crucial component of our holistic model, addressing the biomechanical consequences of excess weight and enhancing the body’s ability to heal and adapt.

Addressing Biomechanical Pain: Excess weight places tremendous stress on the musculoskeletal system, leading to conditions like osteoarthritis, degenerative disc disease, and chronic back and joint pain. In my clinical observations, I frequently see patients whose weight-related concerns overlap with low back pain, sciatica, and knee pain. This pain creates a vicious cycle: it hurts to move, so the person becomes more sedentary, which can lead to further weight gain. Through precise chiropractic adjustments, spinal decompression, and soft tissue therapies, we can alleviate pain, improve joint function, and restore mobility. This enables patients to engage in the physical activity essential for weight loss.
Improving Neurological Function: The spine houses the central nervous system, which is the master controller of all bodily functions, including metabolism and hormonal regulation. By correcting spinal misalignments (subluxations), we can reduce interference in the nervous system, potentially improving the body’s ability to self-regulate and heal.
Functional Medicine and Lifestyle Coaching: As a practitioner certified in functional medicine, I look beyond the symptoms to find the underlying root causes of dysfunction. We may use advanced testing to assess gut health, hormonal imbalances, or nutrient deficiencies that contribute to weight gain. Based on these findings, we develop highly personalized nutrition plans, stress-reduction protocols, and targeted supplement recommendations to optimize metabolic function from the inside out.
Rehabilitation and Muscle Preservation: A major concern with weight loss, particularly rapid loss, is the loss of lean muscle mass. Muscle is critical for resting metabolic rate, glucose disposal, and long-term weight maintenance. My clinical approach, as reflected on my professional platforms like ChiroMed and my LinkedIn profile, emphasizes a rehabilitation-focused plan that includes progressive resistance training, core stabilization, and balance work to preserve this metabolically active tissue. Movement is metabolic medicine.

By integrating these approaches under the medical direction of Dr. Cardenas, we ensure that the patient is supported on every level—structurally, neurologically, metabolically, and medically.

Final Clinical Takeaway

If there is one concept I want patients and clinicians to remember from this post, it is this: obesity care must be individualized, medically safe, and integrated. Before adding a medication, we must ask whether current medications are worsening weight gain. Before recommending exercise, we must ask whether pain, injury, or joint dysfunction is limiting movement. Before assuming noncompliance, we must ask whether binge eating disorder, depression, anxiety, or sleep apnea are present.

With the collaborative oversight of Dr. Maria Guadalupe Cardenas, MD, and the integrative chiropractic, functional medicine, and rehabilitation services I provide, our El Paso practice model is designed to evaluate the whole patient. Modern obesity medicine is no longer about simply telling people to eat less and move more. It is about understanding physiology, reducing harm, improving function, supporting the nervous and musculoskeletal systems, and applying evidence-based tools with compassion and precision. This is the future of effective and compassionate obesity care.

References

American Diabetes Association Professional Practice Committee. (2026). Standards of Care in Diabetes 2026. Diabetes Care.
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015). Pharmacological management of obesity: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 100(2), 342–362. https://doi.org/10.1210/jc.2014-3415
Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J. (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity & Metabolism, 19(9), 1242–1251.
Grunvald, E., Shah, R., Hernaez, R., Chandar, A. K., Pickett-Blakely, O., Teigen, L. M., Yanovski, S. Z., & Singh, S. (2022). AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology, 163(5), 1198–1225. https://doi.org/10.1053/j.gastro.2022.08.045
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine, 387(3), 205–216.
Jastreboff, A. M., Kaplan, L. M., Frías, J. P., Wu, Q., Du, Y., Gurbuz, S., Coskun, T., Haupt, A., Milicevic, Z., Hartman, M. L., & Retatrutide Phase 2 Obesity Trial Investigators. (2023). Triple-hormone-receptor agonist retatrutide for obesity: A phase 2 trial. The New England Journal of Medicine, 389(6), 514–526. https://doi.org/10.1056/NEJMoa2301972
McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., Wang, J., Whitaker, T., Jonas, J., & Gasior, M. (2015). Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder. JAMA Psychiatry, 72(3), 235–246. https://doi.org/10.1001/jamapsychiatry.2014.2162
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002.

SEO Tags: Obesity Management, Integrative Care, Chiropractic, Functional Medicine, Weight Loss Medication, Semaglutide, Tirzepatide, Weight Bias, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas MD, El Paso, TX, Chronic Disease, Pharmacotherapy, Lifestyle Intervention, Adipose Tissue Dysfunction, Appetite Regulation, GLP-1 Agonists, Binge Eating Disorder, Lisdexamfetamine, Collaborative Healthcare, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, metabolic health, personal injury rehabilitation, chiropractic weight loss support, prediabetes, type 2 diabetes, obesity treatment, musculoskeletal pain, rehabilitation, internal medicine collaborative care, El Paso Texas healthcare

Category: Advanced Practice Registered Nurses (APRN)

Integrative Platelet-Rich Plasma Care for Scalp, Joint, and Skin

A Practical, Evidence-Based Guide from the Procedure Room

Abstract

Integrative PRP and Peptide Therapy: A First-Person Walkthrough

Key steps I emphasize during PRP prep

Why Separator Gel Contact Matters: The Physiology and Physics

Patient Sensations During Scalp PRP: What They Feel and Why

Adding Peptides and Topical Carriers: Synergy with PRP

PRP for Joints and Soft Tissue: Mechanisms that Matter

Physiologic mechanisms

Integrative Chiropractic Care in a Multidisciplinary PRP Framework

How we integrate care

Clinical Workflow: Reasoning Behind Each Protocol

Patient Experience: Comfort Measures that Matter

Evidence Base: What Modern Research Shows

Why Integrative Chiropractic Fits: Biomechanics Meet Biology

Safety, Oversight, and Ethical Practice

Practical Tips We Use Every Day

Clinical Observations from My Practice

The Team Behind the Care

Takeaways for Patients and Clinicians

References

PRP Therapy Overview on Plantar Fasciitis & The Achilles Tendon

Educational Abstract: Integrative Achilles Tendon and Plantar Fascia Care in a Modern Multidisciplinary Clinic

Integrative Clinical Framework: Collaborative Care for Foot and Ankle Pain

Achilles Tendinopathy and Plantar Fasciitis: Why Precision Matters

Anatomy Essentials: The Achilles, Gastrocnemius, Soleus, and Plantar Fascia

Pathophysiology: Tendinopathy, Tendinosis, and Fasciopathy

Evidence-Based Rationale: PRP, Prolotherapy, and Rehabilitation

Safety First: Aspiration, Needle Orientation, and Avoiding Vascular Injury

Integrative Chiropractic Care in Foot and Ankle Disorders

Step-by-Step Technique: Finding the Achilles Entry Point and Bifurcation

Medial and Lateral Calcaneal Targets: Plantar Fascia Interface

Why Not the Heel Fat Pad: Risks and Long-Term Consequences

Prolotherapy vs PRP: Practical Protocols and Expectations

Rehabilitation: Eccentric Loading, Stretching, and Motor Control

Clinical Observations and Practice Insights

Procedure Safety: Aspiration and Injection Checks

Managing Morning Pain: Night Positioning and Behavioral Strategies

Functional Medicine Layer: Systemic Influencers of Tendon Healing

Imaging: Ultrasound Guidance Elevates Precision

Patient Education: Setting Expectations and Building Confidence

Case Flow: A Typical Integrative Visit

Evidence Threads: Modern, Rigorous Methods

Clinical Pearls: Tactile Feedback and Tissue Planes

Outcome Targets and Metrics

Personal Injury Context: Documentation and Communication

Practical Load Progressions

Orthoses and Footwear

Manual Therapy and Soft Tissue Care

Nerve Considerations: Tibial, Sural, and Plantar Branches

Activity Modification and Return to Sport

When Surgery Is Considered

Pediatric and Adolescent Considerations

Older Adults: Vascular and Comorbidity Awareness

Practical Troubleshooting

Patient Stories and Expectations

How Our Team Works: Roles and Collaboration

Practical Checklist for Clinicians

Research Integration and Continuous Improvement

Final Takeaways

References

The Future of Regenerative Medicine: Peptides, Aesthetics, and Integrative Chiropractic Care

Abstract

The Integrative Clinical Model: Bridging Chiropractic Care and Medical Oversight

Understanding Biological Messengers: Peptides and Bioregulators

A Brief History of Peptides in Medicine

The Science of Delivery: Enhancing Bioavailability and Efficacy

Strategic Weight Management: The GLP-1 Agonist Evolution

Comprehensive Hair Restoration: Reawakening the Follicles

Regenerative Aesthetics: Beyond Topical Skincare

Neurological Optimization and Longevity: Bioregulators in Practice

Oral Formulations and Targeted Healing Protocols

The Peptide Protocol Portal and AI Integration

My Personal Journey with Regenerative Healing

Conclusion

References

Musculoskeletal Health Innovations for Regenerative Medicine

Abstract